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Abstract 
 
Angiogenesis is characterized by the sprouting of new vessels from pre-existing 
ones, with sprouts headed by a specialized endothelial cell (EC) known as the tip cell. 
The trailing ECs are referred to as stalk cells and help form the vessel proper and 
lumenize. Newly formed sprouts must come into contact with adjacent tip cells via 
filopodia to fuse and lumenize to form an additional functional vessel loop able to 
support blood flow. Here I describe the process of anastomosis in detailed spatial and 
temporal resolution. Interestingly tip cells do no necessarily form a new connection at 
their first contact but tend to have a “negotiation” phase whilst tip cells are in contact. 
This time delay is between 1 hour and 2.5 hours suggesting a possible genetic 
regulation of anastomosis. Interestingly cessation of filopodia activity is observed upon 
lumenization of the sprouts and not on the establishment of cell junctions. 
A gene important in fusion cells in Drosophila tracheal morphogenesis (the 
equivalent of EC tip cells) was investigated for its role in angiogenesis and anastomosis. 
Knockdown of heca, the homologue of the drosophila headcase gene, leads to 
precocious and ectopic connections between the Dorsal Lateral Anastomotic Vessels 
(DLAVs) over the neural tube in zebrafish embryos. Heca’s function does not appear 
dependent on the TGF/BMP pathway as in the trachea. Gain of function experiments at 
the whole organism and cell-autonomous level show that Heca overexpression leads to 
complete lumenization of some of the migrating intersegmental vessels by 26hpf. 
This suggests that heca’s possible involvement in instructing ECs to form a 
lumen or to sense the level of oxygenation/requirement to decrease activity may explain 
the opposing phenotypes observed. Taken together with observations about lumen 
formation with initiation of flow and the termination of filopodia activity, the data here 
presented could mean that lumenization is involved dampening EC activation. 
 
 5 
Acknowledgement 
 
I would like to begin to thank all the people at Cancer Research UK that do their very 
best in running the Charity, and have allowed me such a privileged experience here at 
the London Research Institute. With this, I must not forget all the thousands of 
supporters and volunteers that are the backbone of the Charity’s success. 
I owe an awful lot to Holger Gerhardt for placing his confidence in me almost 5 years 
ago and welcomed me into the VBL. I received immense support from you for all these 
years, while also allowing me the freedom to learn, develop and mature my scientific 
methodology and thinking. You have been a great mentor and I hope our paths will 
cross many times in the future so that I can repay you. And it seems you didn’t 
appreciate too much your first male student, as the following 3 are now girls! 
My time here has been so enjoyable also because of the family that I had the pleasure of 
joining, the VBL. I might have had to break the ice with a group hug but form then on it 
went splendidly. Thanks to past members: Li-Kun, Denise, Lars and Marta. To the 
current members: Benni, Irene, Raquel, Eleonora, Katie, Russ, Claudio and Martin you 
guys were wonderful to work around (most of the time) and congratulations for having 
survived my abuse for so long, I doubt there are better labs out there. Dominique and 
Jane, you’ve had the pleasure of seeing me grow (and regress mentally), you’ve been 
great support and fun throughout. Not to forget the sister lab, LDL. Good to have 
another perspective on almost anything.  
Thanks to all my classmates especially Sophie, Caroline and Anna. Having someone 
complaining to you and to complain to is very therapeutic, you girls are awesome. A big 
thank you to all the people in the Institute that I’ve been able to interact with 
scientifically and socially, it has all helped to heighten the experience. 
The work presented here would not have been possible without the help received from 
Peter Jordan in Light Microscopy; Phil Taylor, Darren Martin and Chris Seargent in the 
fish facility; Sue, Claire and all those who have helped along the way at the mouse unit 
in Clare Hall and Lucy and Hannah in the EM unit, great science with great smiles, the 
 6 
perfect collaborators. Sally, Emma, Nicola and the rest of the admin and assistants team 
always ready to lend a hand wherever possible, and of course all the support staff. 
Thanks also to the many external collaborators: Richard Lang’ group, Andy Bushby’s 
group and Tim Chico’ group have all helped out in the work in some way or another.   
Last but not least thanks to my parents and my sister for always allowing me to do as I 
please and trying to understand all about my work.  
Of course it must not be forgotten why so many of us strive to understand more about 
cancer and ways to cure it, therefore I dedicate this work to all those patients who suffer 
and show great bravery dealing with cancer. Hopefully all our little pieces of the puzzle 
will help them all one day. 
 
 
 7 
Table of Contents 
 
Abstract ................................................................................................................ 4	  
Acknowledgement .............................................................................................. 5	  
Table of Contents ................................................................................................ 7	  
Table of figures ................................................................................................. 10	  
List of tables ...................................................................................................... 12	  
Abbreviations .................................................................................................... 13	  
Chapter 1.	   Introduction .................................................................................. 15	  
1.1	   Vascular Development ....................................................................................... 16	  
1.2	   Angiogenesis ........................................................................................................ 18	  
1.3	   Models for the Study of Sprouting Angiogenesis ............................................ 19	  
1.3.1	   The mouse post-natal retina .......................................................................... 19	  
1.3.2	   The Zebrafish Intersegmental Artery Sprouting ........................................... 22	  
1.3.3	   Embryoid Body Sprouting Assay ................................................................. 26	  
1.4	   Mechanism of Sprouting Angiogenesis ............................................................ 28	  
1.5	   VEGF Signalling in Angiogenesis ..................................................................... 29	  
1.6	   Delta/Notch Signalling in Tip Cell selection and Angiogenesis ...................... 36	  
1.6.1	   The Notch Pathway ....................................................................................... 36	  
1.6.2	   Notch Signaling in Angiogenesis .................................................................. 37	  
1.6.3	   CSL-independent Notch activity ................................................................... 40	  
1.7	   Repulsive cues in angiogenesis .......................................................................... 41	  
1.7.1	   Semaphorins/Plexins ..................................................................................... 41	  
1.7.2	   Eph Receptors/Ephrins .................................................................................. 43	  
1.7.3	   Netrins/Unc5B and Slits/Robos .................................................................... 46	  
1.8	   Macrophages in Angiogenesis ........................................................................... 48	  
1.9	   Tubulogenesis and Lumen Formation ............................................................. 51	  
1.10	   Endothelial Cell Junctions ................................................................................. 56	  
1.11	   A Model of Tubulogenesis – Drosophila Tracheal Morphogenesis ............... 60	  
1.11.1	   Initiation of sprouting .................................................................................... 60	  
1.11.2	   Sprout elongation and tip cell selection ........................................................ 63	  
1.11.3	   Terminal Differentiation ............................................................................... 64	  
1.11.4	   Sprout fusion/anastomosis ............................................................................ 65	  
1.11.5	   Headcase ....................................................................................................... 68	  
1.12	   Summary ............................................................................................................. 71	  
1.13	   Aims of PhD ........................................................................................................ 71	  
Chapter 2.	   Materials and Methods ................................................................ 72	  
2.1	   Zebrafish Experiments ...................................................................................... 72	  
2.1.1	   Transgenic lines ............................................................................................ 72	  
2.1.2	   Morpholino Microinjection ........................................................................... 73	  
2.1.3	   Microangiography ......................................................................................... 74	  
2.1.4	   Cell Proliferation Assay ................................................................................ 74	  
2.1.5	   Wholemount in situ hybridization ................................................................. 74	  
2.1.6	   Wholemount Immunolfuorescence antibody staining .................................. 77	  
2.1.7	   Confocal microscopy .................................................................................... 79	  
2.1.8	   Reverse-Transcription PCR .......................................................................... 79	  
 8 
2.1.9	   Quantitative Relative PCR ............................................................................ 80	  
2.1.10	   3-Dimensional Electron Microscopy ............................................................ 80	  
2.2	   Embryoid Body Assays ...................................................................................... 83	  
2.2.1	   ESC Spheroid formation, Differentiation and Sprouting in Collagen .......... 83	  
2.2.2	   Immunostaining ............................................................................................ 85	  
2.3	   bEND5 assays ..................................................................................................... 86	  
2.3.1	   Quantitative PCR .......................................................................................... 86	  
2.4	   Mouse experiments ............................................................................................. 86	  
2.4.1	   Whole mount immunostaining ...................................................................... 86	  
Chapter 3.	   Qualitative and Quantitative Observation of Zebrafish 
Angiogenesis ..................................................................................................... 87	  
3.1.1	   Filopodia along the ISA suggests all ECs have some level of activation ..... 87	  
3.1.2	   Changes in EC morphology during ISA migration ....................................... 92	  
3.1.3	   Tip cell proliferation does not affect sprout elongation ................................ 93	  
3.1.4	   Qualitative and quantitative observations of tip cell anastomosis ................ 98	  
3.1.5	   Lumen formation ......................................................................................... 104	  
3.2	   3-Dimensional Electron Microscopy .............................................................. 109	  
3.2.1	   FIB/SEM setup ............................................................................................ 110	  
3.2.2	   Identification and 3D Reconstruction of ISA Anastomosis through 
Correlative Confocal – FIB/SEM Imaging ............................................................. 114	  
3.2.3	   Ultrastructure of the Formed DLAV using SBF/SEM ................................ 117	  
3.2.4	   3D EM dataset contain a wealth of information ......................................... 119	  
3.3	   Discussion .......................................................................................................... 120	  
3.3.1	   All ECs in Sprouting ISA exhibit some level of activation ........................ 120	  
3.3.2	   Adaptive morphological changes ................................................................ 122	  
3.3.3	   Tip cell Proliferation does not Affect Tip cell Selection and Migration ..... 124	  
3.3.4	   Mechanism of Lumen Formation ................................................................ 126	  
3.3.5	   Anastomosis in Angiogenesis ..................................................................... 127	  
3.3.6	   3 Dimensional EM techniques in Angiogenesis ......................................... 130	  
3.3.7	   Future Directions ......................................................................................... 131	  
Chapter 4.	   The Role of heca in angiogenesis and lumen formation ....... 134	  
4.1.1	   Knockdown of heca in zebrafish embryos leads to early cross over of the 
DLAVs .................................................................................................................... 134	  
4.2	   Heca overexpression leads to early lumenization of migrating sprouts ...... 139	  
4.2.1	   Migrating sprouts lumenize precociously due to heca expression .............. 139	  
4.2.2	   Cell cluster phenotype is a result of increased cell numbers ...................... 140	  
4.2.3	   Cell adhesions in ectopic lumen formation ................................................. 144	  
4.3	   Heca expression ................................................................................................ 145	  
4.3.1	   Zebrafish ..................................................................................................... 145	  
4.3.2	   Heca expression in mouse retinal vasculature and embryoid bodies .......... 155	  
4.3.3	   Possible Regulation of Heca ....................................................................... 156	  
4.4	   Discussion .......................................................................................................... 167	  
4.5	   Future Directions ............................................................................................. 171	  
Chapter 5.	   Macrophages in Angiogenesis ................................................. 172	  
5.1	   Macrophages in retinal vasculature ............................................................... 172	  
5.2	   Macrophages interact with ECs during DLAV formation ........................... 178	  
5.3	   Loss of macrophages leads to delay in anastomosis ...................................... 178	  
5.4	   Discussion .......................................................................................................... 183	  
 9 
5.4.1	   Macrophages actively interact with ECs during anastomosis ..................... 183	  
5.4.2	   Future Directions ......................................................................................... 185	  
Chapter 6.	   Conclusion ................................................................................. 186	  
Chapter 7.	   Reference List ............................................................................ 188	  
 10 
Table of figures 
 
Figure 1.1 Vasculogenesis and the formation of the primary capillary plexus. .............. 17	  
Figure 1.2 Sprouting Angiogenesis and Anastomosis. ................................................... 20	  
Figure 1.3 Mouse post-natal retinal angiogenesis. .......................................................... 21	  
Figure 1.4 Zebrafish Vascular Development. ................................................................. 23	  
Figure 1.5 ES cell embryoid body sprouting assay. ........................................................ 27	  
Figure 1.6 Tip / stalk cells and the role of Dll4/Notch signalling in tip cell selection. .. 30	  
Figure 1.7 Vascular Endothelial Growth Factor family and Receptors. ......................... 33	  
Figure 1.8 The involvement of repulsive cues in angiogenesis. ..................................... 44	  
Figure 1.9 Models for vascular lumen formation. ........................................................... 52	  
Figure 1.10 Endothelial Cell junctional complexes. ....................................................... 59	  
Figure 1.11 Drosophila tracheal morphogenesis. ............................................................ 62	  
Figure 1.12 Pathways involved in control of tracheal sprouting and fusion/terminal cell 
fate determination. .................................................................................................. 66	  
Figure 1.13 Fig 1.13 Protein sequence alignment of heca. ............................................. 69	  
Figure 2.1 flk1:mG construct map .................................................................................. 72	  
Figure 3.1 ISA sprouting from DA. ................................................................................ 88	  
Fig 3.2 Filopodia Projections present on stalk cells. ....................................................... 89	  
Fig 3.3 Close up of ECs squeezing upon reaching neural tube ....................................... 90	  
Fig 3.4 Intracellular trafficking of vacuoles and filaments towards the sprouting front . 94	  
Fig 3.5 Tip cells proliferate in zebrafish ISAs. ............................................................... 96	  
Fig 3.6 Anastomosing cells can undergo division without affecting connectivity of cells.
 ................................................................................................................................. 97	  
Fig 3.7 Filopodia contacts between adjacent ISAs prior to anastomosis. ....................... 99	  
Fig 3.8 Anastomosis parameters for quantification. ..................................................... 100	  
Fig 3.9 Quantitative parameters of anastomosis. .......................................................... 101	  
Fig 3.10 Comparison of quantitative parameters from in vivo and in silico experiments
 ............................................................................................................................... 102	  
Fig 3.11 Lumen formation by EC junction opening ..................................................... 106	  
Fig 3.12 Lumen formation by a mechanism that might involve intracellular lumen 
formation. .............................................................................................................. 107	  
Fig 3.13 Cell proliferation in lumenized vessel. ........................................................... 108	  
Fig 3.14 FIB/SEM setup. .............................................................................................. 111	  
Fig 3.15 Localisation of ISA by FIB/SEM ................................................................... 113	  
Fig 3.16 Anastomosis of the DLAV by correlative fluorescence confocal and FIB/SEM.
 ............................................................................................................................... 115	  
Fig 3.17 CurveSlice to improve visualization of EC connection. ................................. 116	  
Fig 3.18 Ultrastructure of the formed DLAV. .............................................................. 118	  
Fig 3.19 3D Reconstruction of neuronal projections in a FIB/SEM dataset originally 
collect for a vascular study. ................................................................................... 119	  
Figure 4.1 Heca gene structure ...................................................................................... 136	  
Figure 4.2 Knockdown of heca expression does not lead to general vasculogenic or 
angiogenic abnormalities. ..................................................................................... 138	  
Figure 4.3 Early crossover of DLAVs is observede upon decreased heca expression. 141	  
 11 
Figure 4.4 No general developmental defects are induced by moderate heca 
overexpression. ..................................................................................................... 142	  
Figure 4.5 Heca overexpression leads to early ISA lumenization. ............................... 143	  
Figure 4.6 Endothelial cell autonomous effect of Heca on ISA lumenization. ............. 146	  
Figure 4.7Lumen phenotype observed in Heca overexpressing embryos is open lumen 
connected with trunk circulation. .......................................................................... 147	  
Figure 4.8 Heca overexpression leads to cell clumping due to increase in the number of 
ECs per ISA. ......................................................................................................... 148	  
Figure 4.9 Extreme case of nuclei crowding at leading edge of ISA in Heca 
overexpressing embryo. ........................................................................................ 149	  
Figure 4.10 Adhesions in heca overexpressing embryos. A-A’’’. ................................ 150	  
Figure 4.11 heca in situ hybridization reveals weak expression. .................................. 151	  
Figure 4.12 Heca expression in the trunk seem concentrated in the somites. .............. 152	  
Figure 4.13heca is expressed throughout zebrafish embryonic development. .............. 153	  
Figure 4.14Custom Heca antibody staining of zebrafish embryos. .............................. 154	  
Figure 4.15 Heca is present in ECs and astrocytes within mouse retinal vasculature. . 158	  
Figure 4.16 Heca is present in EC in EB sprouting assay. ............................................ 159	  
Figure 4.17 Evidence of BMP signalling zebrafish. ..................................................... 160	  
Figure 4.18 BRE-RFP reporter line shows similar BMP signalling activity as P-Smad 
1/5/8 immunofluorescence. ................................................................................... 161	  
Figure 4.19 Snail in zebrafish. ...................................................................................... 162	  
Figure 4.20 BMP4 is present in close association with ECs in retinal vasculature. ..... 164	  
Figure 4.21 EB response to different signalling inhibitors. .......................................... 165	  
Figure 4.22 EB TGF-β stimulation leads to increased differentiation of pericytes with 
poor attachment. .................................................................................................... 166	  
Figure 5.1 Microglia interact with tip cells in mouse retinal vasculature. .................... 173	  
Figure 5.2 Macrophages interact with endothelial cell filopodia in zebrafish developing 
ISAs. ...................................................................................................................... 174	  
Figure 5.3 Macrophages aid the correct fusion and maturation of failing anastomoses.
 ............................................................................................................................... 176	  
Figure 5.4 Macrophage guides contact of filopodia between two anastomosing tip cells.
 ............................................................................................................................... 177	  
Figure 5.5 Filopodia actively grow towards macrophages by abrupt changes in filopodia 
direction. ............................................................................................................... 179	  
Figure 5.6 Macrophage depletion through loss of pu.1 leads to ISA morphology defects 
and delay in anastomosis. ...................................................................................... 181	  
Figure 5.7 Loss of macrophages through two other strategies leads to similar ISV 
defects. A. ............................................................................................................. 182	  
 
 
 12 
List of tables 
 
Table 2-1 Morpholino oligonucleotide sequences .......................................................... 73	  
Table 2-2 Primer pairs used to generate fragments for in situ probe generation ............ 75	  
Table 2-3 Antibodies used for immunofluorescence ...................................................... 77	  
Table 2-4 Peptides used for immunization to generate anti-Heca antibodies ................. 79	  
Table 2-5 Primers to test heca knockdown by RT-PCR .................................................. 80	  
Table 2-6 Taqman qPCR probes used for gene expression assays ................................. 80	  
Table 2-7 Recipe for ES medium (and EB) .................................................................... 84	  
Table 2-8 Collagen gel recipe for EB sprouting assay for 15 wells ................................ 85	  
Table 3-1 Summary of quantitative parameters of anastomosis ................................... 100	  
 13 
Abbreviations 
 
Ang1-­‐2	   Angiopoetin	  1-­‐2	   	  
bFGF	   basic	  Fibrobalst	  Growth	  Factor	  
bHLH	   Basic	  Helix-­‐Loop_Helix	   	  
BM	   Basement	  membrane	  	   	  
CNS	   Central	  Nervous	  System	   	  
COUP-­‐TFII	   Chicken	  ovalbumin	  upstream	  promoter-­‐transcription	  factor	  II	  
CSL	   CBF/Suppressor	  of	  Hairless/Lag2	  
DA	  	   Dorsal	  Aorta	   	  
DLAV	   Dorsal	  Lateral	  Anastomotic	  Vessel	  
Dll1	   Delta-­‐like	  1	   	   	  
Dll3	   Delta-­‐like	  3	   	   	  
Dll4	   Delta-­‐like	  4	   	   	  
DSL	   Delta,	  Serrate,	  Lag2	   	  
EC	   Endothelial	  cell	   	  
ECM	   Extracellular	  matrix	   	  
EGF	   Epidermal	  growth	  factor	   	  
eGFP	   Enhanced	  Green	  fluorescent	  protein	  
Flt1/VEGFR1	   FMS-­‐like	  tyrosine	  kinase	  1/	  VEGF	  receptor	  1	  
Flt4/VEGFR3	   FMS-­‐like	  tyrosine	  kinase	  4	  /VEGF	  receptor	  3	  
Hes	   Hairy/Enhancer	  of	  Split	   	  
Hey	   Hes-­‐related	  protein	   	  
hpf	   hours	  post	  fertilization	   	  
HSPG	   Heparan	  sulfate	  proteoglycan	  
ISA	   Intersegmetnal	  Artery	   	  
ISH	   In	  situ	  hybridization	   	  
ISV	  	   Intersegmetnal	  Vein	   	  
Jag1/2	   Jagged	  1/2	   	   	  
 14 
JAM	   Junctional	  adhesion	  molecule	  
Kdr/flk1/VEGFR2	  
Kinase	  insert	  domain	  protein	  receptor/fetal	  liver	  kinase	  1/VEGF	  
receptor	  2	  
Lfng	   Lunatic	  Fringe	   	  
Mfng/Rfng	   Manic	  fringe/	  Radical	  fringe	  
MO	   Morpholino	   	   	  
NG2	   Chondroitin	  sulfate	  proteoglycan	  4	  
NICD	   Notch	  intracellular	  domain	  
Nrp1/2	   Neuropilin	  1/2	   	  
P	   Postnatal	  day	   	  
PAV	   Parachordal	  vessel	   	  
PCV	   Posterior	  cardinal	  vein	   	  
PDGFB	   Platelet-­‐derived	  growth	  factor	  B	  
PDGFRβ	   Platelet-­‐derived	  growth	  factor	  receptor	  β	  
PECAM	   Platelet	  endothelial	  cell	  adhesion	  molecule	  
PI3K	   Phosphoinositide(3,4,5)-­‐phosphate	  kinase	  
qPCR	   Quantitative	  	  Polymerase	  Chain	  Reaction	  	  
S1P	   Sphingoshine-­‐1-­‐Phosphate	  
SEM	   Scanning	  Electron	  Microscopy	  
TAM	   Tumour	  Associate	  Macrophage	  
TEM	   Transmission	  Electron	  Microscopy	  
Tie2	   Endothelial-­‐specific	  Tyrosine	  Kinase	  
VE-­‐cadherin	   Vascular	  Endothelial	  cadherin	  
VEGF	   Vascular	  Endothelial	  Growth	  Factor	  
vSMC	   vascular	  Smooth	  Muscle	  Cell	  
ZO-­‐1	   Zona	  Occludens-­‐1	   	  
 
Chapter 1. Introduction 
 15 
Chapter 1. Introduction 
 
The evolution of organisms from single cells to multicellular beings raised a new 
problem with regards to the supply of oxygen and nutrients and the removal of 
metabolic waste products. The development of a vascular system helped overcome the 
limitations of diffusion and allowed multicellular organisms to increase in size and 
complexity, by keeping up with increased metabolic demands. 
The vascular system is composed of two separate but connected tubular networks, 
the blood vasculature and the lymphatic vasculature. The blood vessels act as conduits 
for the transport of nutrients from the stomach and intestine, and oxygen from the lungs 
to all tissues while removing metabolic waste and delivering it to the kidneys and lungs. 
The driving force for blood flow is supplied by the pumping of the heart. The 
vasculature transports red blood cells to carry gases, platelets required for clotting and 
wound healing and white blood cells allowing them to carry out immunosurveillance 
and respond to injury and inflammatory insults. Long-range hormone signalling takes 
advantage of the extent of the vasculature’s reach to deliver signals at distant sites or at 
the whole organism level.   
The lymphatic vasculature is responsible for maintaining the tissue fluid balance 
by removing excess extracellular liquid and macromolecules and delivering them back 
to the blood circulation through the lympho-venous connection in the subclavian vein. 
The movement of lymph is a more passive process that occurs without a pump but it is 
believed that muscle contraction and the presence of unidirectional valves aid the flow 
away from the extremities towards the trunk to prevent backflow. The lymphatics are 
composed of blind-ended capillaries where absorption occurs, which drain into 
collecting vessels that carry the lymph to the thoracic duct prior to re-entering the blood 
stream. Defects in the lymphatic vasculature due to genetic mutations or physical 
damage to the vessels (as through surgery) result in poor tissue fluid homeostasis 
leading to lymphoedema, a swelling of tissues which tends to concentrate in the limbs 
and especially the legs. 
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The blood vasculature comprises arteries and arterioles that carry oxygenated 
blood from the heart to capillaries within tissue where exchange of substances occurs, 
and venules and veins that return deoxygenated blood back to the heart. The different 
types of vessels have specific characteristics at the macroscopic and cellular level that 
are crucial to their function. Arteries possess thick muscular walls to withstand the high 
pressure with which blood is pumped from the heart, as well as maintaining this 
pressure during transport. Capillaries are thin walled, small diameter vessels to 
maximise the surface area of contact with the tissues and allow efficient diffusion or 
transport of nutrients, oxygen and metabolic waste. Veins have unidirectional valves to 
prevent backflow of blood due to the lower pressure present in such vessels. Blood 
vessels are composed of a layer of endothelial cells (ECs) that surround the lumen and 
are important in modulating vessel permeability (especially in the capillary network). 
Accessory cells such as pericytes and smooth muscles cells (SMCs) are associated with 
the EC to help them carry out their function, and extracellular matrix (ECM) is 
deposited to form the basement membrane (BM), which also provides physical support. 
 
1.1 Vascular Development 
Because of its critical role in the survival and growth of tissues, the blood 
vasculature is the first organ system to develop during embryogenesis. Accordingly 
most mutations that severely affect vessel growth lead to embryonic lethality by mid-
gestation (Carmeliet et al., 1996, Ferrara et al., 1996, Shalaby et al., 1995). Vascular 
development occurs in two distinct stages: vasculogenesis, which leads to the formation 
of a primary capillary plexus, and angiogenesis which expands the initial plexus and 
remodels it giving rise to a mature, hierarchical and functional network. Vasculogenesis 
(Fig 1.1) begins with the differentiation of precursor cells in the lateral plate mesoderm 
into a bipotent cell type known as haemangioblasts.  
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Figure 1.1 Vasculogenesis and the formation of the primary capillary plexus. 
A. Lateral plate mesodermal precursor cells are induced to express VEGFR2 (B, green), 
possibly through the action of bFGF. C. The resultant haemangioblasts aggregate into 
structures known as blood islands through VEGF-directed migration. D. 
Haemangioblasts begin to differentiate into haematopoietic stem cells (red) or 
angioblasts (green) that will later differentiate   into endothelial cells. E. Angioblasts 
proliferate, migrate and coalesce to form a rudimentary vascular network known as the 
primary capillary plexus. 
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The exact factors involved in this initial differentiation step are still unknown but it is 
believed FGF family members are involved (Fig 1.1A)(Risau, 1997). Haemangioblasts 
express flk1 (also known as VEGF Receptor 2 described in 1.3.1) (Fig 1.1B), the most 
important receptor for Vascular Endothelial Growth Factor A (VEGFA, described in 
1.3.1). In response to VEGFA haemangioblasts aggregate into structures known as 
blood islands and differentiate to either the haematopoietic lineage or into EC 
precursors known as angioblasts (Fig 1.1C-D)(Risau, 1997). More recent work has 
revealed the possibility of a haemogenic endothelium intermediate where cells only 
acquire the haematopoietic fate following initial angioblast differentiation (Lancrin et 
al., 2009). The resulting blood islands are composed of an inner core of haematopoietic 
cells surrounded by endothelial-like angioblasts (Fig 1.1D), which subsequently connect 
to a rudimentary network termed the primary capillary plexus (Fig 1.1E). The main 
axial vessels, the dorsal aorta and the cardinal vein, form through this vasculogenic 
process and are not dependent on angiogenesis. However, once the primary plexus has 
been established it must expand to keep up with the growth of the embryo and this 
occurs through angiogenesis. 
 
1.2 Angiogenesis 
Angiogenesis is the process by which new vessels are formed from pre-existing 
ones. Two modes of angiogenesis are currently known, sprouting angiogenesis and 
intussusceptive angiogenesis. The latter occurs through the enlargement of the parent 
vessels through EC proliferation, leading to a large calibre vessel. This vessel can then 
split via the formation of extracellular, intraluminal pillars that expand resulting in the 
bifurcation of the parent vessel until two separate, smaller calibre vessels are formed 
(Burri and Djonov, 2002). 
Sprouting angiogenesis (from here on also referred to as angiogenesis, Fig 1.2) 
occurs when ECs from a pre-existing vessel branch out and form a blind-ended 
structure that grows towards the target tissue that requires increased blood supply. This 
newly formed sprout must then connect to another growing sprout or to an existing 
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vessel through anastomosis. Anastomosis is the process by which two separate tubular 
structures connect (from hereon also referred to as fusion, not to be confused with 
cellular fusion).  The main concepts surrounding the mechanism of sprouting 
angiogenesis leading to a mature hierarchical vasculature will be introduced in this 
chapter. 
 
1.3 Models for the Study of Sprouting Angiogenesis 
 
1.3.1 The mouse post-natal retina 
Peri-natal mouse retinas are void of blood vessels and their vascularisation 
begins shortly after birth. ECs enter the retina from the optic nerve and grow through 
the superficial layers of the retina, between the inner limiting membrane and the retinal 
ganglion cells (Fig 1. 3A), expanding radially and reaching the periphery within 7-8 
days following birth (Fig 1.3B). The growth of this primary plexus is tightly regulated 
by the establishment of a VEGFA gradient (Gerhardt, 2003). The retina is pre-patterned 
by a network of astrocytes, microglial cells required for the support of the vasculature in 
the CNS. Astrocytic expression of VEGFA is a hypoxia driven process (Stone et al., 
1995). The greater the distance from the optic nerve, the greater the hypoxia and 
therefore the higher VEGFA expression. As the ECs migrate towards the periphery and 
establish functional vessels, the hypoxia is relieved and VEGFA expression is 
downregulated, maintaining a steep gradient away from the centre of the retina 
(Gerhardt, 2003). The vascular pattern of the growing plexus tightly aligns with the 
adjacent astrocytic plexus, which act as a track to direct outgrowth (Gerhardt, 2003). 
Mural cells and pericytes are recruited to stabilize the vessels and as the primary plexus 
expands, the older parts begin to mature and acquire arterial-venous identity, while the 
capillary beds are pruned by vessel regression to remove excessive vasculature. The 
orchestration of these morphogenetic processes forms a functional, patterned and 
hierarchical vascular tree (Fruttiger, 2007). 
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Figure 1.2 Sprouting Angiogenesis and Anastomosis. 
A. ECs in a quiescent vessel are activated upon exposure to angiogenic factors such as 
VEGF. B. This leads to migratory behaviour, detachment of pericytes and breakdown of 
the basement membrane through secretion of matrix metalloproteases. C. One EC is 
selected to lead sprout migration, the tip cell (green). Trailing ECs are referred to as 
stalk cells (blue) and are involved in sprout elongation through proliferation and lumen 
formation. D. Newly formed sprouts must connect with one another through 
anastomosis to give rise to a functional vessel loop (E). 
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As the superficial plexus matures two further plexus are formed deeper in the 
retina. In this instance VEGFA is expressed by the Müller cells in the inner nuclear 
layer, attracting sprouts to firstly migrate to the outer plexiform layer boundary to form 
the outer deeper plexus and later just above the inner nuclear layer to form the inner 
deeper plexus (Fig 1.3A).  
 Even though the use of this model currently only allows imaging on fixed tissue 
one can gain information on morphogenetically distinct processes thanks to its 
stereotyped development and spatio-temporal relationship. Active angiogenesis occurs 
at the leading edge of the growing plexus, vessel morphogenesis and recruitment of 
pericytes occurs behind the growing front, differentiation, regression and pruning 
occurs further back in the plexus. Therefore one snapshot of the retina includes all 
processes involved in angiogenesis, allowing the interrogation of genetic or 
pharmacological manipulations on all phases simultaneously. 
 
1.3.2 The Zebrafish Intersegmental Artery Sprouting 
The tropical fresh water fish Danio reiro, commonly known as the zebrafish, has 
become an important tool in biomedical research over the last 40 years. Zebrafish 
possess many characteristics that have been instrumental in their rise in popularity as a 
model system for developmental biology. They are easy and cheap to maintain, mating 
is easily controlled and females produce large amounts of eggs. The embryos develop 
externally from their mothers and are optically clear allowing the visualization of 
developmental processes, which occur quickly. These attributes enable live imaging of 
growing embryos giving unprecedented detail on tissue morphogenesis dynamics. The 
ability of dynamic live visualization, which has been difficult to perform in other 
organisms, opened up a whole new avenue in vascular biology. The use of angiography 
with fluorescent microbeads in the mid 90s   initiated the use of zebrafish in the study of 
vasculogenesis and angiogenesis (Weinstein et al., 1995).  
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Figure 1.4 Zebrafish Vascular Development.  
A. Schematic representation of the zebrafish trunk vasculature at 36hpf. N –Notochord, 
light blue; NT- Neural Tube, green; DA – Dorsal Aorta, red; PCV – Posterior Cardinal 
Vein, Blue; DLAV – Dorsal Lateral Anastomotic Vessel; ISVs – Intersegmental 
Vessels, red and blue. Adapted from (Armer et al., 2009). B. Cross section through 
trunk from A (dashed line), M – Myotomes, YT – Yolk Tube. C. Confocal micrograph 
of a 48hpf fli1:eGFP zebrafish embryo (Lawson, 2002). D. High magnification electron 
micrograph from C (red box). DA, PCV, ISVs and DLAVs are fully formed by this 
stage. PAV – Parachordal Vessel, is almost formed. 	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Another important development for zebrafish in research has been the use of 
Morpholino oligonucleotides to induce sequence-specific gene knockdown, promoting 
the investigation of gene function during vascular development (Nasevicius and Ekker, 
2000). Morpholinos are oligonucleotides with a modified backbone where morpholine 
rings replace ribose residues and are linked through uncharged phosphorodiamidate 
groups instead of the charged phosphates for improved stability. Morpholinos exert 
their function by either binding over the mRNA ATG and blocking translation or by 
binding at exon/intron boundaries and preventing correct splicing of the nascent RNA 
(Summerton and Weller, 1997). It must be noted that thanks to their minute size, 
zebrafish embryos are able to continue developing without blood flow or functional 
blood vessels up to at least 48hpf as sufficient oxygen is obtained through passive 
diffusion. This enables the investigation into genes that are embryonic lethal in mouse 
models and therefore unsuitable  for understanding their roles in vasculogenesis and 
early angiogenesis. With the development of further technologies and discovery of 
tissue specific promoters, transgenesis in zebrafish became reality and with it the 
possibilities for use of confocal live imaging expanded. The first and still most widely 
used transgenic line is the Tg(fli1:eGFP)y1 line (from here on fli:eGFP) generated by 
Lawson and Weinstein (Lawson, 2002). The line expresses eGFP under control of the 
fli1 promoter, which drives expression almost exclusively in ECs. Many more lines 
have since been generated using different promoters (such as flk1) and expressing 
fluorescent proteins with different subcellular localizations or as part of a fusion 
protein.  
The zebrafish vasculature is less complex than that of higher vertebrates. Most 
studies have focused on the trunk vasculature as both vasculogenesis and angiogenesis 
occur in a stereotyped fashion (Fig 1.4) (Isogai, 2001, Isogai, 2003). The zebrafish trunk 
vasculature is initially composed of the axial vessels: the Dorsal Aorta (DA) and the 
Posterior Cardinal Vein (PCV). They form through the coalescing of angioblasts that 
differentiate in the lateral mesoderm and migrate to form the Inner cell Mass (ICM), 
later giving rise to ECs and haematopoietic cells (Herbert et al., 2009). The aggregation 
of angioblasts forms a precursor DA by 19.5hpf from which EC progenitors sprout and 
segregate to form the PCV, allowing the differentiation of the precursor vessel into the 
DA . By 23hpf both vessels are formed, become lumenized and circulation commences 
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around 25hpf (Herbert et al., 2009). The other vessels in the trunk are the 
intersegmental vessels that connect the DA to the Dorsal Lateral Anastomotic Vessels 
(DLAVs). The intersegmental vessels emerge from DA at ~22hpf through primary 
angiogenic sprouting and at this stage are referred to as InterSegmental Arteries (ISAs) 
as they have yet to assume venous identity. They emerge from the DA ipsilaterally at 
the level of the myotome boundaries giving rise to parallel vessels on both sides of the 
embryo. ISAs migrate dorsally between the notochord and the somites in the ventral 
portion of the embryo and between the neural tube and the somites in the dorsal portion 
as they make their way to dorsal aspect of the embryo (Fig 1.4B). Around 28hpf the 
ISAs reach the top of the neural tube and bifurcate, growing rostrally and caudally to 
make connections with adjacent ISAs to form the DLAVs through anastomosis (Isogai, 
2001). By 1.5dpf all ISAs complete migration and fuse to form the DLAVs, resulting in 
a new lumenized and functional vascular loop originating from the DA (Fig 1.4C-D). At 
this stage a secondary round of sprouting originating exclusively from the PCV begins. 
Secondary sprouts can fuse with the ISAs, connecting the PCV to the primary 
angiogenic network (Isogai, 2003). This connection is rapidly lumenized and upon the 
initiation of blood flow, the portion of the ISA connecting it to the DA regresses, 
leaving the intersegmental vessels connected solely to the PCV and inducing venous 
differentiation. Alternatively the sprout can migrate dorsally between the somites and 
the notochord to the level of the myoseptum and become integral part of the parachordal 
vessel (PAV). The PAV was believed to be a functional vessel but more recent analysis 
has demonstrated that these are ECs pre-destined to become part of the lymphatic 
system, which develops later (Hogan et al., 2009). The PAV-derived lymphatic ECs 
require ISAs to direct their migration during lymphangiogenesis (Bussmann et al., 
2010). The decision whether to connect to an ISA or to form the PAV is believed to be 
stochastic but leads to an almost equal and well-spaced pattern of ISAs and ISVs 
through the trunk. The PCV expands in the tail region through sprouting to form the 
posterior caudal plexus. By 48hpf the trunk vasculature has developed with DA, PCV, 
ISAs, ISVs and the DLAVs carrying blood flow (Fig 1.4D). At this stage the parallel 
bilateral DLAVs begin to zipper up in a caudal to rostral direction, forming a plexus 
over the neural tube by 7dpf (Isogai, 2001).  
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The study of the zebrafish trunk vasculature development has confirmed many 
discoveries made in mouse and in vitro, combining the benefits of an in vivo setting 
with the possibility of live imaging.  The genetic tractability and ease of genetic 
manipulation through Morpholino knockdown and mRNA injection or transient 
expression of DNA constructs have helped this model to become a standard in the field 
of vascular biology. Recently the importance of understanding single cell behaviour 
within a population of endothelial cells has been uncovered, and clonal expression and 
tracking by transient expression of DNA constructs in zebrafish has allowed this type of 
investigation (Jakobsson et al., 2010).  
 
1.3.3 Embryoid Body Sprouting Assay 
Embryonic Stem Cells (ESCs) derived from blastocysts can be cultured and 
induced to differentiate into most if not all cell lineages present in the adult organism 
(Thomson, 1998). Using immortalised EC lines in culture systems can be laden with 
many potential drawbacks, especially on the relevance of the biological discoveries 
made. Therefore many have employed an in vitro system utilizing ESCs and inducing 
their differentiation into ECs in a 3D sprouting assay (reviewed in (Jakobsson et al., 
2007b)). ESC are cultured in the absence of feeder cells and Leukaemia inhibitory 
factor (LIF) as hanging droplets in a petri dish, and incubated for 4 days (Fig 1.5A). 
This induces the aggregation of ESCs and the formation of ESC spheroids, also known 
as embryoid bodies (EBs). At this stage VEGF and VEGFR2 signalling are not required 
for the initial differentiation of ESC into ECs, but are necessary for cell migration and 
vessel formation (Schuh et al., 1999). The EBs can be plated on a 2D surface to assess 
their potential for EC network formation or they can be seeded in 3D collagen gels to 
induce sprouting. Once placed in collagen the growth medium is supplemented with 
VEGF-A to induce EC sprouting and migration, which can be observed eight days after 
initiation of spheroid formation (Fig 1.5B). Sprouts are headed by tip cells displaying 
filopodia extensions polarized in the direction of growth, as described in in vivo models 
(Fig 1.5B/C) (Gerhardt, 2003, Lawson, 2002, Jakobsson et al., 2007b),  
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The vessels formed are composed of cells expressing many EC-specific markers such as 
CD31 and VE-cadherin (Vittet et al., 1996) (Fig 1.5C). Due to the presence of ESCs in 
the EB core, other vascular associated cells can also differentiate and take part in vessel 
formation. Mural cells are found in close contact with and surrounding the vessels (Fig 
1.5B), expressing cell-specific markers NG2 and smooth muscle actin (SMA). Recent 
work has highlighted the importance of understanding EC-EC interaction and how 
slight genetic variations (such heterozygous loss of a gene) can influence cellular 
behaviour (Jakobsson et al., 2010); the EB sprouting system offers an opportunity to 
investigate such relationships and competitive behaviours through the use of chimeric 
spheroids. This system can be easily imaged live to further investigate the dynamics of 
angiogenic processes at the single cell level.  
The EB sprouting assay circumvents the problem of early embryonic lethality in mice 
lacking genes critical for vascular development, as loss of the same genes does not 
affect cell viability in this assay (Ng et al., 2004). One of the limitations of this model is 
the lack of flow and therefore the role of haemodynamic forces.  
 
1.4 Mechanism of Sprouting Angiogenesis 
The requirement for angiogenesis and thus the increase in blood supply to a tissue 
is linked to an increase in metabolic needs. Angiogenesis is induced through the 
expression of the most important morphogen required for vessel growth, Vascular 
Endothelial Growth Factor-A (VEGFA). VEGFA activates VEGFR2 to induce 
sprouting through the activation of ECs, leading to a change in behaviour from the basal 
quiescent state. Upon stimulation, ECs break out from the pre-existing vessel, lose 
pericyte coverage and degrade the ECM to allow outgrowth. Angiogenic sprouts are 
headed and directed by an EC characterized by polarized migratory morphology 
towards the VEGFA gradient, long filopodia extensions to sense the environment for 
guidance cues and lack of proliferation (at least in the mouse retina), which is hence 
referred to as tip cell (Gerhardt, 2003). The ECs that trail behind tip cells, supporting 
sprout growth by proliferation, keeping up with migration and establishing the vascular 
lumen are known as stalk cells. It is clear that these two phenotypically different ECs 
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respond to VEGF in different ways: tip cells polarize and migrate with regards to a 
gradient whereas stalk cells proliferate proportionally to total VEGF present and take 
part in vascular morphogenesis (Gerhardt, 2003) .  
Tip cell selection at initiation of sprouting is dependent on the lateral inhibition 
pathway involving Delta-like 4 ligand (Dll4) and Notch receptors, evidence for which 
has been provided in both zebrafish and mouse (Leslie et al., 2007, Siekmann and 
Lawson, 2007, Hellström et al., 2007, Suchting et al., 2007, Lobov et al., 2007). It is 
now clear that tip/stalk cell fates are not permanent but are in flux, with stalk cells 
overtaking the original tip to assume its role and cells within the sprout shuffling 
(Jakobsson et al., 2010). Alongside morphological differences, tip and stalk cells also 
display differential gene expression. Some genes that are expressed at higher levels in 
tip cells (or at least in the sprouting front) include dll4, pdgfb, lama4a, unc5b, flk1 and 
flt4 (Fig 1.6A) (Gerhardt, 2003, Claxton and Fruttiger, 2004, Lu et al., 2004, Siekmann 
and Lawson, 2007, Tammela et al., 2008, Del Toro et al., 2010, Strasser et al., 2010, 
Estrach et al., 2011a, Stenzel et al., 2011). Conversely other genes are present at higher 
levels in stalk cells such as robo4 and flt1 (Huang et al., 2009). Tip and stalk cells also 
deposit different BM components, for example laminin α4 is deposited by tip cells 
(Stenzel, 2011) while stalk cells deposit fibronectin (Stenzel et al., 2011). However, no 
tip cell specific markers have yet been characterized. 
 
1.5 VEGF Signalling in Angiogenesis 
When cells sense a decrease in oxygen tension, the enzyme prolyl hydroxylase 
(PDH) becomes unable to hydroxylate Hypoxia Inducible Factor 1α (HIF1α), which is 
then not degraded and instead accumulates in the cell, forming heterodimers with 
HIF1β. HIFα and β are basic Helix-Loop-Helix (bHLH) transcription factors and 
HIFα/β heterodimers initiate the transcription of genes with a Hypoxia Responsive 
Element (HRE) in their promoter. Hypoxia responsive genes change the cellular 
behaviour leading to altered metabolism, erythropoiesis and the induction of 
angiogenesis.  One such gene is VEGFA. 
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(Kdr and flkt4 respectively) to induce upregulation of dll4 expression. This will 
increase Notch signalling in the neighbouring cell, resulting in a downregulation of 
VEGFR2, VEGFR3 and Nrp1 and upregulating VEGFR1, acting as a VEGFA sink and 
further decreasing VEGFR2-driven signalling, resulting in low dll4 expression. C. 
Following lateral inhibition through Dll4/Notch signalling a tip cell is selected (green) 
with high DLL4 and VEGFR2, whilst the stalk cell (light blue) will have high VEGFR1 
and low Dll4 and VEGFR2. Adapted from (Phng and Gerhardt, 2009). 
 	  
VEGFA is a member of the vertebrate VEGF family that also comprises PLGF, 
VEGFB, VEGFC and VEGFD (Fig 1.7A). VEGFC and D have a major role in 
lymphangiogenesis, although VEGFC has also been shown to induce angiogenesis 
(Benest et al., 2008), for example in zebrafish VEGFC is required for correct ISA 
migration (Covassin et al., 2006). Two variants of VEGF have also been found in 
viruses (VEGFE) and snake venom (VEGFF). VEGF is a secreted homodimeric 
glycoprotein of around 40kDa consisting of head-to-tail monomers connected by two 
disulphide bridges (Olsson et al., 2006). VEGFA is crucial for the proliferation of ECs 
and haematopoietic cells, and later differentiation, vasculogenesis and angiogenesis. 
The effects of VEGFA are dose-sensitive as loss of one functional allele results in 
embryonic lethality at around embryonic day 11 (E11) due to abnormal and delayed 
vessel development. . This haploinsufficiency is exacerbated by loss of both alleles but 
does not prevent initial EC differentiation (Carmeliet et al., 1996, Ferrara et al., 1996). 
Zebrafish VEGFA morphants exhibit similar vascular defects, where the initial 
specification and patterning of the axial vessels is not altered but vessel enlargement 
and intersegmental vessel development are defective (Nasevicius and Ekker, 2000). 
VEGFA is also critical in neonatal development as loss of VEGF function, either by 
gene deletion or by VEGF sequestration, leads to lethality up to the fourth week post-
partum (Gerber et al., 1999).  
VEGF-A can be spliced into various isoforms that differ in their ability to bind 
heparan sulphate proteoglycans (HSPGs, heparin), important for the establishment of a 
gradient, and the VEGF co-receptors neuropilin 1 and 2 (nrp1 and 2). There are 12 
reported human isoforms, 7 pro-angiogenic VEGFAxxx (denoting the number of 
residues): 121, 145, 148, 165, 183, 189 and 206; and 5 anti-angiogenic isoforms: 121b, 
145b, 165b, 183b and 189b. Anti-angiogenic b isoforms are believed tp exert much 
reduced angiogenic activity resulting from the C-terminal exon with a variant lacking an 
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Nrp1-binding site, thus induces suboptimal phosphorylation of VEGFR2 (Harper and 
Bates, 2008). Murine isoforms have one less residue compared to human and are 
therefore denoted  VEGF120 etc. In mouse VEGF120 and 164 are the most highly 
expressed even though cells express a combination of isoforms. The heparin/HSPG 
binding capaity  of the longer VEGF isoforms (164, 188) is important for setting up the 
gradient required for correct vascular patterning (Ruhrberg, 2002, Gerhardt, 2003). The 
difference in HPSG binding leads to different retention of the VEGF isoforms by cells 
(on their surface) and by the ECM, resulting in differential diffusion. The shortest 
isoform (120) is thought to be freely diffusible and thus acts at long range, affecting the 
steepness of the gradient (Ruhrberg, 2002). In HUVECs VEGF165 binding to heparin 
increases VEGFR2 phosphorylation, an effect dependent on VEGF’s exon 7 (Ashikari-
Hada, 2005). Growth factor binding to HSPGs stabilizes growth factor interaction with 
its cognate receptor (Ibrahimi et al., 2004) (Fig 1.7B) and recent work confirmed that 
such interactions potentiate signaling and biological activity, whilst altering signaling 
properties (Chu et al., 2011, Chen et al., 2010). EBs deficient for N-deacetylase/N-
sulfotransferase 1 and 2 (NDST1/2), an enzyme important for the biosynthesis of 
HSPGs, and VEGFR2-/- are unable to sprout in response to VEGF164. This sprouting 
defect can be overcome by co-culturing cells so that the VEGFR2-/- ESCs supply 
HSPGs in trans, potentiating VEGFR2 signalling in the NDST1/2-/- cells to allow normal 
sprouting (Jakobsson et al., 2006). 
Embryonic vascular development occurs normally in mice expressing 
exclusively VEGF164 (Stalmans, 2002), suggesting this isoform has intermediate 
retention, sufficient to set up a steep enough gradient to properly pattern the 
vasculature. On the other hand sole expression of VEGF188 in the mouse retina induces 
a denser capillary plexus but hinders arterial specification (Stalmans, 2002), possibly as 
a result of proteolytic cleavage and thus minimal diffusion, preventing gradient 
formation.  If the VEGF gradient is completely abolished by either expressing only the 
freely diffusible isoform VEGF120 or by injecting VEGF120 in post-natal eyes, tip cell 
display decreased migration and filopodia extension, the plexus has a shorter migratory 
distance and ECs overproliferate forming larger calibre vessels (Ruhrberg, 2002, 
Gerhardt, 2003). 
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VEGF family members bind to their cognate receptor tyrosine kinases Vascular 
Endothelial Growth Factor Receptors (VEGFR) 1, 2 and 3, respectively encoded by flt1, 
flk1and flt4 (Fig 1.7A). VEGFRs belong to the type III receptor tyrosine kinase family, 
single-pass transmembrane proteins containing seven extracellular immunoglobulin 
domains and a split intracellular tyrosine kinase domain. Zebrafish express flt1 and flt4 
as well as two other VEGFR genes It was initially thought that kdra and kdrb arose 
through gene duplication but sequence analysis revealed that kdrb is the closest 
homologue to flk1 and that kdra is part of a fourth group of VEGFRs lost in placental 
mammals, and has therefore been named  kdr-like (kdrl) (Bussmann et al., 2008). VEGF 
ligands have different affinities for the 3 receptors, with VEGFR1 binding VEGFA+B 
and PLGF, VEGFR2 with VEGFA, C and D (following processing) and VEGFR3 with 
VEGFC+D (Fig 1.7A) (Olsson et al., 2006). These receptors are mainly expressed in 
ECs but VEGFR2 also plays a role in neuronal maturation (Khaibullina et al., 2004) and 
VEGFR1 is involved in macrophage migration (Sawano, 2001). VEGFR3 drives 
lymphatic development but also has a role in developmental angiogenesis (Tammela et 
al., 2008). VEGFRs homodimerize upon ligand binding, bringing together the kinase 
domains and inducing catalytic activity. The receptor auto-phosphorylates the adjacent 
monomer on the intracellular tail, activating downstream signalling pathways such as 
PI3K, p38MAPK and ERK1/2 to induce migration, proliferation and survival. VEGFRs 
can heterodimerise in a context and cell-specific manner, such as VEGFR2/3 complexes 
(Dixelius, 2003, Nilsson et al., 2010) but the signalling events downstream of such 
heterodimers are yet to be elucidated.  
VEGFR2 and VEGFR3 effectively induce receptor phosphorylation and 
downstream signalling whereas VEGFR1 has weak signalling activity in ECs. VEGFR1 
has a much higher binding affinity for VEGFA, with Kd of 2-10pM whereas the affinity 
of VEGFR2 is at least one order of magnitude lower (Shibuya, 2006). This has led to 
the hypothesis that flt1 acts as a VEGFA sink and sequesters it, thus preventing binding 
to VEGFR2 and activation of downstream signalling. VEGFR1 negatively regulates tip 
cell formation by antagonizing the effects on VEGFA in zebrafish (Krueger et al., 
2011). Expression of a soluble isoform of VEGFR1 results in decreased angiogenesis 
(Zygmunt et al., 2011), which is necessary to keep certain clear tissues avascular i.e. the 
cornea (Ambati et al., 2006). Loss of VEGFR1 increases EC proliferation and network 
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formation resulting in embryonic lethality by E9 (Fong et al., 1995), suggesting this 
may be due to increased VEGFR2-driven signalling. Loss of both VEGFR2 alleles 
induces embryonic lethality at E8.5, with defects in vascular network formation as in 
VEGF knockouts, but also defects in EC specification and early migration (Shalaby et 
al., 1995). Recently, a soluble isoform of VEGFR2 has been described and is important 
for modulation of lymphangiogenesis by blocking VEGFC function (Albuquerque et al., 
2009). Apart from its role in lymphangiogenesis VEGFR3 is involved in 
vasculogenesis, with associated embryonic lethality at E9.5 in knockout mice (Dumont, 
1998), as well positively influencing angiogenic post-natal sprouting (Tammela et al., 
2008), findings that have been observed in zebrafish (Ober et al., 2004). 
The longer isoforms of VEGFA can bind neuropilins, single pass 
transmembrane receptors best known for their expression in the nervous system and 
ability to bind semaphorins (Larrivee et al., 2009). Nrp1 and 2 are expressed during 
early vascular development with nrp2 becoming restricted to the lymphatic 
endothelium. Nrp1 co-immunoprecipitates with VEGFR2 whilst nrp2 associates with 
VEGFR2 and 3. Nrp1 deficiency leads to embryonic lethality caused by early heart and 
vascular defects, along with neuronal guidance defects (Kawasaki et al., 1999). These 
defects are dependent on aberrant sprouting and arterial differentiation but not EC 
proliferation. Accordingly, nrp1 becomes preferentially expressed in arterial ECs later 
in development (Stalmans, 2002). Similarly, in zebrafish loss of nrp1 expression 
abrogates VEGF-dependent ISA sprouting (Lee et al., 2002). Nrp2 loss affects the 
lymphatic vasculature but not the blood vasculature (Yuan et al., 2002). Overexpression 
of nrp1 induces ectopic vascular sprouting that ultimately leads to embryonic lethality, 
similar to loss of VEGFR1. The co-binding of Nrp1 to VEGF is not important in the 
activation of VEGFR2 and its phosphorylation (Fig 1.7B) (Larrivee et al., 2009), but 
recent work suggests a role in the sorting of the endocytosed receptors to different 
endosomal compartments in a synectin-dependent mechanism, leading to altered 
downstream signalling (Ballmer-Hofer et al., 2011).  The guidance of EC tip cell 
migration is dependent on the presence of functional Nrp1 (Gerhardt et al., 2004). 
Evidence also points to the requirement of Nrp1 for p38MAPK phosphorylation 
downstream of VEGFR2, important for EC sprouting, branching and interaction with 
pericytes (Kawamura et al., 2008). A recent hypothesis on the VEGFA specificity of 
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Nrp1 hint that Nrp1 binds both VEGFA164 and VEGF120, but the latter cannot induce 
Nrp1-VEGFR2 complex formation and thus fails to activate downstream signalling 
(Pan et al., 2007). Overall the above data suggest nrp1 is an important player in 
sprouting angiogenesis through its interaction and affect on VEGFR2 downstream 
signalling. Blood flow can also influence VEGFR2 signalling through interactions with 
VE-cadherin and PECAM-1 (Tzima et al., 2005) and this mechanosensory complex can 
activate integrin-mediated shear stress responses (Fig 1.7C). 
 
1.6 Delta/Notch Signalling in Tip Cell selection and 
Angiogenesis 
1.6.1 The Notch Pathway 
Upon VEGFA stimulation ECs begin to sprout from a pre-existing vessel. The 
mechanism of tip cell selection has been attributed to effects of Delta/Notch signalling 
pathway. The Notch pathway is a well-conserved cell-to-cell lateral signalling pathway 
that relies on contact between adjacent cells and has been implicated in 
inhibition/induction of cell fates in many tissues (reviewed in (Lewis, 1998)). In mouse 
the pathway consists of four Notch receptors and five canonical Delta, Serrate, LAG-2 
(DSL) ligands: Delta-like1 (Dll1), Dll3, Dll4, Jagged-1 (Jag1) and Jag2. 
Notch receptors are type I single pass transmembrane proteins, comprising an 
extracellular domain responsible for ligand interaction (with many EGF-like repeats), a 
transmembrane domain involved in receptor activation and an intracellular domain that 
relays downstream signalling. DSL ligands are type I transmembrane proteins with 
many EGF repeats in the extracellular domain. Jag1 and Jag2 have almost twice as 
many EGF repeats and contain a cysteine rich region in the juxtamembrane extracellular 
portion. Notch signalling requires the signal-sending cell to express one of the DSL 
ligands and the signal-receiving cell to express one of the receptors. DSL ligands 
interact with the extracellular domain of Notch receptors, activating a proteolytic 
cleavage cascade. This begins with the ADAM family metalloprotease TACE, cleaving 
the Notch receptor extracellular domain (S2 cleavage). This domain remains bound to 
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the DSL ligand and is believed to be endocytosed by the signal sending cell; whether 
this results in active signalling is the subject of on-going investigations. The final 
proteolytic cleavage involves γ-secretase that separates the Notch intracellular domain 
(NICD) from the transmembrane domain (S3 cleavage). NICD can then translocate to 
the nucleus and bind CBF1, Su(H), LAG1 (CSL) transcription factor. In the absence of 
NICD CSL represses the transcription of Notch target genes by recruiting a repressor 
complex involving the histone deacetylase HDAC-1 (Kao et al., 1998). NICD 
translocation to the nucleus disrupts this repressor complex, allowing transcriptional 
activators such as mastermind-like 1 and the histone acetyltransferase p300 to induce 
expression of Notch target genes such as the  Hairy/Enhancer of Split (Hes) and Hes-
related protein (Hey/HRT/HERP) families. The expression of Notch target genes is cell-
type dependent. Some of the induced genes such as hes and hey act as repressors of 
other genes as well as of their own transcription, leading to tight feedback regulation of 
their expression (Phng and Gerhardt, 2009).  
Notch receptor maturation requires cleavage by a furin-like protease whilst in 
the Golgi (S1 cleavage) (Logeat et al., 1998) and the mature heterodimer must be 
glycosylated to allow correct signaling, evidenced by loss of O-fucosylation leading to 
inactive receptors. The fucose is then further modified via the addition of N-
acetylglucosamine by fringe (fng) family glycosyltransfereases present in both mouse 
and zebrafish (Johnston et al., 1997, Prince et al., 2001). Fng family members can 
increase or inhibit DSL-specific Notch signaling, adding another layer of regulation to 
the Notch pathway (Stanley, 2007). 
 
1.6.2 Notch Signaling in Angiogenesis 
The vasculature expresses a specific subset of Notch receptors and DSL 
Ligands. Notch 1 and 4 are expressed in ECs and Notch 3 in vSMC, while Dll1 and 4, 
and Jag1 and 2 are expressed in ECs (Villa et al., 2001, Claxton and Fruttiger, 2004). 
Loss of most of these components either leads to embryonic lethality by midgestation or 
severe vascular defects, sometimes involving postnatal lethality.  
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Notch pathway components are mainly found expressed in arterial ECs (Lawson 
et al., 2001, Claxton and Fruttiger, 2004, Leslie et al., 2007, Siekmann and Lawson, 
2007). This finding raised the question of whether Notch pathway components are 
induced in arteries or whether they are required for arterial differentiation. In zebrafish 
mindbomb (mib) mutants, which lack functional Notch signaling, downregulation of 
arterial marker ephrinB2 is observed in the DA, as well as notch3 and deltaC (Lawson 
et al., 2001). Mib mutants display ectopic expression of the venous marker flt4 in the 
DA, suggesting that arterio-venous differentiation is dependent on Notch signalling 
(Lawson et al., 2001). The gridlock mutation (hes family) is also implicated in arterio-
venous identity as mutants have arterio-venous shunts (Weinstein et al., 1995). Similar 
results have been described in mice lacking rbpj (CSL) (Krebs, 2004) and hey 1 plus 2 
(Fischer, 2004).  Heterozygous loss of dll4 in mice is sufficient to induce arterio-venous 
malformation and leads to embryonic lethality (Krebs, 2004, Gale et al., 2004, Duarte, 
2004). The link between venous fate and Notch signalling is established by COUP-TFII 
(chicken ovalbumin upstream promoter-transcription factor II), which is required cell-
autonomously for venous differentiation and maintenance of the venous fate. 
Endothelial-specific loss of COUP-TFII results in expression of the arterial marker 
ephB2 in veins, along with arterial notch components notch1, Jag1 and hey (You et al., 
2005) and concurrent downregulation of markers of venous identity (You et al., 2005). 
During sprout initiation the Notch pathway plays an important role in tip cell 
selection.  Blocking Notch signaling with pharmacological inhibitors such as γ-secretase 
inhibitors (GSI), Dll4-Fc, Dll4 blocking antibodies or dll4 Morpholino results in vessel 
hypersprouting and ectopic branching with an increased number of tip cells each 
projecting greater number of filopodia (Leslie et al., 2007, Hellström et al., 2007, 
Siekmann and Lawson, 2007, Suchting et al., 2007, Lobov et al., 2007). Dll4 is 
expressed more strongly at the sprouting vascular front, with a pattern often described 
as salt and pepper to illustrate the non-homogeneous nature (Leslie et al., 2007, Lobov 
et al., 2007). It is clear that functional dll4 is required for correct vascular patterning and 
the above findings have led to the current model of tip cell selection (Fig 1.6B-C): 
VEGFA stimulates ECs to increase dll4 expression and stochastically, one cell acquires 
slightly higher levels (Fig 1.6B). The cell expressing higher levels of Dll4 signals to the 
adjacent ECs through Notch1 receptor. As loss of Notch signalling results in higher 
Chapter 1. Introduction 
 39 
levels of VEGFR2 (Suchting et al., 2007), it is likely that Notch activation results in 
downregulation of VEGFR2 through expression of hey1 (Holderfield et al., 2006) and 
upregulation of VEGFR1, making the signal-receiving cell less receptive to VEGF (Fig 
1.6C). This difference in VEGF responsiveness gives rise to the different behaviour of 
tip and stalk cells: high VEGF signalling due to higher expression of VEGFR2 allows 
tip cells to migrate, lower VEGFR2 and higher VEGFR1 leads to decreased VEGF 
signalling in stalk cells and which respond by proliferating. 
A recent investigation has uncovered that EC dependence on VEGFR levels of 
EC behaviour is only important in the presence of active Notch signalling. In EB 
sprouting assays, cells possessing only half the amount of VEGFR1 or 2 (flt1+/- and 
flk1+/-) were grown as chimeras with wildtype cells. A lower level of VEGFR2 allows 
normal differentiation and sprouting but cells are less likely to be found at the tip 
position. Conversely, having half the amount of VEGFR1, thought to act as a VEGF 
sink, increases the competitive potential of cells to reach the tip position. Blocking 
Notch signaling with GSI abolishes the difference in tip cell prevalence between 
heterozygous cells and wildtype cells, suggesting that Notch acts upstream of VEGFRs 
during sprouting angiogenesis. The creation of chimeric mice containing heterozygous 
VEGFRs cells recapitulated the competitive advantage of VEGFR1+/- and the lower 
presence at the tip of VEGFR2 +/-cells (Jakobsson et al., 2010). ECs can shuffle and 
change position within growing sprouts in the EB assay. The levels of VEGFRs do not 
alter the directionality and speed of migration but the persistence at the tip position was 
lower for VEGFR2+/- and substantially higher for VEGFR1+/- compared to wildtype 
cells (Jakobsson et al., 2010). 
Jag1 has been recently implicated in this regulatory mechanism by competing 
with Dll4 for Notch receptor, decreasing signaling and therefore having proangiogenic 
effects by preventing Dll4-induced VEGFR2 downregulation (Benedito et al., 2009). 
Loss of lunatic fringe phenocopies Jag1 gain of function (increased sprouting) as it 
normally enhances Dll4 signaling while dampening Jag1 signaling. It is important to 
note that Notch pathway components can sometimes segregate asymmetrically to 
induce different cell fates in daughter cells (Le Borgne and Schweisguth, 2003) but this 
has so far not been observed for Notch components in ECs. Notch signaling can be 
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affected at the level of NICD stability through sites competing for acetylation and 
ubiquitination that control its degradation, as has been shown to be the case for SIRT1, 
a member of the sirtuin family of NAD+-dependent deacetylases. SIRT1-induced 
deacetylation allows ubiquitination and subsequent degradation of NICD, reducing its 
signaling effect (Guarani et al., 2011). Some ECM components can alter Notch 
signaling. Laminin α4 can influence tip/stalk cell selection by enhancing dll4 
expression in ECs (Estrach et al., 2011b). 
 
1.6.3 CSL-independent Notch activity 
 
Notch signaling is able to induce CSL-independent events such as the activation 
of β1 integrin. Notch1 activation increases β1 integrin affinity for fibronectin, collagen 
I and IV, and is independent of transcriptional activation but reliant on the release of 
NICD from the membrane fraction (Hodkinson et al., 2007). The small GTPase R-Ras 
is responsible for the increase in integrin binding and Notch activity counteracts H-Ras 
and MAPK-dependent decrease of integrin binding (Hodkinson et al., 2007). This effect 
is not dependent on changes in integrin expression. Notch signaling has also been 
implicated in increased expression of ECM such as fibronectin, laminin and collagen I 
and IV. As stalk cells experience higher Notch signaling, the upregulation of basement 
membrane components fits with their role in vessel morphogenesis, along with the 
decreased expression of metalloproteases important in ECM break down (Trindade et 
al., 2008). 
Notch signaling is able to affect the vasculature by directing differentiation of 
cells other than ECs. It is known that smooth muscle cells surrounding arteries and 
veins are functionally and molecularly different. Arterial vSMCs express smoothelin, a 
marker for contractile function (van der Loop et al., 1996), along with SM22α 
(Moessler et al., 1996). Notch is implicated in arterio-venous differentiation of ECs as 
described above, but it is also involved in the determination of arterial/venous vSMCs. 
Loss of Notch3 in mice results in deficiency in arterial vSMCs identity without 
affecting ECs’ expression of ephB2 and thus their arterial identity (Domenga, 2004). 
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Aberrant Notch3 signalling is linked to defective expression of Platelet Derived Growth 
Factor Receptor-β (PDGFR-β), an important receptor in the differentiation and 
recruitment of vSMCs, an effect that is CSL-dependent (Jin et al., 2008). CADASIL 
syndrome (cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy) is a hereditary disorder characterized by stroke, dementia and 
vSMC dysfunction. Notch3 mutations are responsible for the syndrome and lead to a 
similar PDGFR-β downregulation as in mice and loss of arterial vSMCs in CADASIL 
patients (Jin et al., 2008). 
 
 
1.7 Repulsive cues in angiogenesis 
The growing vessels not only experience attractive cues, but are also affected by 
repulsive signals, which prevent the vascularization of tissues where blood vessels are 
not required and could even be detrimental.  There are a number of signaling pathways 
identified as repulsive cues in angiogenesis such as Semaphorins/Plexins, Ephrins/Eph 
receptors, Netrins/Unc5B and Slit/Robo. All these pathways were firstly characterized 
in neuronal guidance, stressing the similarities of the guidance and patterning 
mechanisms between the two branched systems. 
 
1.7.1 Semaphorins/Plexins 
Semaphorins (Semas) are secreted or membrane-associated glycoproteins 
implicated in heart morphogenesis, skeletal muscles development, immune system 
signaling, cancer and vascular development (Kruger et al., 2005). Over 20 Semas have 
been described to date and are classified based on their similarity. They all contain a 
SEMA domain, a conserved 400-residue stretch containing a seven blade β-propeller 
fold similar to the one found in integrins. 
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Semas can bind to the extracellular domains of neuropilins and plexins (Fig 1.8). 
Plexins are transmembrane receptors that contain the SEMA domain required for 
interaction with Semas. Additionally Plexins contain cysteine rich extracellular domains 
homologous with the Met scatter factor receptor. The Sema3 family (Seam3A-G) and 
PlexinA1-4 and D1 have been implicated in vascular development. Nrp1 and 2 provide 
the ligand recognizing subunit while Plexins signal downstream of Sema3s, and the 
three together form the functional ligand-receptor complex (Takahashi et al., 1999). The 
common effect of Sema signaling in neurons is the repulsion of growth cones and thus 
excluding particular nerves from certain areas of tissue (Kruger et al., 2005). 
Compelling work in zebrafish using Morpholinos targeted against the plexinD1 gene 
confirmed that in ECs, Sema/Plexin signaling is involved in the repulsion of angiogenic 
sprouts and the prevention of mispatterning of the vasculature (Torresvazquez, 2004). 
Similar mispatterned vasculature develops in out of bounds (obd) mutants, where the 
ISA sprout from regions of the DA that are not at the somite boundaries. The obd 
mutation has been pinpointed to plexinD1 (plxnD1) (Torresvazquez, 2004). PlexinD1 
deficiency is reiterated by loss of its ligand sema3a2 expression, normally expressed in 
somites dorsal to the DA, although the phenotype is not as severe, possibly due to 
redundancy between Sema3s (Torresvazquez, 2004). Transplantation experiments 
indicate that plxnD1 is required EC-autonomously for the correct guidance of ISA 
migration (Torresvazquez, 2004, Zygmunt et al., 2011). Loss of Sema/PlexinD1 
signaling not only leads to mispatterning of ISAs, it also increases the number of 
angiogenic ECs in the DA of zebrafish embryos. Loss of one allele of plxnD1 (as in 
heterozygous obd/+ embryos) is sufficient to increase the angiogenic potential of ECs, 
with such cells being found at the tip of ISAs in ~70% of cases in chimeric embryos 
(Zygmunt et al., 2011). This increase in angiogenic potential is a consequence of 
Sema/PlexinD1-dependent post-transcriptional splicing of flt1 mRNA. It increases the 
amount of flt1 that is translated as the soluble isoform, supported by the finding that 
sflt1 expression is absent in obd embryos (Zygmunt et al., 2011). Mispatterning is not 
related to membrane bound flt1  (mflt1) changes, and overexpression of mflt1 causes 
extremely mild inhibition of sprouting, whereas ectopic expression of sflt1 has drastic 
effects (Zygmunt et al., 2011). The effect of sflt1 on ISA sprouting and patterning is 
cell-autonomous, only preventing ectopic sprouting in expressing cells. Surprising as 
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this is, it means that soluble decoy receptors are not able to diffuse far from the 
secreting cell. This data therefore indicates that Sema/PlexinD1 effect on sprouting is 
through modulation of VEGFR output. Interestingly in obd mutants Notch signaling is 
not affected but when disrupted, these pathways can have additive effects on 
angiogenesis (Zygmunt et al., 2011).  
Loss of plxnD1 in mice results in congenital heart disease and vascular 
patterning defects, especially in the coronary arteries and the intersomitic vessels, which 
are unable to follow the somite boundaries as in obd zebrafish (Gitler et al., 2004). 
Sema3E deletion phenocopies plxnD1 deficiency and the signaling involved does not 
require Nrps as had been earlier suspected (Gu, 2005). Again these effects were shown 
to be EC-autonomous by use of the Tie2-Cre driver line to induce endothelial-specific 
gene deletion. Post-natal angiogenesis in the retina also suffers from developmental 
problems upon plxnD1 deletion (Zhang et al., 2009). In this model plxnD1 expression is 
dependent on VEGF signaling and is strongest at the sprouting front (Kim et al., 2011, 
Fukushima et al., 2011). The retinal ganglion cells supply Sema3E and 
Sema3E/PlexinD1 signaling inhibits dll4 expression in the vasculature (Kim et al., 
2011). Surprisingly unlike in the zebrafish, Sema3E/PlexinD1 are required to balance 
Notch signaling, thus tip/stalk cell selection and network formation (Kim et al., 2011). 
 
1.7.2 Eph Receptors/Ephrins 
Another receptor/ligand pair that was firstly discovered for their repulsive role 
in neuronal guidance is the Eph receptor family and the Ephrin ligands. Eph receptors 
are single pass transmembrane receptor tyrosine kinases containing a globular domain 
important for ligand interaction. So far there have been 16 receptors described in 
mouse, 10 EphA and 6 EphB, classified based on their affinity for ephrinA or ephrinB 
ligands (Kuijper et al., 2007). In zebrafish the situation is a lot more complex due to 
gene duplication. Ephrin ligands are grouped based on their mode of membrane 
attachment: ephrinAs are anchored via glycosylphosphatidylinisotol while ephrinBs are 
transmembrane proteins (Kuijper et al., 2007).  
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The peculiarity of Eph receptor/ephrin signaling is the presence of two types of 
signaling: the classical forward signaling where the ligand activates the receptor, which 
in turn relays the signal to intracellular pathways, but also reverse signaling where the 
ligand signals back into the signal-sending cell. The main members expressed in ECs 
are EphB4 (ephB4) in venous ECs and ephrinB2 (efnB2) in arterial ECs. As described 
above their expression is regulated by Notch signaling as well as by blood flow (Héroult 
et al., 2006). Because of their arterio-venous specific expression pattern, it was believed 
that EphB4 and ephrinB2 were important for vascular specification. Indeed loss of 
EphB4 and ephrinB2 leads to defects in vascular remodeling causing embryonic 
lethality by midgestation. However, these embryos do not display defects in the overall 
differentiation of arteries and veins, only in their maturation. It has also been 
hypothesized that EphrinB2/EphB4 are important for arterio-venous segregation, due to 
their repulsive behaviour. However, this is not observed in knockout embryos. Along 
with this, knockout mice for the TGF-ß co-receptor endoglin, which lack proper arterio-
venious segregation, still express ephrinB2 (Sorensen et al., 2003). 
In vitro work has shown that activating either forward or reverse signaling can 
lead to a pro-angiogenic response to EphrinB2, even though some conflicting reports 
describing opposite effects have been published (Adams and Alitalo, 2007). Two 
investigations have highlighted a contribution from ephrinB2 to enhancing VEGF-
induced sprouting. EphrinB2 is required for the internalization of VEGFR2 and 
VEGFR3 (Sawamiphak et al., 2010, Wang et al., 2010b), and EC-specific loss of efnb2 
results in decreased endocytosis of the VEGFRs. This internalization is critical to 
activate downstream signaling (Rac1, Akt and Erk in the case of VEGFR3) (Wang et 
al., 2010b), and VEGF-induced filopodia extension through ephrinB2 PDZ signaling-
dependent mechanisms (Sawamiphak et al., 2010). This could also explain why 
sprouting vasculature tends to express arterial markers such as ephrinB2, possibly 
giving ECs an angiogenic advantage. The PDZ domain of ephrinB2 is similarly vital for 
correct lymphatic development (Makinen, 2005). The migration and recruitment of 
pericytes to microvascular capillaries requires the cell-autonomous presence of 
ephrinB2, suggesting it might also have a cell-to-cell-independent function (Foo et al., 
2006). 
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1.7.3 Netrins/Unc5B and Slits/Robos 
Netrins are secreted laminin-like proteins that were discovered for their ability to attract 
or repel neuronal growth cones depending on the receptor they engage (Fig 1.8) 
(Colamarino and Tessier-Lavigne, 1995). Netrin-1 can have a pro- or anti-angiogenic 
effect and much debate around the supporting data has occurred. The receptor to which 
netrin-1 binds in believed to be Unc5B, a member of the dependence receptor family, 
composed of DCCs and the Unc5 families. Unc5B can signal upon ligand binding but 
will also signal (albeit differently) in the absence of netrin-1, often leading to apoptosis 
(Mehlen, 2005). Unc5B is selectively expressed in ECs and the first report of an Unc5B 
knockout mouse describes increased filopodia, suggesting the receptor possess anti-
angiogenic properties, reliant on Netrin-1/Unc5B signaling (Lu et al., 2004).  Unc5B is 
described as expressed exclusively in arteries in quiescent vasculature but is rapidly 
upregulated upon the initiation of angiogenesis (Larrivee et al., 2007). Tumour 
xenograft studies highlight the importance of netrin-1/Unc5B in the repulsion of ECs as 
observed in the full knockout mouse. Unc5B-dependent signaling is responsible for 
Netrin-1 induced repulsion and is believed to dampen sprouting angiogenesis (Larrivee 
et al., 2007). The opposing school of thought reported that Netrin-1 is an EC and vSMC 
chemoattractant and mitogen in vitro (Park et al., 2004). This effect synergizes with 
VEGF in in vivo angiogenesis assays (Park et al., 2004). The same group later reported 
that in their EC-specific Unc5B knockout the only vascular abnormalities were in the 
placental vasculature, where the plexus is structurally and functionally deficient, 
especially the arterioles (Navankasattusas et al., 2008), thus ascribing a pro-angiogenic 
role to the receptor, in line with their earlier data. It therefore remains unclear the exact 
role of Netrin/Unc5B signaling in the vasculature, possibly due to the dependence 
nature of the receptor and what appears to be vessel-bed specific effects. Another report 
attempts to reconcile the different interpretations by suggesting Unc5b in zebrafish 
induces caspase-mediated apoptosis in the absence of Netrin-1. Sprouting defects in 
Netrin-1 morphants can be rescued by caspase inhibition, Unc5b silencing as well as its 
downstream target DAPK (Castets et al., 2009). Overall it is clear that Netrin-1/Unc5B 
signaling is required for angiogenesis and hopefully further investigations will clear the 
divergences of current data. 
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Slits/Roundabout (Robo) are another ligand receptor pair that was identified in 
axonal growth. The name given to the receptor, roundabout, stems from the Drosophila 
knockout phenotype where robo mutants possess neurons that instead of crossing the 
midline once, turn around and cross back over (Seeger et al., 1993) and similar neuronal 
defects occur in mouse knockouts (Kidd et al., 1998). In the Robo family of receptors, 
Robo4 is endothelial-specific and plays a role in vascular development (Huminiecki, 
2002, Park, 2003). Robo4 contains only two of the usual five extracellular 
immunoglobulin domains, and only two out of three fibronectin type III domains 
compared to other members of the Robo family (Fig 1.8) (Huminiecki, 2002). In mouse 
Robo4 is expressed during embryonic vascular development, firstly in the trunk vessels 
and then intersomitic vessels and capillaries (Park, 2003). Interestingly, Robo4 
expression is highly upregulated in TGF-ß receptor Alk-1 deficient embryos that show 
general vascular patterning defects as well as lack of arterio-venous segregation (Park, 
2003). This expression pattern persists in the adult, where it is also present in vessel-
associated vSMCs. Slit2-Robo4 signaling is able to prevent EC migration in vitro (Park, 
2003). In contrast to this, it seems that expression of soluble Robo4 Fc-fusion acts to 
inhibit angiogenesis suggesting that its physiological role and that of Slits is to promote 
angiogenesis, in contrast with Park et al. In zebrafish, robo4 and slit-like2 are expressed 
in the vasculature (Bedell et al., 2005, Chen et al.). Endothelial robo4 expression in 
zebrafish is reliant on sox7 and sox18 transcription factors, without affecting endothelial 
differentiation  (Samant et al., 2011). Morpholino knockdown of robo4 results in 
misguidance of ISA sprouting (Bedell et al., 2005). Robo4 overexpression almost 
completely prevents angiogenic sprouting from the DA. This suggests that robo4 
directed signaling has a repulsive effect or at least is required for proper guidance. In 
agreement with this, loss of Robo4 in mouse post-natal retina aggravates pathological 
angiogenesis whereas ectopic Slit2 is able to dampen it, hinting that Slit2-Robo4 
signaling is important in vascular stability by affecting VEGF-induced increase in 
vascular permeability and EC migration (Jones et al., 2008). Slit2-Robo4 signaling can 
attenuate the effects of sepsis-induced cytokine storm and resultant vascular 
hyperpermeability. This is through a decrease in cytokine-induced VE-cadherin 
endocytosis by stabilizing VE-cadherin/p120-catenin complex, stabilizing EC-junctions 
and decreasing vascular leakage (London et al., 2010). The two opposing mechanisms 
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have been linked with differing downstream pathways: the pro-angiogenic effect of 
Robo4 is dependent on Cdc42 and Rac1 Rho GTPases and in vitro experiments indicate 
that Robo4 expression changes EC morphology and phenotype in a similar fashion to 
Rho GTPases (Kaur, 2006). EC motility and filopodia formation depend not only on 
Robo4 but also on heterodimeric complexes containing Robo1 and Robo4, the former 
being required for signal transduction. Robo4 activates actin remodeling pathways by 
interacting with Wiskott-Aldrich syndrome protein (WASP) (Sheldon et al., 2008). The 
repulsive effects of Slit2-Robo4 depend on the recruitment of paxillin and the Arf-GAP 
GIT1, inhibiting Arf6 activation and therefore Rac1. This prevents VEGF165-
dependent effects such as increased vascular permeability and migration (Jones et al., 
2009). 
More recent work has provided further evidence for a lack of binding between 
Robo4 and Slit2 but indicates that Robo4 might actually be binding to Unc5B, the 
dependence receptor described above. This interaction is able to block VEGFR2-Src 
association and signaling, along with VE-cadherin phosphorylation (Koch et al., 2011). 
Robo4-Unc5B complex formation is important in postnatal angiogenesis but not during 
development (Koch et al., 2011), reiterating what is observed in robo4-/- mice, where an 
effect is seen on vascular permeability and stability but not on patterning (Jones et al., 
2008). 
 
1.8 Macrophages in Angiogenesis 
Macrophages are myeloid derived cells that are produced in tissues upon 
differentiation of monocytes. Their primary role is the phagocytosis of necrotic cell 
debris and pathogens, playing a role in both innate and adaptive immunity. 
Macrophages have become an important component in understanding the effects 
of the tumour microenvironment on tumour progression. Many inflammatory cells are 
found in the tumoral stroma and most of these are tumour-associated macrophages 
(TAMs). Depletion of Tie2-expressing macrophages results in inhibition of tumour 
angiogenesis in subcutaneous xenograft models (De Palma et al., 2005). Similar effects 
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are observed in mice deficient for csf-1, a cytokine required for macrophage 
development, crossed with MMTV-PyMT oncogene-induced breast cancer mouse 
model. Tumours display decreased vascularization and progression (Lin et al., 2006). 
The use of liposome-encapsulated clodronate, which leads to macrophage apoptosis 
upon phagocytosis, delays angiogenesis and tumour growth (Zeisberger et al., 2006). It 
is thus clear that macrophages play a role in stimulating angiogenesis during tumour 
growth. Many signaling pathways have been implicated in the stimulation of tumour 
vasculariztion by macrophages: VEGFA, PLGF, angiopoietins, SDF-1, MCP-1 and 
semaphorins have all been reported to play a role (Squadrito and Palma, 2011). Recent 
work suggests that the Tie2/Ang2 axis mediates cell-to-cell interaction between TAMs 
and ECs to induce tumour angiogenesis. Blockade of Ang2 prevents Tie2 upregulation 
by TAMs and thus decreased EC interaction and angiogenesis. TAM-specific deletion 
of Tie2 is sufficient to reduce tumour angiogenesis, stressing the importance of this 
signaling axis between TAMs and ECs to promote vessel growth (Mazzieri et al., 2011).  
With regards to macrophage function in developmental angiogenesis, the picture 
is not as clear but recent reports have begun to shed light on possible mechanisms. 
Polverini et al first suggested their role in angiogenesis by demonstrating that activated 
macrophages induced vascular proliferation in the corneal stroma, concluding they are a 
major source of proangiogenic factors (Polverini et al., 1977). Neuronal tissue specific 
macrophages, termed microglia, are present in the retina prior to the emergence of the 
vasculature form the optic nerve head. They pre-pattern the retinal superficial layers, 
with even spacing from the center to the periphery (Gerhardt, 2003). The first direct 
evidence of the importance of macrophages in developmental angiogenesis is their 
effect on hyaloid vessel regression. Hyaloid vessels supply the lens during its 
development, and must regress to allow proper vision. PU.1 is an ETS-domain 
transcription factor important for gene expression leading to myeloid cell 
differentiation, especially macrophages and B cells. In PU.1-/- mice, loss of 
macrophages prevented proper hyaloid regression through lack of EC apoptosis. 
Macrophage-induced apoptosis is dependent upon secretion of Wnt7b ligand (Lobov et 
al., 2005). Macrophages are not required but appear to fine tune post-natal retinal 
vascularization as well as pathological neoangiogenesis, without affecting mature 
vasculature in the adult. Similar observations were made in osteopetrotic mice (op/op) 
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that lack functional M-CSF resulting in the failure of macrophage differentiation 
(Kubota et al., 2009).  Developmental defects are also manifested in lymphatics but 
again the adult lymph vessels are not affected. In these mutants tumour angiogenesis 
and lymphangiogenesis are reduced, with a decrease in tumour metastasis (Kubota et 
al., 2009). 
Fantin et al demonstrate that microglia are found in the hindbrain prior to 
vascularization and interact with VEGFA-induced tip cells to aid their anastomosis with 
adjacent tip cells. Loss of macrophages in PU.1-/- or op/op mice show decreased 
branching in the hindbrain vasculature. This was shown not to be dependent on 
monocyte-derived macrophages and VEGFA was not required in microglia (Fantin et 
al., 2010). Interestingly the microglial cells that aid tip cell anastomosis display similar 
molecular characteristics as angiogenic TAMs, with expression of tie-2 and nrp1, but 
are not necessary for the initiation of angiogenesis (Fantin et al., 2010). In post-natal 
retinal vascularization, microglia play a similar function and seem to act as bridges to 
aid tip cell anastomosis (Gerhardt, 2003, Rymo et al., 2011). Microglial loss results in 
decreased branching of the plexus along with reduced filopodia on tip cells, and a more 
radial trajectory of the growing sprouts (Rymo et al., 2011). In vitro experiments show 
that such an effect is dependent on two-way communication between microglia and 
ECs, reliant on the release of pro-angiogenic factors by the microglia, the identity of 
which still remains to be determined (Rymo et al., 2011). Microglia are also required to 
limit the extent of vascularization in the development of the deeper retinal plexus. 
Autocrine non-canonical Wnt signaling induces sFlt1 expression and secretion in 
microglia, limiting the angiogenic potential of the adjacent migrating sprouts (Stefater 
et al., 2011). Some evidence suggests that Notch1 is activated in microglia by Dll4 
present on tip cells and Notch1 in myeloid cells is necessary for the correct recruitment 
of microglia to sites of anastomosis. Myeloid loss of Notch1 results in a vascular plexus 
that resembles macrophage ablation described above, with decreased branching and 
anastomosis (Outtz et al., 2011). 
Overall it is becoming clearer that macrophages play a non-essential role in 
angiogenesis, fine-tuning the vasculature in some vascular beds during development. 
The interactions between ECs and macrophages still remain to be investigated as well 
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as the factors secreted by macrophages that are important in their modulation of 
angiogenesis. 
 
1.9 Tubulogenesis and Lumen Formation 
The process of angiogenesis must result in the formation of a functional vessel loop. 
Following EC activation, tip cell selection and sprouting, sprout migration and 
anastomosis, the newly formed vessel must lumenize. Vessel morphogenesis must occur 
without affecting the integrity of the tubular structure, whilst allowing the blood to flow 
through the newly formed lumen.  
In vitro experiments with human endothelial cells in 3D matrix gels highlighted that 
lumen formation in such a model occurred through the development of intracellular 
pynocytic vesicles, which fused into a larger vacuole that subsequently fused with the 
plasma membrane giving rise to an intracellular lumen (Davis and Bayless, 2003). The 
evidence for the pynocytic nature of the intracellular vacuoles is the presence of 
extracellular membrane proteins and fluorescent tracer found within such vacuoles 
(Davis and Bayless, 2003). Integrins are important in the formation of such vacuoles in 
3D matrix gels, with integrin α2β1 necessary in collagen gels whilst RGD-dependent 
vacuole formation and lumenization in fibrin gels depend on αvβ3 and α5β1 (Davis and 
Camarillo, 1996, Bayless et al., 2010, Davis and Bayless, 2003). The formation of 
integrin-dependent vacuoles relies on the function of the Rho GTPases Cdc42 and 
Rac1, found localized to the intracellular structures. Expression of dominant-negative 
variants decreases vacuole and lumen formation (Davis and Bayless, 2003).  
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Cdc42 and Rac1 regulate lumen formation through the p21-activated kinases Pak2 and 
Pak4, which alter endothelial cell stability and cytoskeletal architecture respectively 
(Koh et al., 2008), signaling downstream to induce cell polarization though the polarity 
proteins Par3 and Par6 (Koh et al., 2008). A much-debated paper reported the 
involvement of pinocytic vacuole fusion in vivo where the authors describe the presence 
of Cdc42-positive vacuoles within ECs (Fig 1.9A) (Kamei et al., 2006). Time-lapse live 
imaging of eGFP-Cdc42 transgenic zebrafish embryos suggests intracellular pinocytic 
vesicle formation and intercellular vacuolar fusion leading to vessel lumenization, 
findings that were replicated through in vitro 3D tube formation assays (Kamei et al., 
2006). 
 The importance of EC membrane polarization is supported by the activation of 
Par-family proteins (Koh et al., 2008). ECs do not have luminal-abluminal polarization 
when sprouting and must therefore specify these domains to allow the correct 
lumenization of the vessel. In formation of the aortic lumen, the targeting of CD34 
sialomucins to the luminal membrane is important to induce lumen opening (Strilic et 
al., 2009). In this model, vessel lumen formation appears to be an extracellular event 
(Strilic et al., 2009). Sialomucins are found intracellularly prior to lumen formation and 
later relocalize to EC junctions that will form the luminal domain, relying on VE-
cadherin for their relocalization. VE-cadherin may aid the exocytosis of 
CD34/podocalyxin vesicles by interacting with the phosphoinositide phosphatase 
PTEN. The requirement of VE-cadherin for the stability of vessels and lumen formation 
is also important in zebrafish (Montero-Balaguer et al., 2009, Wang et al., 2010a). 
Podocalyxin, a member of the sialomucin family, is required for lumen formation and 
the negative charge on sialomucins is required for EC repulsion leading to the initial 
opening of EC junctions (Strilic et al., 2009, Strilić et al., 2010). CD34 is connected to 
the actin cytoskeleton through interaction with the Ezrin-Radixin-Moesin proteins and 
this was shown to be through binding of Moesin, linking the sialomucins to F-actin. 
Moesin1 is required for ISV lumenization through its effect on luminal membrane 
formation and regulation of adherens junctions (Wang et al., 2010a). Experiments using 
PKC and ROCK inhibitors highlighted the requirement for PKC for Moesin1 
phosphorylation, allowing it to connect CD34 to the cytoskeleton. ROCK is required for 
non-muscle MyosinII phosphorylation and activation needed to generate force to induce 
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cell shape changes to aid lumen opening, a VEGF-dependent process (Strilic et al., 
2009). Overall such studies indicate that VE-cadherin-dependent relocalization of 
sialomucins is required for apical membrane specification and initial opening of the 
junctions, followed by recruitment of Moesin that is phosphorylated in a PKC-
dependent manner. This links the apical membrane to the actin cytoskeleton, followed 
by recruitment of non-muscle MyosinII, ROCK induces MyosinII phosphorylation and 
the contractile force changes cell shape leading to lumen formation (Fig 1.9B). Recent 
3D collagen assays have implicated RhoJ as another member of the Rho GTPase family 
in EC lumen formation. RhoJ exhibits endothelial-specific expression and requires the 
endothelial transcription factor ERG (Yuan et al., 2011). Loss of either protein results in 
increased activation of RhoA and downregulation of Cdc42 and Rac1 activity and their 
effectors, decreasing lumen formation (Yuan et al., 2011). The control of Rho GTPase 
activity is dependent on the Ras interacting protein 1 (Rasip1) and its binding partner 
Rho GTPase Arhgap29.  Rasip1-/- embryos exhibit severe lack of lumen and 
mislocalization of Par3, suggesting defective apical membrane specification, and 
aberrant adhesion to the ECM (Xu et al., 2011). Loss of ECM adhesion is due to 
alterations in the cytoskeleton affecting integrin-ECM binding, effects that can be 
attributed to the increase of RhoA/ROCK/myosinII activity and the concomitant 
decrease of Cdc42 and Rac1 (Xu et al., 2011). 
An alternative mechanism of lumen formation is observed in the zebrafish, 
which goes hand-in-hand with the unusual mechanism of PCV formation. ECs that 
sprout from the precursor DA to form the PCV engulf the developing erythrocytes via 
PI3K-directed migration (Wiley et al., 2011). It is not yet clear whether the differences 
observed between zebrafish and mouse are simply due to the identity of the vessels 
being studied but the most likely explanation is probably that a hybrid of the two 
models best describes lumen formation, where the apical membrane must be specified 
for initial lumen formation, and this is later expanded by vesicular fusion. 
As described above, interfering with EC-ECM interaction through integrin 
activity can affect vessel morphogenesis and lumen formation. In vitro tubulogenesis is 
severely affected by the reduction of fibroblast-secreted ECM components (Berthod et 
al., 2006). Components of the basement membrane include laminins, heterotrimeric 
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basement membrane glycoproteins composed of an α, β and γ subunits, with various 
members present in each family. Loss of most subunits leads to early embryonic 
lethality. In the embryoid bodies sprouting assay lamc1 deficiency (encoding laminin 
γ1) results in normal EC differentiation and vessel formation but increases the vessel 
diameter, an effect independent of flow but dependent on EC proliferation (Jakobsson et 
al., 2007a). Correct cell movement is required during tubulogenesis and lumenization, 
and is partially governed by EGF-like domain 7 protein (Egfl7). Egfl7 is expressed in 
the developing vasculature of mouse and zebrafish. Deficiency in egfl7 results in 
aberrant EC rearrangement and lumen formation (Parker et al., 2004), as a consequence 
of preventing EC junction release and the presence of ectopic junctions at the luminal 
surface (De Mazière et al., 2008). Embryonic vascular development is delayed in egfl7 
knockout mice, leading to embryonic lethality (Schmidt et al., 2007). Similar 
rearrangement defects are observed as in the zebrafish, with cells aggregating (Schmidt 
et al., 2007). The basement membrane shows mislocalization of components such as 
collagen IV. Egfl7 is found in the ECM suggesting that the migration problems are due 
to lack of spatial cues to direct polarization and tubule formation (Schmidt et al., 2007). 
This role in collective EC migration and tubulogenesis was reiterated in EB sprouting 
assays of egfl7 knockout ES cells (Durrans and Stuhlmann, 2010). Moreover in 
neuronal stem cells EGFL7 can interact with all four Notch receptors resulting in 
inhibition of Jagged driven signaling (Schmidt et al., 2009). The miRNA miR-126 is 
found within intron 7 of egfl7. This miRNA is endothelial specific and believed to be 
the actual cause of the knockout phenotype. The phenotypes of egfl7 and miR-126 
knockouts are similar but not identical, and egfl7 is also believed to be a miR-126 
target. Overall it is clear that each take part in tubulogenesis during vasculogenesis and 
angiogenesis (Nikolic et al., 2010). Sphingosine-1-phosphate has been implicated in 
inducing metalloprotease-dependent migration and lumen formation (Bayless and 
Davis, 2003) and its role in this process is an active area of interest for a number of 
groups. 
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1.10 Endothelial Cell Junctions  
An important function of the vasculature is the transport and exchange of gases and 
solutes with the tissue. This in turn implies that ECs must act as a selective barrier 
preventing the extravasation of red and white blood cells, platelets and other plasma 
components unless required. The barrier function of the endothelium must also be 
adapted to the particular tissue/organ in which it resides. In the central nervous system 
the vascular permeability must be tightly controlled due to the delicate homeostasis of 
neuronal tissue and therefore ECs have to prevent vascular leakage that could be fatal. 
On the other hand in the kidney where blood is filtered for metabolic waste, ECs 
possess small pores (10 nm range) to allow a lot of small molecules to pass through the 
cell, a phenomenon known as fenestration. Endothelial cell junctions control the 
permeability of vascular beds and there are two main types of junctions: adherens and 
tight junctions. 
Adherens junctions are formed by homophilic interactions of cadherins in trans. 
Cadherins are Ca2+-dependent adhesion molecules consisting of a transmembrane 
glycoprotein. In ECs the main cadherins expressed are VE-cadherin and N-cadherin 
(Bazzoni and Dejana, 2004). N-cadherin has been shown to be important for the correct 
recruitment of pericytes, and functional blocking results in disturbed vascular 
morphogenesis (Gerhardt et al., 2000). N-cadherin does not localize to adherens 
junctions in the presence of VE-cadherin (Navarro et al., 1998). VE-cadherin (cdh5) is a 
type II classical-cadherin composed of 5 extracellular cadherin domains, a 
transmembrane region and a highly conserved intracellular tail (Fig 1.10A). It is one of 
the earliest endothelial markers and is expressed as a cell commits to the endothelial 
lineage (Breier et al., 1996, Larson et al., 2004). The cytoplasmic tail interacts with the 
armadillo proteins p120-catenin and either β-catenin or plakoglobin, through which it 
can indirectly interact with α-catenin, α-actinin, vinculin and ZO-1 linking adherens 
junctions with the cytoskeleton (Bazzoni and Dejana, 2004). VE-cadherin expression is 
regulated by ETS family transcription factors such as Erg and Ets-1 (Dejana et al., 
2007). Snail family proteins such as Snail, Slug and Twist can directly interact with the 
VE-cadherin promoter, repressing its expression (Lopez et al., 2009), suggesting that 
some degree of endothelial-to-mesenchymal transition may be involved in the decrease 
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of junctional stability or initiation of sprouting.  VE-cadherin deficiency in mice does 
not prevent the formation of the primary plexus but induces vascular remodeling defects 
resulting in embryonic lethality by E9.5 (Carmeliet et al., 1999). Morpholino 
knockdown of cdh5 in zebrafish again does not affect axial vessel formation but 
prevents formation of new stable junctions during angiogenesis, preventing the 
formation of lumen (Montero-Balaguer et al., 2009). 
The stability of adherens junctions is regulated through a couple of mechanisms, 
one of which is VE-cadherin phosphorylation. Certain tyrosine residues in the 
intracellular portion of VE-cadherin are phosphorylated by the activation of receptor 
tyrosine kinases such as VEGFR2. VEGFA induces Src-dependent phosphorylation of 
Tyr668 and is required for VEGFA-induced EC migration (Wallez et al., 2007), as well 
as increased permeability (Eliceiri et al., 1999). Deletion of the cytoplasmic tail can 
have effects on VEGFA-driven survival signals through VEGFR2 and Akt due to 
decreased VE-cadherin/VEGFR2/β-catenin/PI3K interaction (Carmeliet et al., 1999). 
Through interactions with ICAM-1, leukocytes can also induce VE-cadherin 
phosphorylation at Tyr 658 and Tyr731, binding sites for P120-catening and β-catenin 
respectively. These phosphorylation events are driven by the activation of Src and Pyk2 
kinases, which increase leukocyte transendothelial migration (Allingham et al., 2007). 
VE-cadherin phosphorylation is negatively regulated by the presence of the EC-specific 
phosphatase Vascular Endothelial receptor-type PTP (VE-PTP) and loss of VE-PTP 
induces similar early embryonic defects to VE-cadherin deficiency, stressing the 
importance of regulated VE-cadherin phosphorylation and dephosphorylation 
(Dominguez et al., 2007). VEGFA and leukocytes are able to dissociate VE-PTP from 
VE-cadherin, allowing phosphorylation to increase vascular permeability (Nottebaum et 
al., 2008). The above-mentioned effects of VE-cadherin phosphorylation on 
permeability are also observed through phosphorylation of the other adherens junction 
components (Dejana et al., 2009). A second method of VE-cadherin regulation is 
through controlling its availability at the cell surface. Association of p120-catenin is 
believed to prevent VE-cadherin endocytosis, stabilizing EC junctions (Xiao et al., 
2005). VEGF can induce the activation of PAK, through Src, Vav2 and Rac1, to 
phosphorylate VE-cadherin on Ser665 and allowing β-arrestin2 recruitment. This in 
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turn induces detachment from the cytoskeleton and clathrin-mediated endocytosis of 
VE-cadherin,  thus increasing vessel permeability (Gavard and Gutkind, 2006). 
Angiopoietin-1 is able to block this by sequestering Src via mDia, resulting in the 
stabilization of junctions (Gavard et al., 2008). Cells stop proliferating at confluence 
through contact inhibition; VE-cadherin is required for preventing VEGF-induced 
proliferation (Lampugnani, 2003). Blocking adherens junction stability with VE-
cadherin function blocking antibodies is able to reduce tumour growth and angiogenesis 
(Corada, 2001, Corada, 2002) and can induce the disassembly of newly formed vessels 
during development (Crosby et al., 2005). 
As VE-cadherin binds β-catenin, adherens junctions can affect Wnt signaling 
through modulating the availability of cytoplasmic β-catenin. Wnt is involved in vessel 
stability (Phng et al., 2009) and Wnt/β-catenin is crucial for the establishment of the 
blood brain barrier (BBB) (Liebner et al., 2008). Endothelial specific deletion of β-
catenin results in developmental defects and vessel instability (Cattelino, 2003).  
Another type of junctional complexes found between ECs are tight junctions. 
Tight junctions are composed of three transmembrane proteins, the junctional adhesion 
molecules  (JAMs), occludins and claudins. The architecture of endothelial tight 
junctions varies depending on the vascular bed, with most found in CNS vasculature 
due to the requirement for strong barrier function in the blood brain barrier.  Occludins 
are four pass transmembrane proteins of ~65kDa with both the N- and C-temrinus found 
in the cytoplasmic side of the membrane. They are components of tight junctions but 
knockout experiments have demonstrated that they are not necessary for the formation 
of such junctions, even though occludins are expressed at high levels in the BBB 
(Bazzoni and Dejana, 2004). 
Claudins have similar structure to occludins but share no sequence similarity 
and are much smaller (~22kDa) (Bazzoni and Dejana, 2004). ECs express a specific 
claudin, claudin-5 (Morita et al., 1999), whose loss results in defective BBB function 
for molecules below 800Da meaning there exists some functional redundancy with 
other claudins (Nitta et al., 2003). 
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such strands gives rise to tight junction belts in epithelial structures; adapted from 
(Niessen, 2007). 
 
 
Most of what is known about tight junctions has been studied in epithelial 
systems due to lack of easily accessible models in the vasculature. There is some 
interdependence between adherens and tight junctions as adherens junction formation is 
required for the establishment of tight junctions in ECs and VE-cadherin is required for 
the upregulation of claudin-5 (Taddei et al., 2008). 
 
 
1.11 A Model of Tubulogenesis – Drosophila Tracheal 
Morphogenesis 
A well-studied model of tubulogenesis and anastomosis is the Drosophila trachea. Here 
I will describe its development, cellular and genetic events leading to its correct 
morphogenesis and the similarities with what has been described in sprouting 
angiogenesis. Some slight differences in response to the various genes mentioned below 
are observed between different portions of the developing trachea but for the sake of 
this introduction I will describe a generalization of their effects and concepts. 
 
1.11.1 Initiation of sprouting 
The Drosophila trachea exhibits similar phases of development as the vasculature: 
differentiation of progenitor cells, initiation of sprouting and associated tip cell 
selection, sprout elongation to target tissue and anastomosis to form a functional 
network. The trachea forms from 10 ipsilateral clusters of ectodermal cells, resulting in 
20 hemisegments composed of ~80 cells each that migrate and connect to give the 
tracheal network (Fig 1.11A). The specification of such cells is dependent on the 
expression of the basic helix-loop-helix-PAS transcription factors (bHLH-PAS) 
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trachealess (trh) and Ventral veinless (Vvl), directing the ectodermal cells towards the 
tracheal fate and to the formation of the tracheal placode (Wilk et al., 1996, Anderson et 
al., 1995). Subsequently these 20 hemisegments invaginate and form tracheal buds (Fig 
1.11B) through an EGF- and FGF-dependent mechanism (Cabernard and Affolter, 
2005). Tracheal cells form primary branches and migrate towards sources of branchless 
(bnl) (Fig 1.11B’), an FGF family ligand (Sutherland et al., 1996). The migration is 
dependent on the expression of breathless (btl) in the tracheal cells, the sole Drosophila 
homologue of FGF-R (Klambt et al., 1992, Glazer and Shilo, 1991). FGF signalling 
leads to the phosphorylation of MAPK, which becomes restricted to the cell at the tip of 
the sprout (Fig 1.12A) (Ikeya and Hayashi, 1999). Bnl and btl are expressed throughout 
tracheal morphogenesis and are important in both the initial sprouting and subsequent 
elongation and migration of the growing trachea. FGF signalling alters cellular 
morphology, inducing filopodia extensions at the tip of the growing sprout, polarized in 
the direction of growth (Fig. 1.11B”’) (Ribeiro et al., 2002, Sato and Kornberg, 2002). 
These primary branches can either connect to form the transverse connective or go on to 
form secondary branches which will then either become terminal branches or fuse with 
the neighbouring metameres (Samakovlis et al., 1996a). The pattern of primary and 
secondary branching is highly stereotyped suggesting the cues guiding the patterning 
are genetically encoded (Samakovlis et al., 1996a). On the other hand terminal branches 
that supply the tissue show large variability between embryos hinting at environment-
regulated patterning (Samakovlis et al., 1996a).  The environmental effects are 
dependent on the Drosophila version of the human HIF pathway, where similar (sima) 
is the closest HIF-1α homologue and the β subunit is represented by tango (Bacon et 
al., 1998), both bHLH-PAS transcription factors. Sima is degraded in an oxygen-
dependent manner much like HIF and this is dependent on the prolyl hydroxylase fatiga 
(Bruick, 2001). Sima induces the expression of btl, the FGF receptor, in tracheal cells 
whereas in non-tracheal cells it induces the expression of FGF ligand bnl, therefore 
increasing responsiveness of tracheal cells whilst upregulating the morphogenetic cue 
required for growth (Centanin et al., 2008). In the early stages of tracheal development 
sprout growth is less dependent on hypoxia-driven gene expression, but this becomes 
more important in later stages, especially during terminal branching and the refinement 
of the network later in the life cycle (Mortimer and Moberg, 2009). 
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 The tracheal system develops without any DNA synthesis, cell division or apoptosis, 
relying on the initial 80 or so cells contributed by each hemisegment (Samakovlis et al., 
1996a). With no increase in cell numbers, the network must form by extensive cell 
migration, cell shape changes, rearrangements and intercalation. Tracheal tubules start 
off as paired cells with two cells per cross-section and undergo adherens junction 
rearrangement and cell intercalation, resulting in the formation of unicellular tubes that 
surround the lumen and possess autocellular junctions (Ribeiro et al., 2004). 
This process is controlled by the presence of Dpp and Wnt at sites distal to the 
primary trunk tubules, allowing the thinning out and elongation of the sprouts as they 
grow towards target tissues. Dpp and Wnt prevent the expression of spalt, a 
transcription factor that inhibits cell intercalation and therefore leads to large 
multicellular tubules unless downregulated (Ribeiro et al., 2002). 
 
1.11.2 Sprout elongation and tip cell selection 
Expression of localized Bnl is dependent on the presence of the member of the TGF 
superfamily decapentaplegic (Dpp) (Vincent et al., 1997). Loss of Dpp signalling 
through the loss of functional receptors (tk and punt) results in lack of migration of 
tracheal cells, an observation mirrored by ectopic expression of Dpp that suggests Dpp 
is extremely dose sensitive, as both over- and underactivation affect migration. 
Defective migration is also caused by altering Dpp signalling specifically in tracheal 
cells, therefore bnl expression is not sufficient to induce migration. This FGF signal 
must be somehow integrated with the Dpp signal within tracheal cells to direct the 
growth (Fig 1.12A) (Vincent et al., 1997).  
Similarly to sprouting angiogenesis, the Delta/Notch lateral inhibition pathway is 
important in the sprouting and tip cell selection in tracheal development. Btl-driven 
expression of Delta (Dl) is present in 2-3 cells upon initial sprouting (Ikeya and 
Hayashi, 1999), confirming its dependence on FGF. These cells also express pantip 
markers such as pointed, which later become restricted to two tip cells (Samakovlis et 
al., 1996b, Llimargas, 1999). Dl is later restricted to a single tip cell, which will assume 
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the fusion cell fate. Loss of Notch function increases the number of tip cells, with the 
concomitant increase in cells expressing the fusion marker esg (Ikeya and Hayashi, 
1999, Steneberg et al., 1999). This coincides with a loss of restriction of MAPK 
signalling at the tip of growing sprouts, as well as the defective fusion of many sprouts, 
whereas terminal branching is decreased (Fig 1.12B) (Llimargas, 1999). The Notch 
target hairy is also able to affect tip cell differentiation by modulating bnl expression in 
muscles close to where terminal branching occurs. Loss of hairy results in higher bnl 
expression and higher number of terminal cells (Zhan et al., 2010).  
 
1.11.3 Terminal Differentiation 
Once the growing sprouts have migrated to their final destination they acquire the 
terminal branching fate whilst a small number must connect with adjacent subunits by 
anastomosis to give a complete network. Terminal branching occurs by the extension of 
cytoplasmic protrusions emanating from the terminal cell adjacent to the fusion cell at 
the tip of the sprout. Terminal cell branching results in a dense covering of the tissue, 
with thin processes containing intracellular lumen (Samakovlis et al., 1996a). Terminal 
cell fate is determined by the expression of terminal markers such as pruned, which 
encodes dSRF and regulates the cytoplasmic branching much like the mammalian SRF 
does (Fig 1.12B). Loss of pruned results in lack of terminal branching, whilst 
overexpression results in excessive and unregulated branching (Guillemin et al., 1996). 
Pruned expression is regulated by presence of bnl (Sutherland et al., 1996), whilst 
expression of terminal markers is repressed in fusion cells by esg. Importantly, other 
signalling pathways important in angiogenesis also have a role in the guidance of 
tracheal growth such as the Roundabout (Robo) and Slit family members involved in 
branch-specific pathfinding (Englund et al., 2002).  
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1.11.4 Sprout fusion/anastomosis 
Tracheal sprouts are headed by a tip cell that begins to express a set of genes important 
for the fusion of the tracheal network upon reaching target regions (Samakovlis et al., 
1996b). The first gene expressed is escargot (esg), which determines the cell to acquire 
the fusion cell identity. Esg is a zinc finger transcription factor part of the Snail family 
of transcriptional regulators. Esg expression is induced by Dpp, which is expressed in 
locations where fusion must occur (Fig 1.12B) (Steneberg et al., 1999). Accordingly, 
loss of Dpp signalling leads to a decreased number of fusion cells whereas gain of 
function manipulations increase esg expression and result in an increase in fusion cells. 
Interestingly modifying Dpp effects also affects terminal branch differentiation 
(Steneberg et al., 1999), hinting at signal integration with the Notch pathway to limit 
fusion cells. 
Expression of esg kicks off the fusion cell genetic programme (Steneberg et al., 
1999), initiating the expression of the other fusion markers: dysfusion (dys), headcase 
(hdc), members only (mbo), shotgun (shg), bloated tubules (blot), CG13196 and 
CG15252. These genes are expressed in an order related to the cellular functions they 
play during the fusion process. Dys is a bHLH-PAS transcription factor expressed in all 
fusion cells. Tracheal tubules in embryos carrying dys mutations migrate normally but 
fusion does not occur in most branches (Jiang, 2006). Filopodia from the two fusion 
cells come into contact but do not make firm adhesions, as a result of the failure to 
accumulate DE-cadherin (which is encoded by shg). Misexpression of dys results in 
reduced branching and migration, along with various ectopic fusion sites that lack 
detectable lumen through the fusion points (Jiang, 2006). To induce transcriptional 
activation dys must dimerize with tango, and together they bind various NCGTG 
binding sites (Jiang and Crews, 2007) and go on to activate the expression of mbo. 
CG13196, CG15252 and lead to the upregulation of shg from basal levels (Jiang, 2006). 
Dys also indirectly affects levels of trh resulting in the downregulation of btl in fusion 
cells, thus preventing bnl-driven branching (Fig 1.12B) 
CG15252 is an unknown protein, but it does share sequence homology with the 
bacterial FtsI protein that is a transpeptidase involved in cell wall peptidoglycan 
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synthesis and cell division (Errington et al., 2003), therefore its function in tracheal 
fusion remains unclear. The function of blot is also unclear, as it is a neurotransmitter 
symporter but has been linked to the formation of actin filaments in the apical cortex 
(Johnson et al., 1999).  
 
 
Figure 1.12 Pathways involved in control of tracheal sprouting and fusion/terminal 
cell fate determination.  
A. Schematic representing the major signalling pathways that integrate to control tip 
cell selection and sprouting. Bnl and Dpp act on their cognate receptors Btl and 
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Tkv/Punt. Btl expression is induced by Trh, a bHLH-PAS transcription factor. Btl-
driven signalling leads to MAPK phosphorylation and this somehow integrates with the 
Dpp-driven signal, leading to sprouting, migration and branching (Tip cell fate). Dpp 
signalling also induced the expression of Dl which activates Notch signalling in 
neighbouring cells, preventing the activation of MAPK, leading to a decrease in Dl as 
well as a decrease in migration and branching (stalk cell fate). B. Upon secondary 
branching and reaching target tissue, tip cells must assume either a fusion cell fate to 
connect with neighbouring metameres or the terminal cell fate, which will supply 
tissues. Here Dpp induces expression of the fusion gene Esg, which leads to the 
expression of Dys. Dys in turn upregulates DE-cadherin that is required for fusion cells 
adhesion during anastomosis. Dys also indirectly decreases Trh levels, lowering Btl 
thus preventing extra branching in fusion cells. Esg also represses terminal cell markers, 
upregulates Hdc that non-autonomously prevents stalk cell branching, and other fusion 
genes. The neighbouring terminal cell receives Dl signalling through the Notch receptor 
which prevents the expression of Esg. This maintains high Btl levels that drive dSRF 
expression leading to terminal branching. 
 
Mbo attenuates nuclear export of proteins  (Roth, 2003) even though it is not clear 
what its target in fusion cells maybe. It could be important in the nuclear accumulation 
of dys to allow binding to tango and therefore affect gene expression.  CG13196 is a 
zona pellucida protein (Jaźwińska and Affolter, 2004) and is likely to be involved in the 
formation of cell adhesion together with shg. Downregulation of CG13196 only slightly 
affects fusion but misexpression increases ectopic fusion events (Jiang, 2006). 
Shg encodes the drosophila homologue of mammalian E-cadherin, DE-cadherin. 
It accumulates as a dot at the sites of initial contact between two fusion cells. This later 
expands to a ring as the fusion cell bodies move closer and the ring enlarges to allow 
the formation of lumen through the fusion point (Tanaka-Matakatsu et al., 1996). These 
molecular events are very similar to what has been described during zebrafish ISA 
anastomosis with regards to VE-cadherin accumulation and ring formation (Blum et al., 
2008). Mutants with lower levels of DE-cadherin or mislocalization of the protein away 
from the junctions have defective fusion where either the spot does not expand or the 
ring fails to enlarge only allowing a very thin lumen to form (Tanaka-Matakatsu et al., 
1996). Shg expression is esg-dependent as esg controls dys expression, and therefore 
esg mutants show defective DE-cadherin expression and accumulation. These mutants 
also display increased motility suggesting that affecting cell-cell contacts by 
downregulating DE-cadherin affects cell motility (Tanaka-Matakatsu et al., 1996). 
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Interestingly ectopic expression of DE-cadherin in such esg mutants was able to 
partially rescue to fusion defects observed, stressing the importance of making firm 
adhesions during anastomosis. Formin3 is a member of the formin family, proteins that 
are involved in many actin-based processes, and is important in directing the 
accumulation of DE-cadherin at fusion sites as well as in the formation of actin 
structures required for the lumenization of the newly connected tubule (Tanaka, 2004). 
The importance of adhesion molecules such as VE-cadherin during anastomosis has 
been demonstrated in zebrafish ISA sprouting and anastomosis (Abraham et al., 2009).  
 
1.11.5 Headcase 
Hdc is a peculiar protein as it contains no conserved structural/functional domains and 
is in a protein family that is solely composed of its orthologues. It is cysteine rich, has a 
pI of 9.6 and accumulates in the cytoplasm of Drosophila cells and therefore it is 
thought to be involved in protein-protein or protein-RNA interaction (Weaver and 
White, 1995). Hdc was originally discovered in imaginal discs where it is expressed just 
prior to re-entry of cells into the mitotic cycle, but expressions ceases before the end of 
proliferation (Weaver and White, 1995). Loss of hdc expression neither prevents 
imaginal disc formation nor changes in their size but causes pupal lethality and affects 
the development of adult tissues to varying degrees. The tissues affected are the internal 
structures of the head, hence the gene name headcase (Weaver and White, 1995). 
Hdc was later described as one of the fusion genes induced by esg and used as a 
marker for tracheal fusion cells. Its expression precedes cell-cell contact (Samakovlis et 
al., 1996b). Embryos mutant for hdc are still able to specify tip cells but extra branching 
occurs. Misexpression of hdc has the opposite effect and reduces terminal branching. 
These effects are non-autonomous suggesting that hdc is preventing its neighbour in the 
stalk from expressing pantip markers and terminal branching genes (Steneberg et al., 
1998). Interestingly the hdc gene contains 2 ORFs but only the full length ORF can 
rescue mutant embryos, though it is not clear whether the smaller fragment has a 
function working together with the larger one (Steneberg et al., 1998). As there is no  
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Figure 1.13 Fig 1.13 Protein sequence alignment of heca.  
Amino acid sequence alignment of human, mouse and zebrafish of heca showing high 
degree of identity, especially at the C-terminus. 
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cell division during tracheal morphogenesis, hdc does not play a role in prefiguring cells 
for division in this context. 
The mouse homologue of hdc is heca. It is well conserved between vertebrates showing 
96% and 70% target identity with humans and zebrafish. The C-terminus is especially 
conserved showing ~90% identity in the last 100 residues (Fig1.13). The only other 
investigations regarding the function of heca have studied its role in tumours. Heca is 
expressed at lower levels in the blood or faeces in healthy patients compared to 
colorectal cancer patients.  
The level of expression in cancer patients correlates with the stage of their 
disease and can be considered an early-stage marker (Chien et al., 2006). Another study 
reports that a chromosomal region that contains heca (6q23-q24) is commonly deleted 
in pancreatic cancers and ~80% of pancreatic and renal cell carcinoma lines tested show 
lower heca mRNA levels compared to healthy tissue (Makino, 2006)}. In oral 
squamous cell carcinoma (OSCC) heca is less abundant than healthy tissue, especially 
in basal cells (Dowejko et al., 2009). Overexpression of heca in OSCC cell line PCI 13 
increases doubling time by 45% and holds cells in G2/M phase, decreasing the number 
of proliferating cells down to 30% compared to control (Dowejko et al., 2009). No other 
work investigating the heca’s role in tubulogenesis in vertebrate networks (lung, 
kidney, angiogenesis) has been undertaken. 
 
It is clear that many parallels can be drawn between sprouting angiogenesis and tracheal 
morphogenesis, for example: 
• The requirement for the presence of a morphogen to attract sprout growth and 
the expression of its cognate receptor in migrating cells 
• The role of Dl/notch in the selection of tip/fusion cells 
• Regulation of patterning at the genetic and environmental level 
• The integration of many pathways leading to a well patterned network 
(Dpp/TGF. Slit, Robos, Wnts) 
• The necessity of anastomosis to form a functional system  
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1.12  Summary 
Vascular development is a complex and tightly regulated process that ultimately enables 
the supply of  oxygen and nutrients to an organism’s tissues. Endothelial cells that make 
up the vasculature can be activated to grow through stimulation by VEGF and other 
pro-angiogenic factors. Many pathways are involved in the initial sprouting and 
guidance of vessel growth to result in a well-patterned, hierarchical and functional 
network. Similar tubular systems such as the Drosophila trachea show similarities in 
development at the molecular and cellular level, and can therefore be utilised to guide 
investigations into angiogenesis. 
 
1.13 Aims of PhD 
Angiogenesis is a very dynamic process involving multiple steps to lead to the 
formation of new functional vessels. Only in recent years have we begun to investigate 
this process in live organisms. This study set out to improve our understanding on the 
dynamics of sprouting angiogenesis with particular attention to anastomosis. Headcase, 
a gene expressed in Drosophila tracheal fusion cells, was investigated for its potential 
regulation of sprout fusion. Finally, as macrophages appear to play a role in 
angiogenesis, zebrafish embryos were used to visualize the interactions between ECs 
and macrophages. 
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Chapter 2. Materials and Methods 
2.1 Zebrafish Experiments 
 
Zebrafish were maintained at standard conditions (28°C, 14/10 hours light/dark cycle). 
Fish were fed daily, twice prior to mating. 
 
2.1.1 Transgenic lines 
A number of transgenic lines were used in the following studies: 
Tg(fli:eGFP)y1 generated by Nathan Lawson ((Lawson, 2002) by cloning eGFP 
downstream of the fli promoter region. 
Tg(fms:nfsB.mCherry) generated by Caroline Gray (Gray et al., 2011) which is 
comprised of :  
• Tg(fms:GAL4.VP16)i186 - the fms promoter driving the expression of 
Gal4.VP16  
And  
• Tg(UAS-E1b:nfsB.mCherry)i149 - mCherry fusion protein with nitroreductase 
driven by UAS-E1b promoter 
 
Tg (flk1:mG) which I generated by cloning  the mG construct (gift of Richard 
Behringer) downstream of the zebrafish flk1 promoter (gift of Markus Affolter) 
 
Figure 2.1 flk1:mG construct map 
Chapter 2 Materials and Methods 
 73 
The mCherry-labelled H2b allows the visualization of nuclei whilst the GPI-anchored 
eGFP labels the inner leaflet of the cell membrane. The self-cleaving 2A peptide is a 
short stretch of amino acids that allows the bicistronic expression of the two transcripts 
and has been shown to work in both mice and zebrafish (Szymczak et al., 2004). This is 
a preferred method of expressing two transgenes from a single promoter as compared to 
using internal ribosome entry sequences (IRES), which give mixed results in zebrafish 
(Mizuguchi, 2000) 
 
2.1.2 Morpholino Microinjection 
Microinjections were performed using a 200nm borosilicate glass capillary tube to 
inject 2nl of solution into the yolk/cell of 1-4 cell stage embryos. The following 
Morpholino oligonucleotides (GeneTools) were used. 
The pu.1 Morpholino sequence has been previously published and shown to induce a 
significant knockdown in gene expression. (Su et al., 2007) The heca and l-plastin 
Morpholinos were designed to block translation (MO1) and splicing of the first and 
second intron (MO2). p53 Morpholino was co-injected as Morpholino oligonucleotides 
can induce p53-dependent but unspecific toxic effects (Robu et al., 2007). The standard 
control oligonucleotide used was the one offered by GeneTools and should not have any 
off target effects. 
Morpholino Sequence 
Control 5’-CCTCTTACCTCAGTTACAATTTATA-3’ 
Zf p53 5’-GCGCCATTGCTTTGCAAGAATTG-3’ 
Heca MO1 5’-TCCATCTTTTAAACACAGACGCCAT-3’ 
Heca MO2 5’-TGACGGTCGGTTCTTACCGCTTCTG-3’ 
Pu.1 (Su et al., 
2007) 
5’-GATATACTGATACTCCATTGGTGGT-3’ 
L-plastin MO1 5’-GATCTGTGCTGCTGCCATCTTCAAC-3’ 
L-plastin MO2 5’-CATGTCTCTGTACTGACCGACTTTA-3’ 
Table 2-1 Morpholino oligonucleotide sequences 
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2.1.3 Microangiography 
Embryos were anaesthetised in 1X tricane and immobilised in a dish with low melt 
agarose. Qdot 655 (3 in10 dilution, Invitrogen) was injected using a glass capillary tube 
in the pericardial region. 
 
2.1.4 Cell Proliferation Assay 
EdU is a synthetic analogue of thymidine and is incorporated into DNA during its 
replication in S phase. Embryos were incubated in a diluted stock of EdU in fish water 
for the desired period of time. They were then fixed in 4%PFA for 2 hours at room 
temperature and subsequently washed with PBT.  The Click-iT Imaging kit (Invitrogen) 
was used to detect EdU by adding azide-conjugated Alexa-Fluor (molecular Probes) 
that reacts with a chemical moiety on the EdU. Embryos were incubated in the detection 
solution for 2-4 hours. 
 
2.1.5 Wholemount in situ hybridization 
2.1.5.1 Probe generation 
Zebrafish embryos were collected at 24 and 48hpf and lysed using a glass homogenizer 
(wheaton) with RTL buffer (RNeasy Mini it, Qiagen) an cleared using a QiaShredder 
column (Qiagen) and total RNA was isolated using the RNeasy Mini kit protocol. The 
isolated RNA was used to synthesise first strand cDNA using oligodT (20) primers and 
SuperScript III (Invitrogen) according to manufacturer’s protocol. 
Primers were designed to clone the full length heca cDNA (Table 2-2) for probe 
synthesis and later use. The cDNA was generated using Taq DNA Pol HotMasterMix 
(Eppendorf) and cloned into pCR2.1 TOPO® using the TOPO-TA cloning kit 
(Invitrogen). The plasmid was transformed into One Shot TOP10® (Invitrogen) 
competent cells and cultured on LB agar antibiotic selection plates at 37°C. Clones 
were selected and grown in LB broth containing antibiotic and the plasmid was isolated 
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using Mini/MaxiPrep kit (Qiagen). The plasmid was sequenced using the ABI BigDye 
Terminator v3.1 kit using the Applied Biosystems 3730 DNA analyser. Plasmids 
encoding the template for in situ probe synthesis were linearized so as to generate 
probes. The digests were checked on a 1% agarose gel and reactions where either 
cleaned using column purified (Qiagen) or gel purified. The following in vitro 
transcription reaction was set up: 
1ug linearized DNA 
1x Transcription buffer 
1X DIG-labelled RNA labelling Mix (Roche) 
1U RNasin (Promega) 
1U T7 RNA polymerase (supplier) 
The reaction mixture was made up to 20µl in nuclease free water. The reaction was 
incubated at 37°C for 2 hours and probe quality was assayed on a 1% agarose gel to 
check yield and correct size of band. Plasmid DNA was digested by adding 1ul of 
RNAse-free DNase I (Ambion) and incubating for 30 minutes at 37°C. The probes were 
precipitated by the addition of 2.5µl of 4M lithium chloride and 75µl of ethanol and 
incubated at -80°C for 30mins or at -20°C overnight. RNA was pelleted by 
centrifugation at 10,000g at 4°C and washed in 70% ethanol. 
For Primer Rev Primer 
5’- CTCGGCTTGACAACCCCGT-3’ 5’- TCAATAAGCTTCAAGAACTTTGAA-3’ 
5’-AACGCACGAATAGTAGCGGGGGCGAGC -
3’ 
5’-TCCTGACAGTTCTGCCAATCTGCTG-3’ 
5’-GTCAGGCTTCTCCTCCTTCTCC-3’ 5’-GGTTTCCCACAATGCTTGCAGTTC-3’ 
5’-
GCAACAAGGGGAAGAGAAATAAACGCACG-
3’ 
5’-AGGAACTCGCCCAGATGTC-3’ 
5’-TGAGGAGGCTGGATCTTTCAGAGCTGC-3’ 5’-CCAGATTGCCGCAGTGAGGACACT-3’ 
Table 2-2 Primer pairs used to generate fragments for in situ probe generation 
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2.1.5.2 Solutions for ISH 
• PBSTw: 1xPBS; 0.1%Tween20 
• HB4: 50% formamide; 1.3X SSC; EDTA 5mM; yeast RNA 50ug/ml; 100ug/ml 
heparin; 0.2%Tween 20; CHAPS 0.5% 
• 2x SSCTw: 2x SSC 0.1% Tween20 
• Staining buffer (SB): 100mM NaCl; 50mM MgCl2; 10mM Tris pH 9.5 
• 0.1% Tween 20 
• Staining solution (SS): SB + 3.5ul of NBT and BCIP per ml  
Solutions used up to and including the hybridization step were RNase-free 
 
2.1.5.3 Fixation and rehydration 
Embryos were dechorionated at desired stage and fixed overnight in 4% PFA. They 
were subsequently briefly washed twice with PBSTw followed by 3 washes for 5 
minutes with PBSTw. 100% methanol was used to fix the embryos at -20°C for 30mins-
1hr. Embryos were rehydrated by incubating with 75%MeOH/PBSTw for 5mins at RT, 
followed by 50% and 25% MeOH/PBSTw, finishing the process with 2 washes of 
5mins in PBSTw. 
 
2.1.5.4 Digestion and Hybridization 
Embryos were digested with proteinase K for 2 mins. The proteinase K was removed 
and embryos were fixed with 4% PFA for 20mins at RT and washed twice in PBSTw 
for 1min followed by 3 washes for 5mins at RT. Embryos were incubated in 
hybridization mix at 65°C for 2 hours. Riboprobes were diluted 1:10 in HB4 (100ul 
final/embryo) and heated to 80°C for 10mins following cooling on ice. The 
hybridization solution was removed from the embryos and replaced with the diluted 
probes and incubated overnight at 70°C. 
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2.1.5.5 Colorimetric reaction 
Embryos were washed twice for 30 mins in 2x SCCtW/50% formamide at 65°C, once 
in 2x SSCTw for 15mins at 65°C and twice in 0.2x SSCTw for 30mins at 65°C. 
Embryos were blocked in 5% sheep serum PBSTw for 2hrs at RT and incubated for 
2hrs in 100µl of sheep anti-DIG Fab fragments at 1:2000 in PBSTw at RT and 
subsequently washed 6 times at RT with PBSTw for 5,10,15, 20,25 and 30 mins. The 
two subsequent washes were for 5mins with SB to equilibrate the embryos for the 
colour reaction. Staining solution was added and embryos were incubated at RT in the 
dark or at 4°C overnight. The reaction was stopped with the addition of EDTA. 
 
2.1.6 Wholemount Immunolfuorescence antibody staining 
Embryos were dechorionated at the desired developmental stage and fixed in 4% PFA 
for 2 hours at RT or O/N at 4°C. Embyos were then washed in PBS + 0.1% Tween20 
(PBT) to remove PFA. Embryos were stained as described below and were post-fixed 
for 15mins in 4% PFA following antibody staining. 
Antibody Species Reactivity Supplier Cat.No. Dilution 
BMP4 Rabbit Mouse Abcam Ab39973 1:200 
PECAM-1/CD31 Rat Mouse BD 553370 1:200 
Heca (C-19) Goat Human Santa Cruz sc-103543 1;200 
IsolectinB4-488 Griffonia Mouse Molecular 
Probes 
I21411 1:500 
P-Smad 1/5/8 Rabbit  Cell Signaling 9516 1:200 
NG2 Rabbit Mouse Chemicon AB5320 1:100 
Snail Rabbit Mouse Abcam Ab17732 1:200 
ZO-1 Mouse Humn Zymed 268404 1:200 
Table 2-3 Antibodies used for immunofluorescence 
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Acetylated tubulin 
This staining protocol was kindly provided by Claudia Linker from the Lewis lab at the 
London Research Institute. Embryos were washed five times in PBS + 0.5% Triton X-
100 following fixation.  Blocking was performed in PBS + 10% Goat serum, 2%BSA, 
0.5% Triton X-100 and 10mM sodium azide for 1 hour at RT. Incubation with mouse 
monoclonal anti- acetylated tubulin (1:300) was performed O/N at 4°C. Embryos were 
then washed 4x30mins at RT with PBS + 0.5% Triton X-100. Goat anti-mouse Alexa-
568 (Molecular Probes) was used as the secondary antibody, O/N at 4°C. Six washes of 
30mins with PBS + 0.5% Triton X-100.  
 
Heca, Snail and P-Smad1/5/8 
Embryos dechorionated and fixed in 4% PFA for 2hours RT and then blocked for 1 
hour in PBS + 5% normal goat serum + 1% BSA + 0.5% Tween20. Embryos were 
incubated in primary antibody (1:200) O/N at 4°C in blocking solution. The following 
steps were performed as above using the correct secondary antibody. 
 
ZO-1 
Embryos were permebilized in PBST + 0.5% TritonX-100 at RT for 30mins. They were 
then blockedfor 2hours at RTin PBST + 0.1% TritonX-100 + 10% normal goat serum + 
1%BSA and the antibody was added at in blocking solution and incubated O/N at 4°C. 
Six washes with PBST were performed, each of at least 30mins at RT, and one O/N at 
4°C. Secondary antibody staining as normal. 
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Peptides used to immunise rabbits 
aa 442-457: CKSRWDGSWHQLGTMY aa 487-502: GMQYFSEYSNVQQCPH 
Table 2-4 Peptides used for immunization to generate anti-Heca antibodies 
 
2.1.7 Confocal microscopy 
For live imaging, embryos were anaesthetised at the desired developmental stage using 
1X tricane, dechorionated and immobilised in a cover slip Matek dish using 0.2% 
agarose.  Embryos were imaged on a Perkin Elmer spinning disk confocal set up on a 
Nikon T2000 microsocpe using a 63X NA1.2 water immersion lens and kept at 28.5°C 
in an environmental chamber. Confocal stacks were taken every 1-2 minutes. 
Fixed tissue samples were mounted on slides using Mowiol mounting medium and later 
imaged on a Zeiss 710 or 780 point scanning confocal microscope. 
 
2.1.8 Reverse-Transcription PCR 
2.1.8.1 RNA isolation 
Embryos (~200) were dechorionated at the desired developmental stage and 
homogenized using a dounce homogenizer with the addition of 350 µl of Buffer RLT 
(RNeasy Mini kit, Qiagen) and the lysate was cleared of debris using a Qiashredder 
column (Qiagen). Total RNA was isolated using the RNeasy Mini kit according to 
manufacturer’s protocol, using on-column DNAse I (Qiagen) digestion to remove 
genomic DNA. The concentration of RNA purified was measured using a NanoDrop 
ND-1000 spectrophotometer. 
 
2.1.8.2 Reverse transcription 
First strand cDNA was synthetized by reverse transcription of isolated RNA using the 
SuperScriptIII (Invitrogen) kit, with oligo dT(20) primers according to manufacturer’s 
protocol.  cDNA was incubated with RNase H for 20 minutes at 37°C to remove the 
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remaining RNA. The cDNA was then used along with the appropriate primers to carry 
out a PCR reaction and the products were separated on a 1% agarose gel. 
 
Forward Primer Reverse Primer 
5’-GTAACCCCAGACGCAGAGGCTCC-3’ 5’-AAGCACCACCTCCGCAGGCC-3’ 
Table 2-5 Primers to test heca knockdown by RT-PCR 
 
2.1.9 Quantitative Relative PCR 
cDNA generated was used to carry out the qPCR reaction. The Taqman  Gene 
Expression Assay system was employed (Applied Biosysitems) following the 
manufacturer’s protocol. 
Gene Taqman probe ID 
bact Dr03432610_m1 or 435241E for mouse 
heca Dr03148787_m1 
kdr1 Dr03432904_m1 
lcp1 Dr03099284_m1 
Snail Mm00441531-m1 
Table 2-6 Taqman qPCR probes used for gene expression assays 
 
2.1.10 3-Dimensional Electron Microscopy 
2.1.10.1 Zebrafish Immunostaining 
Please see above for acetylated-tubulin immunostaining 
 
2.1.10.2 Transmission Electron microscopy 
Zebrafish were fixed at the desired stage with 2% PFA/ 1.5% glutaraldehyde in 0.1 M 
sodium cacodylate (pH 7.4) for 1 hour and post-fixed in 1% osmium tetroxide/ 1.5% 
potassium ferrocyanide for 1 hour, followed by staining with 1% tannic acid in 0.05 M 
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sodium cacodylate (pH 7.4) for 45 minutes at RT. An ethanol series was used to 
dehydrated the samples, which were then placed in acetone and embedded in Durcupan 
resin according to the manufacturer’s instructions (TAAB Laboratories Equipment Ltd). 
Embedded embryos were cut into Ultrathin sections of 80 nm, post-stained with lead 
citrate and imaged in a Tecnai Spirit Biotwin 120 keV TEM (FEI Company). Images 
were captured using Ultrascan and Orius CCDs (Gatan Inc.) with TIA (Tecnai Imaging 
and Analysis, FEI Company) and Digital Micrograph software (Gatan Inc.) 
respectively. 
 
2.1.10.3 Focused Ion Beam/Scanning Electron Microscopy (FIB/SEM) 
Embryos were embedded as for TEM above. A razor blade was used to trim the 
blockface was trimmed to expose either a transverse or a lateral section through the 
trunk and polished in a UCT ultramicrotome (Leica Microsystems UK) with a 90° 
diamond trimming knife (Diatome) to ensure all faces were smooth and perpendicular. 
Excess resin was removed from the top and back surfaces of the sample to minimise the 
volume of non-conductive material; the sample was mounted onto a 12.5 mm 
aluminium stub (Agar Scientific) using silver paint (Agar Scientific) and carbon-coated 
(Blazers CED030) to reduce charging. The sample was placed in the stage of a Quanta 
3D FEG FIB/SEM (FEI Company), and adjusted to a distance of 10 mm (where 
electron and ion beams intersect) and tilted to 52°. The block was imaged at an 
accelerating voltage of 5 keV and a current of 1.28 nA. The sample was positioned and 
orientated within the block by using secondary electron imaging mode (SEI, Everhardt 
Thornely Detector), whereas atomic number contrast of osmium within the tissue was 
imaged using a solid-state backscattered electron (BSE) detector. Up to 80,000 mm2 of 
the blockface were coarse-milled at an ion beam current of 65 nA (accelerating voltage 
30 keV) removing superfluous resin to expose the embryonic tissue. A 1 mm layer of 
platinum was deposited using the chamber gas injection system on the block face above 
the AOI to to prevent edge erosion whilst milling and trenches were milled on either 
side of the AOI to prevent sputtering of milled material onto the AOI surface. Polishing 
was performed stepwise at 30, 15, 7, 5 and 3 nA until the surface was smooth. Milling 
conditions for the Slice and View run (S&V|, FEI Company) were 130610 mm at 50 nm 
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slice thickness at a current of 5 nA, giving a mill time of 73 s/slice. BSE imaging 
conditions were set at 5 keV accelerating voltage and 1.28 nA beam current with a 
dwell time of 30 ms, with an acquisition time of 108 s/image. The image width was 
114.5 mm at 2048X1768 pixels giving a final lateral resolution of 56 nm2/pixel. 693 
images were collected over 35 hours. 
 
2.1.10.4 Correlative Live-Confocal FIB/SEM 
Embryos at 28 hpf were anaesthetized and immobilized as described above for confocal 
imaging. Embryos were maintained at constant 28.0°C in an environmental chamber 
throughout the imaging process. Time-lapse microscopy was carried out on a Zeiss 
Axiovert 200 M fitted with an LSM 5 Pascal system. Upon identifying a site of 
anastomosis that was deemed interesting, embryos were fixed in 2% PFA in PBS and 
the AOI containing the anastomosing blood vessels was imaged with 10X and 40X 
objectives for correlative measurements. Zebrafish were processed as for FIB/SEM as 
described above, and placed in specially designed moulds to aid the milling process 
(TAAB Laboratories Equipment Ltd). The confocal images of the fixed embryo were 
used to obtain measurements which aided the relocation of the AOI and the sample was 
manually trimmed and polished to a blockface 700 mm wide by 300 mm deep 
(including part of the yolk sac as an orientation marker) to expose a lateral cross section 
of the AOI . The sample was mounted on an SEM stub and imaged in the FIB/SEM as 
described above. The blockface was coarse milled up to the myotomes followed by 
orientation of the sample. Milling conditions for the S&V|run were 400X5 mm at 72 nm 
slice thickness at a current of 7 nA giving a mill time of 69 s/slice. BSE imaging 
conditions were set at 5 keV accelerating voltage and 1.3 nA beam current with a dwell 
time of 30 ms, giving an acquisition time of 108 s/ image. The image width was 148.6 
mm at 2048X1768 pixels giving a final resolution of 72 nm3/voxel. 1778 images were 
collected over 87 hours. 
 
2.1.10.5 Serial Block Face/Scanning Electron Microscopy (SBF/ SEM) 
Zebrafish embryos at 72hpf were fixed, immunostained and imaged as described above. 
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The sample was trimmed to expose a transverse section through the trunk and inserted 
into the 3View microtome (Gatan Inc.) in the chamber of a Quanta 200 VP-FEG (FEI 
Company). A 50 nm slice was cut from the face with a diamond knife and the surface 
was scanned by SEM. This process was sequentially repeated to collect 1000 slices over 
15 h. Imaging was performed at an accelerating voltage of 4 keV in low vacuum mode 
(0.3 Torr) at 2048X2048 pixels with a pixel resolution of 24 nm2. 
 
2.1.10.6 3D Reconstruction and Segmentation of Data 
The FIB/SEM datasets were processed in Adobe Photoshop for optimal brightness and 
contrast. Alignment, segmentation and reconstruction into a 3D volume were performed 
using Amira (Visage Imaging Inc.). SBF/SEM datasets were aligned and reconstructed 
into a 3D volume using Digital Micrograph (Gatan Inc.) and Imaris (Bitplane Scientific 
Solutions). Features were segmented using Amira and movies were made in Amira and 
Imaris. 
 
2.2 Embryoid Body Assays 
 
2.2.1 ESC Spheroid formation, Differentiation and Sprouting in Collagen 
2.2.1.1 Culturing of Feeder cells 
Irradiated feeder cells were seeded at 2.0-2.5x106 cells/well (6 well plate) in ES medium 
the day prior to culturing ES cells. 
 
2.2.1.2 Culturing of ES cells 
A vial of wildtype R2 ES cells was thawed by placing in a 37°C water bath, followed by 
addition of 3ml of ES medium in a 6 well plate previously seeded with feeder cells. The 
medium was changed after a day to remove all remaining DMSO. Cells can be split 
every second day after 1:10 split 
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Product ES medium 
(ml) 
Supplier Catalog #  
ES Medium    
DMEM Glutamax 406.5 Gibco BRL 61965-059 
Foetal Bovine Serum 75 Gibco BRL 10270-106 
HEPES (1M) 12.5 Gibco BRL 15630-049 
Sodium pyruvate (100mM) 6 Gibco BRL 11360-039 
Monothioglycerol (98%) 6.2µl Sigma M-6145 
ESGRO LIF (107U/ml) 50µl Chemicon ESBG1107 
Collagen type-I (3.0mg/ml) Nutacon 5409 
GlutaMAX Gibco  
*EB medium does not contain LIF 
Table 2-7 Recipe for ES medium (and EB) 
 
2.2.1.3 ES cell Differentiation (Embryoid bodies) 
ES cells were split the same day as medium change. The medium was removed and the 
cells washed with PBS. 700µl of trypsin were added to each well followed by 
incubation for 5mins at 37°C. Cells were resuspended in 3ml of ES medium and 1/10 of 
the cell suspension was placed in each well (without feeder cells) followed by ES 
medium up to 3 ml. Plates were incubated at 37°C with 5%CO2.  
The following day cells were trypsinized again and resuspended in 7 ml of EB medium 
(NO LIF). Cells were counted and diluted to around 60,000 cells/ml. 10 ml of sterile 
water were placed in 10cm Petri dishes. 20µl droplets of cells suspension were placed 
inside the dishes’ lid and the lids were carefully placed of the dishes containing water 
and incubate as before (D0). 
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2.2.1.4 Embryoinic body sprouting assay in collagen-I gel 
The following were mixed in a 50ml falcon tube, collagen being the last thing added 
with VEGF final concentration 30ng/ml: 
Reagent Volume 1st layer (µl) Volume 2nd layer (µl) 
NaOH (0.1M) 1125 1210 
10X E4 medium 1125 1210 
HEPES 225 242 
PBS 175.8 189 
Glutamax 112.5 121 
1X F12 6237 7351 
Collagen 9000 9677 
Total volume 18000 20000 
Table 2-8 Collagen gel recipe for EB sprouting assay for 15 wells 
 
600µl of suspension were added to each well (12 well plate) and allowed to polymerize 
in 37°C incubator for 4 hours. 4 days following ES body set up (D3) the ES bodies were 
flushed into a dish and ~15 were placed in each well with collagen. Another 600µl of 
collagen suspension were added on top of ES bodies and it was made sure that the 
collagen adhered to the well walls. This was allowed to polymerize for 4 hours in 
incubator followed by addition of pre-warmed EB medium (1ml/well). At D7 and D9 
the medium was replaced. 
 
2.2.2 Immunostaining 
The medium was removed from the wells and the EBs were fixed with 750µl of 4% 
PFA at RT. The wells were then washed with PBS and the top layer of the gel was 
removed. If EBs are present on the lower portion of the gel then this was also taken. 
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Collagen gels were cut down to size and blocked as for immunostaining in the 
zebrafish.  
 
2.3 bEND5 assays 
bEND5 cells were cultured in DMEM medium + 10% FCS + penicillin/ streptomyocin 
at 37°C and 5% CO2 . 
2.3.1 Quantitative PCR 
Cells were washed with PBS and then lysed with RLT buffer from the RNAeasy kit 
(Qiagen). The same protocol as for zebrafish RNA extraction, cDNA synthesis and 
qPCR was followed (probes in Table 2-6). 
 
2.4 Mouse experiments 
2.4.1 Whole mount immunostaining 
Eyes from P5 wildtype pups were fixed in 4% PFA for 2hours at RT, washed in PBS to 
remove the fixative, followed by dissection of retinas from the eye. For more detail on 
dissection please refer to (Pitulescu et al., 2010). The immunostaining protocols were 
the same as for the zebrafish apart from IsolectinB4 and NG2 where the retinas were 
incubated in PBlec (PBS (pH6.8) + 1% Tween20 + 1mM CaCl2 + 1mM MgCl2 + 
0.1mM MnCl2), as well as incubating the sample plus staining reagent in PBlec. 
 
Chapter 3 Observations of Zebrafish Angiogenesis  
 87 
 
Chapter 3. Qualitative and Quantitative Observation 
of Zebrafish Angiogenesis 
 
The zebrafish vascular system firstly develops through the formation of the axial 
vessels in the trunk and tail of the embryo via vasculogenesis. The DA and the PCV 
form through the coalescing of differentiated angioblasts. Once the axial vessels are 
formed, primary angiogenic sprouting commences from the DA towards the dorsal 
aspect of the embryo and occurs ipsilaterally. To our knowledge no detailed studies 
investigating the migration of the ISAs, the associated filopodia activity and the 
anastomosis of such sprouts to form the DLAVs at high temporal and spatial resolution 
have been undertaken. In this part of the study I describe a series of qualitative and 
quantitative observations in transgenic zebrafish embryos using live confocal 
microscopy and 3D EM techniques aimed at improving our understanding on the 
dynamics of tip cell anastomosis and EC interaction with the environment. 
 
3.1.1 Filopodia along the ISA suggests all ECs have some level of 
activation 
Primary angiogenic sprouting in zebrafish embryos begins at ~23hpf, with ISAs 
sprouting from the DA and migrating along somite boundaries, between the notochord, 
the neural tube and the somites (Fig 1.4). The ISAs travel to the dorsal aspect of the 
embryo, bifurcate and anastomose with their neighbours to form the DLAVs (Fig 1.4) 
(Lawson, 2002). The use of the fli1:eGFP  transgenic line allows for live imaging of 
such a process thanks to the endothelial specific expression of a eGFP that can be 
imaged using  confocal microscopy (Lawson, 2002).  
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Fig 3.2 Filopodia Projections present on stalk cells.  
Zebrafish embryo at ~30hpf that has been injected with flk1:mG. Transient expression 
of flk1:mG highlights EC membranes thus improving visualization of filopodia and the 
architecture of cell junctions. A. Top portion of the ISA showing filopodia projections 
along most of the sprout. White arrowheads highlight some of such structures. Red 
arrowhead indicates filopodia projecting over the current tip cell. Red bracket marks 
position of neural tube (NT). B. Lower portion of the ISA showing filopodia extensions 
even form the EC directly connected to the DA (white arrowhead). * denotes an area 
where no filopodia are observed, indicating that not all ECs will have basal filopodia 
activity as might be deduced when observing a sprouting ISA. DA – dorsal aorta; PCV 
– posterior cardinal vein. Scale bars represent 10µm. 
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Extensive use of this transgenic line in recent times has helped us understand the 
role of various signalling molecules in angiogenesis. Performing live imaging with a 
conventional point scanning confocal often leads to compromise on frame rate and 
dynamic range, requiring some image saturation to visualize fine structures within the 
embryo. Spinning disk confocals enable image collection at a high frame rate whilst 
maintaining a good signal to noise ratio and dynamic range, important when studying a 
dynamic process such as angiogenesis and anastomosis. I therefore set out to build on 
previous descriptions of the sprouting process and implement novel observations. 
At 26hpf ISAs can be observed migrating with strong filopodia activity at the tip 
of the sprout (Fig 3.1), consistent with the current model of tip cell selection and 
sprouting that is governed by the Dll4/Notch – VEGFRs signalling axis (Siekmann and 
Lawson, 2007, Leslie et al., 2007, Hellström et al., 2007, Suchting et al., 2007). It is 
expected that the EC with the highest level of VEGFR2 leads the migration (tip cell), 
extending long filopodia to sample the environment for morphogenetic cues (Gerhardt, 
2003). A puzzling observation is the presence of filopodia along much of the perimeter 
of the ECs in the sprout (Fig 3.2A). The stalk filopodia are made more noticeable by the 
transient expression of the flk1:mG  construct. This is achieved by microinjecting 
plasmid DNA containing the flk1:mG construct and results in the expression of 
membrane targeted eGFP and thus EC membrane labelling (Fig 3.2.). Very weak 
expression in the neural tube can be attributed to flk1 expression in the central nervous 
system (Fig 3.2A) (Hashimoto, 2003). Filopodia are present along most of the sprout’s 
perimeter (Fig 3.2A-B, white arrowheads) but it must be noted that not all endothelial 
cells forming the vasculature posses such basal filopodia (Fig 3.2B, marked by *) 
suggesting that only ISA ECs show this basal activation. An attempt to differentiate the 
two types of filopodia can be made by describing their physical appearance and 
behaviour: the tip filopodia are longer, with greater curvature, longer persistence and 
appear to be actively searching; the stalk/basal filopodia are shorter, straight and project 
randomly. The searching behaviour of tip cell filopodia during angiogenesis has been 
attributed to the presence of VEGFR2 on their surface (Gerhardt, 2003), possibly acting 
as an amplifier of the effect of the VEGF gradient by exposing the cell to higher VEGF 
level that is present further away from the cell body. This will lead to an increase in 
response to VEGF in tip cells, upregulating Dll4 and establishing a more robust 
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mechanism of tip/stalk cell differentiation  (Bentley et al., 2008). Membrane labelling 
of ECs using flk1:mG confirms that the sprout is comprised of several endothelial cells, 
with filopodia protrusions emerging from more than just the leading cells. The intricate 
cell junction arrangement between the ECs making up the ISA is also highlighted, 
reiterating recently reported localization of junctional molecules VE-Cad and ZO-1 
(Blum et al., 2008). This cellular arrangement is unexpected when taking into 
consideration the latest model of ISA formation when this study was initiated, where it 
was believed that an ISA would most likely be composed of only three cells, one at the 
base, one making up the ISA and one in the DLAV (Childs et al., 2002). 
The presence of these filopodia is at odds with the current simplified model of 
tip cell selection, where only the tip cell possesses filopodia. This does not directly 
negate the involvement of Dll4/Notch lateral inhibition as recent evidence has begun to 
build upon the initial model, albeit complicating the picture somewhat. Expression of 
inhibitors of Notch activation such as Jagged1 are able to modulate tip cells selection in 
vivo, and there are possibly more players in this pathway that will help modulate and 
fine tune tip cell selection (Benedito et al., 2009) and allow partial activation of trailing 
stalk cells. The general ISA ECs activation might simply be a result of the continuous 
competition in which the cells take part, battling for to increasing their Dll4 level and 
thus for the tip cell position (Jakobsson et al., 2010). These observations also fit with 
the description of a third phenotype of ECs that was recently described, the phalanx cell 
(Mazzone et al., 2009), which could ultimately divide ECs in quiescent (Phalanx) 
partially activated (stalk) and fully activated ECs (tip). 
 
3.1.2 Changes in EC morphology during ISA migration 
The ISA migrates towards the dorsal aspect of the embryo and bifurcates 
rostrally and caudally to make contact and fuse with the adjacent ISA (Fig 3.3). The 
environment surrounding the ECs changes as they progress towards the top of the 
neural tube where the DLAV forms. The sprouts start off close the DA, then passes 
between the NC and somites and finally between the NT and the somites (Fig 1.4B) 
During this journey the ISA is exposed to different signals that aid its migration, such as 
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VEGF, Hh, semaphorins, BMPs, Thsd7 to name a few. Furthermore the ECs experience 
spatial restrictions that force them to adapt their morphology accordingly. The space 
between the NT and the somites is extremely restricted (Fig 3.16, discussed later in 
chapter) and the ECs must squeeze into the space (Fig 3.3). This occurs via the 
formation of lamellopodia-like structures around existing filopodia projecting over the 
NT. The lamellopodia expand along the filopodia and join with adjacent lamellopodia 
to give a flattened sheet (white arrowhead Fig 3.3B”-B””). The resulting thin EC 
cellular process gives an imaging advantage thanks to the lower amount of eGFP 
present and decreasing the likelihood of saturation  (Fig 3.3 and Fig 3.4A). This allows 
for even greater resolution of signal to the extent that the contrast allows the discerning 
of eGFP negative structures within the eGFP-filled cytoplasm of ECs. Vesicular and 
filamentous material can be spotted moving to and from the cell body and the region of 
high filopodia activity (Fig 3.4). Interestingly Rab13-driven trafficking of protein 
complexes containing RhoA and its specific GEF Syx from junctions to Grb2-VEGFR2 
at the leading edge of migrating ECs has been shown to be important in directional 
VEFG-driven endothelial cell mobility (Wu et al., 2011).  
 
3.1.3  Tip cell proliferation does not affect sprout elongation 
In the mouse retina model of sprouting angiogenesis the differential response of 
tip and stalk cell ECs to VEGF leads to tip cells extending filopodia and migrating 
while stalk cells proliferate and are involved in the formation of a vascular lumen 
(Gerhardt, 2003). Recent work using an endothelial specific nuclear-localized eGFP has 
shown that the most advanced nucleus in an ISA sprout is able to divide (Blum 2008), 
suggesting tip cells in zebrafish embryo ISAs are able to proliferate. ECs are able to 
move along sprouts and shuffle towards the tip position (Jakobsson et al., 2010) 
therefore a cell’s phenotype cannot be so simply deduced by the position of its nucleus. 
Clonal analysis clearly indicates that single ECs within an ISA can extend from the DA 
all the way to the DLAV (Blum et al., 2008). 
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Fig 3.4 Intracellular trafficking of 
vacuoles and filaments towards the 
sprouting front 
Vesicular and filamentous material 
can be observed being trafficked 
within the cell as it grows over the 
neural tube (A). Red box indicates 
enlarged region in B-B’’’. White 
arrowheads indicate one such 
structure moving through the cell. 
Scale bars represent 10µm. 
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The position of the whole cell and its morphology must be considered when 
deterining the tip cell potential for cell division. The EC prepares for division by 
retracting its lamellopodia and someof its filopodia (Fig 3.5A-C). As the cell divides 
and undergoes cytokinesis, it acquires a blebbing appearance, which could be due to its 
attempt to extend filopodia whilst also attempting to round up for the division (Fig 
3.5D-F). Soon after cytokinesis the EC reacquires its highly polarized and migratory 
behaviour, extending filopodia and lamellopodia (Fig 3.5G-H). Division does not have 
an effect on the overall tip cell selection/migration nor does it induce the formation of 
second tip cell as would be predicted from a computational model of sprouting 
angiogenesis involving the Notch/Dll4 – VEGFRs signalling axis (Bentley et al., 2009). 
The prediction entails that the presence of an additional cell would disrupt the 
Notch/Dll4 balance between adjacent ECs (tip and subsequent stalk) and thus allow the 
stalk cell to sprout due to the decreased exposure to Dll4 from the tip cell. Taking into 
account that there have been no reports of asymmetric Dll4 segregation during cell 
division in ECs, the newly formed daughter cell should begin battling with the original 
tip cell as their Dll4 levels are expected to be similar.  
Other studies using clonal expression of RFP have shown that ECs in ISAs do 
not take part in as much tip cell competition/shuffling when compared with the 
sprouting EB system or in the zebrafish head vasculature (Gerhardt, personal 
communication (Jakobsson et al., 2010)), even though recent work reports cell 
overtaking in ISAs when observing nuclei (Zygmunt et al., 2011). Cell division also 
occurs during tip cell anastomosis, before patent connections are made and a lumen is 
established. The cellular behaviour is very similar to what is described above for 
migrating tip cells. The retraction of filopodia and rounding up is more obvious and the 
cell is able to completely round up, apart form the established connections with the 
neighbouring ISAs (Fig 3.6A-D).  
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Fig 3.5 Tip cells proliferate in zebrafish ISAs.  
Images showing an ISA tip cell retracting its filopodia (A-C), rounding up (C-D), 
undergoing division (E-G) and re-extending its filopodia (G-H). 4 minutes have elapsed 
between each image. Red asterisks indicate cell prior to division and the resulting two 
daughter cells following division. Scale bars represent 10µm. 
 
 
 
* 
* 
* 
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Fig 3.6 Anastomosing cells can undergo division without affecting connectivity of 
cells.  
A tip cell in the process of fusing with adjacent ISAs undergoes cell proliferation, very 
much like the tip cell in Fig 3.7. The cell retracts its filopodia (A-D), rounds up and 
undergoes division (D-F) and assumes its previous morphology with filopodia 
projections (G-H). 4 minutes have elapsed between each image. Red asterisks indicate 
cell prior to division and the resulting two daughter cells following division.  Scale bars 
represent 10µm. 
* 
* 
* 
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3.1.4 Qualitative and quantitative observations of tip cell anastomosis 
 
Once the ISAs reach the top of the neural tube they T-branch in rostral and 
caudal directions to make contact with the neighbouring ISAs and fuse together to form 
the DLAVs. Previous reports on anastomosis have been based on fixed mouse retinas 
where the analysis relies on snapshots of the event and inference of timeline and 
mechanism are extremely difficult. Such observations did not demonstrate the 
importance of filopodia in the initial stages of anastomosis (Gerhardt, 2003). 
Live imaging of fli1:eGFP embryos allows us to appreciate dynamics of 
anastomosis (Fig 3.1, Movie1).  Tip cells leading ISA sprouting and migration begin to 
branch rostrally and caudally and accordingly filopodia project to make contact with the 
adjacent ISAs (Fig 3.7). The exact interaction and timescale of anastomosis have not 
been previously investigated. The two tip cells make various contacts via their filopodia 
prior to remaining connected and forming a patent junction (Fig 3.7). From these 
images it is unclear whether there is active attraction between the cells/filopodia but one 
wonders whether such contacts could be made so regularly based solely on stochastic 
encounters. Most of these contacts do not result in anastomosis and their duration is 
extremely variable. Some tip cells undergo fusion within a relatively short time from the 
first contact while others require longer, with what appears to be a “negotiation” period. 
Such variables were quantified to establish whether any patterns of behaviour are 
noticeable. Fig 3.8 depicts the variables measured: duration of filopodia contact (A), 
number of contacts between two tip cells (B), length of filopodia at time of contact (C) 
and delay between contacts and anastomosis (D). Table3-1 gives an overview of the 
variables collected. 
Tip cells are able to fuse upon first contact but in general tend to make multiple 
connections with a median of 12 contacts per ISA pair. Most of such contacts are short 
lived if one considers a range of 1-68 minutes where the median and 75% is 6 minutes 
(Table 3-1, Fig 3.9A). Filopodia pairs are able to remain connected for extended periods 
before releasing and single cases of 28, 38 and 68 minutes contacts have been observed 
(excluded from Fig 3.9A, right panel) 
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Fig 3.7 Filopodia contacts between 
adjacent ISAs prior to anastomosis.  
Still images from Movie2 of 30hpf 
Tg(fli1:eGFP)y1 embryos showing  filopodia 
from neighbouring ISAs coming into 
contact. White arrowheads indicate a point of 
contact. Time elapsed between each still is 2 
mins (A-A’, B-B’’’). Most contacts are 
release and do not lead to anastomosis (B’’’). 
C. An example of two ISAs following 
anastomosis, red arrowhead indicates point 
of fusion. Scale bars represent 10µm. 
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Fig 3.8 Anastomosis parameters for quantification.  
A-D depict the various parameters that were quantified from various movies of ISA 
anastomosis: duration of contacts before release (A), number of total contacts prior to 
anastomosis (B), filopodia length at contact (C) and time elapsed between contact and 
fusion occurring (D). E. An example of stills showing how filopodia lengths were 
measured. 
 
 Range Mean Median 25%-75% 
#  of contacts 1-37 15.46 12 7.5-23 
Duration of contacts 
(mins) 
1-68 5.76 6 2-6 
Length of 
filopodia 
(µm) 
Fusing 1.7-20.7 8.3 5.6 3.2-13.3 
Releasing 1.2-38.2 9.6 8.4 4.7-13.3 
Time 
elapsed to 
fusion 
(mins) 
From 1st 
contact 
108-262 163 161 130-179 
From last 
contact 
63-144 108 113 80-132 
Table 3-1 Summary of quantitative parameters of anastomosis 
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Fig 3.9 Quantitative parameters of anastomosis.  
A. Graph showing frequency distribution of duration of filopodia contacts. Most are 
short lived (2-6 minutes). Two data points are excluded from the graph (38 and 68 
minutes). B. Graph of fusing/non-fusing filopodia length. Error bars indicate SD.  C. 
Graph displaying time delay between first contact and fusion as well as final contact 
and fusion. Error bars indicate SD.  
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Fig 3.10 Comparison of quantitative parameters from in vivo and in silico 
experiments 
Quantitative analysis of filopodia contact duration (A-B) and contact to fusion delay (C-
D) from in silico simulations (A, C) and in vivo observations in zebrafish 
embryos(B,D). Error bars plotted as +/-S.E.M. E. Visual output of angiogenic tip cell 
selection model. All adapted from (Bentley et al., 2009). 
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Quantification of both fusing and non-fusing filopodia length resulted in some 
interesting observations. Filopodia that come into contact can be just over 1µm long and 
up to almost 40µm in length (Table 3-1, Fig 3.9B). Filopodia can also directly contact 
their neighbour’s cell body. ISAs are actively migrating when they come into contact 
with their neighbours and therefore the time at which they come into contact plays a 
part in dictating the length of filopodia: the tendency is for the later the contact, the 
shorter filopodia as the cell bodies have moved closer. Filopodia that lead to 
anastomosis have a shorter maximal and average length but the latter is not statistically 
significant, most likely because of the dramatic variation in the data (Table 3-1, Fig 
3.9B). The smaller average length at contact of fusing filopodia could be explained by: 
1) a purely mechanical limitation to filopodia length, and if this is exceeded there is not 
sufficient force to hold the filopodia together and preventing their retraction; 2) a 
spatio-temporal aspect is involved such as the ECs need to find themselves in the 
correct environment to be prepared for fusion. As time passes and the cell bodies move 
closer, undoubtedly the filopodia will be shorter before they encounter the neighbouring 
cell. 
The final parameters quantified were the delays between contact and fusion. The 
first value (first to fusion) refers to the time elapsed between the first time two tip cells 
come into contact via their filopodia and the moment when these two EC have formed a 
patent connection following anastomosis. The other value corresponds to the delay 
between the final filopodia contact between tip cells (as mentioned many might have 
occurred prior but released) and the fusion event. Of course the first to fusion parameter 
will always be larger compared to the corresponding final to fusion value unless fusion 
occurs at the first contact, in which case they will be the same value. The rationale 
behind these readings was to determine whether anastomosis was a rapid process 
(minutes) or occurred over a longer timeline (hours). The former scenario would hint 
towards a mechanism where tip cells are already primed for fusion when they come into 
contact and only require the relocalization of adhesion molecules to form a patent 
connection. The latter scenario would suggest that a genetic programme might be 
regulating anastomosis and thus the time for outside-in signalling, subsequent gene 
transcription and translation to occur is required. Interestingly the values for the final to 
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fusion delay range from just over one hour to almost two and a half hours. This hinted 
at a possible role of gene transcription in regulating anastomosis. This will be explored 
further in Ch.4. 
These observation and quantifications were used to inform the generation of an 
updated agent-based computational model of angiogenesis (Bentley et al., 2008). The 
model emulates the Notch/Dll4 – VEGFRs signalling axis to select tip cells upon EC 
stimulation with VEGF. The quantitative filopodia dynamics data was used to integrate 
the effect of contacts and anastomosis in the model and determine how this affects the 
dynamics of tip cell selection. The model was validated by comparing parameters 
extracted from in silico simulations to the same parameters obtained from in vivo 
imaging. The data matched well (χ2 test - p>0.05), suggesting that Notch/Dll4 lateral 
inhibition plays a role in anastomosis and vice versa (Fig 3.10). This was also 
confirmation that the set up of the new version of the model (Bentley et al., 2009) is 
accurately simulating the angiogenic process and predictions made are likely to have a 
biological significance. 
 
3.1.5 Lumen formation 
The process of angiogenesis must lead to the formation of a patent, lumenized 
and functional vascular loop to satisfy the increased metabolic demands of the target 
tissue. The process of vessel lumenization is another event in angiogenesis that has 
recently become of interest as previous models of its mechanism leave many doubts and 
unanswered questions. At the time this study was initiated, there was a much-debated 
model of lumen formation that involves pinocytosis and the fusion of intracellular 
vacuoles into larger ones until a continuous intracellular lumen is formed (Kamei et al., 
2006). The pinocytosis and vacuolar fusion were shown to be integrin and Cdc42/Rac1 
dependent (Davis and Bayless, 2003).  A more recent study attempted to build on these 
observations and provides evidence for VE-cadherin localization to determine the site 
of primary lumen formation, with subsequent vacuole fusion to expand it (Wang et al., 
2010a).  In mice a role for VE-cadherin in lumen formation has been attributed to 
establishing EC polarity and the localization of CD34 sialomucins (Podocalyxin) 
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(Strilic et al., 2009). It appears that the negative charge of such proteoglycans at the 
apical, i.e. pre-lumenal membrane, is responsible for the opening of the lumen (Strilić et 
al., 2010).   
Again the use of zebrafish embryos in the study of lumenization provides 
incredible details on the dynamics of the process.  Observations of lumenization of ISAs 
in zebrafish embryos here presented suggest there could be multiple mechanisms of 
lumen formation. Often the junction between two ECs becomes more evident (Fig 3.11) 
and this correlates with the site of lumen opening. The ECs loosen their junction and 
this allows for transient opening but collapses immediately. The same junction later 
opens up once the lumen has pushed through the whole ISA (Fig 3.11). This suggests 
that the lumen forms via the polarization of the ECs and the selection of a particular 
junction to release, indicating that the lumen is extracellular and formed through the 
rearrangement of junctions. The lumen is established but is not visible until the whole 
vessel opens up. Such a model would be consistent with observations regarding the 
polarization and junction repulsion (Strilić et al., 2010). In other instances the lumen 
appears to be intracellular and pushes through the EC until it reaches other open lumen, 
readjusting the junctions to fuse forming a continuous tube (Fig 3.12, Movie3). Once 
the lumen is formed, there is still a requirement for ECs to proliferate to keep up with 
the expansion of the vasculature to supply the growing embryo. This poses a problem in 
small vessels such as ISVs as usually a maximum of 2 cells are present per cross-
section and therefore the division of one cell may result in the loss of vessel integrity. 
This problem is overcome by the collapsing of the lumen prior to cell rounding (Fig 
3.13 A-H), and following cell division the lumen is re-established (Fig 3.13 I-J). 
The decrease in filopodia activity upon anastomosis and DLAV formation has 
been attributed to the Notch/Dll4 lateral inhibition (Leslie et al., 2007) as the two tip 
cells begin to inhibit one another thus decreasing their tip cell characteristics.  Most 
filopodia activity does not decrease until the lumen is fully established, and the 
termination of filopodia protrusions is very abrupt (Movie4), suggesting that lumen and 
possibly blood flow actually play a big part in the dampening of EC activation, similar 
to recent reports on the effect of haemodynamic forces in zebrafish angiogenesis (Nicoli 
et al., 2010, Bussmann et al., 2011). 
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Fig 3.12 Lumen formation by a mechanism that might involve intracellular lumen 
formation. 
Continuous lumen forms by the fusion of what appears to be intracellular lumen (right 
portion of images, red line) with lumen that forms through cell junction opening as in 
Fig 3.9 (red line segments, central cell in images). 2 minutes elapse between each 
image. Scale bars represent 10µm 
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Fig 3.13 Cell proliferation in lumenized vessel.  
Snapshots of live imaging of cell division in a lumenized ISA in fli1:eGFP 30hpf 
embryos. The ISA collapses its lumen (A-C) prior to division. Following cell division 
(D-H) the lumen reopens by(I-J). Time is indicated in minutes. 
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3.2 3-Dimensional Electron Microscopy 
 
The use of transgenic animals has revolutionized biology by allowing the study of 
gene function in the whole organism, at the tissue level and at cellular resolution. 
Thanks to its optical clarity and external embryonic development, the zebrafish is 
especially amenable for the use of fluorescent protein markers to track lineage specific 
cells and thus investigate their behaviour during developmental morphogenesis. The 
drawback with using cell type-specific fluorescent proteins is the lack of information 
about unlabelled cells and the environment around the cells of interest. One technique 
that is able to circumvent such a problem is electron microscopy (EM). In EM the 
sample is stained with contrast agents allowing the visualization of all material within 
the sample, which is bombarded with electron beams. Electrons have a much narrower 
wavelength compared to visible/near-visible light used in light and fluorescence 
microscopy and allowing considerably higher resolution. EM can either be used to 
obtain topographic images of the sample surface using Scanning Electron Microscopy 
(SEM) or backscattered images of ultrathin sample section through Transmission 
Electron Microscopy (TEM). The drawbacks of each are evident: SEM limits the 
information gathered to the surface of the specimen; TEM requires thin sectioning 
(nms) of the sample. Even serial sectioning through a samples that is a few µm thick 
and aligning the subsequent images is extremely laborious and difficult to even the most 
experienced electron microscopists. 
Here I describe an adaptation of electron microscopy imaging techniques that 
have been extensively used in the semiconductor industry but have had limited use in 
very small biological samples. The first of such techniques is known as Focus Ion Beam 
SEM (FIB/SEM). In FIB/SEM a Ga2+ beam mills away the top layer of the sample 
followed by SEM image acquisition of the exposed surface (Fig 3.14C); this process is 
iterated to ensure a sectioned and well-aligned dataset is collected. The second 
technique is known as Serial Block Face SEM (SBF/SEM). In this case the sample 
chamber has a modified ultramicrotome that is able to section the sample in situ within 
the microscope, and the surface can be imaged by SEM following each cut. FIB/SEM 
and SBF/SEM were adapted to obtain detail on anastomosis at an almost whole 
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organism level. These techniques can help obtain an incredible amount of data on the 
ultrastructure and the interaction between the ECs and the surrounding environment 
during tip cell anastomosis but as will be shown also contain a wealth of information 
about all imaged tissues. 
This part of the study was done in close collaboration with Lucy Collinson and 
Hanna Armer of the LRI EM unit along with external collaborators for access to the 
equipment: Ken Png and Andy Bushby (The Nanovision Centre, Queen Mary, 
University of London, UK) Christel Genoud  (Friedrich Miescher Institute, Basel, 
Switzerland) and Alexander G Monteith (Gatan, Abingdon, UK). All the work 
described in this part of the thesis is related to the publication Armer E.J.H., Mariggi G. 
et al, PLoS One 2009, and therefore I will not continue referencing this work. I am 
grateful to our collaborators that performed all the preliminary work on resin selection 
for this study (in which I had no part) and for allowing us the use of their equipment. 
 
3.2.1 FIB/SEM setup 
Standard TEM embedding protocols using osmium and tannic acid were shown 
to produce suitable atomic number contrast for good backscattered electron imaging in 
FIB/SEM. The sample was embedded in resin within a purposely-designed mould to 
facilitate the orientation and trimming and reduce the deposition of milled material 
during the serial milling/imaging (Fig 3.14A). This also aids the relocation of the trunk 
and area of interest (AOI). The sample was trimmed until the embryo could be seen 
using transmitted light (Fig 3.14B). Trenches where milled either side of the AOI to 
minimise the accumulation of sputtered material from the sectioning onto the surface to 
be imaged (Fig 3.14B), as well as depositing platinum onto the top surface of the block 
to protect the edges during data collection (Fig 3.14, TF). The face was milled at thicker 
sections, using high ion current, until the myotomes were exposed and subsequently the 
milling was altered to obtain thin (50nm) slices.  
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Fig 3.14 FIB/SEM setup. 
 A. Diagram showing orientation of the zebrafish after resin embedding and trimming 
with a diamond knife. The AOI in the zebrafish tail is placed in an overhang of resin to 
optimise milling and minimise curtaining artefacts. The head and yolk sac are used as 
markers for locating the AOI, and are exposed during trimming, seen here in 
backscatter electron images from the FIB/SEM. Top face (TF), front face (FF). Arrows 
represent x (blue), y (green) and z (red) axes. B. Platinum was deposited onto the top 
face of the block to stabilise the edge during milling. The sample was coarse milled 
with the gallium ion beam to expose muscle blocks at the predicted area of interest prior 
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to the milling run. Trenches (arrows) were then milled on either side of the AOI to 
reduce artefacts due to redisposition of sputtered material on the blockface. Scale bar 
represents 100 µm. C. Orientation of the electron and ion beams with respect to the 
front face of the block. D. Transverse view of trimmed trunk and yolk sac (YS) showing 
myotomes (M), neural tube (NT) and notochord (NC). Adapted (Armer et al., 2009). 
 
As a proof of concept a 32hpf zebrafish embryo was stained and mounted for 
FIB/SEM, and underwent sequential milling and imaging to test whether this technique 
was amenable to such a large whole organism sample. 693 serial images were collected 
in ~35h hours, resulting in a dataset with a volume of ~3.3x105 µm3 at 56x56x50nm3 
resolution. Images were loaded into Amira software (Visage Imaging Inc.) for 
visualization and 3D segmentation. Thanks to the high 3D resolution of the images, the 
dataset could be viewed in any orthoslice without loss of quality, aiding the relocation 
and segmentation process of the sample (Fig 3.16D). Large structures within the trunk 
of the embryo such as the notochord and the neural tube were easily segmented (Fig 
3.16E, blue and cyan) but it was immediately clear that identification of ECs would not 
be as straight forward due to the presence of many unexpected cells within the AOI. 
Once the ECs involved in the fusion were located and segmented, they were comparable 
in morphology with the confocal image prior to fixation (compare Fig 3.16B and C). 
The two segmented ECs (Fig 3.16, orange and yellow, Movie6) overlap at the point of 
contact, a mechanism that had been proposed in the formation of proper cell-cell 
junctions during anastomosis (Blum et al., 2008). This event is hard to pinpoint in the 
raw images, as the EC processes cannot be viewed in a single plane or orthoslice 
therefore the CurvedSlice Amira algorithm was used. A sprouting ISA can be observed 
in serial sections, emerging from the DA and migrating along the somite boundary (Fig 
3.15A, red shading). Looking more closely at such an image, the unicellular EC –lined 
DA and PCV are clearly distinguishable; the ECs display the characteristic elongated 
nuclei and nucleated erythrocytes are present within the lumen of the axial vessels (Fig 
3.15B). Even considering the size of the sample viewed in such images it is possible to 
discern intracellular structures such as mitochondria in ECs, z-discs within the muscle 
cells and dense granules in an unidentified cell (Fig 3.15B). Even so, localizing a fusion 
event remains difficult to pinpoint without markers as it occurs in a small volume of the 
trunk.
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Fig 3.15 Localisation of ISA by FIB/SEM  
A. FIB/SEM sections of a 32 hpf zebrafish embryo trunk with the ISA highlighted in 
red. Slices are non-consecutive sections 661, 669, 687 and 691 where one slice is 50 nm 
thick. B. The posterior cardinal vein (PCV) and dorsal aorta (DA) can be observed as 
lumenized vessels containing nucleated erythrocytes (E). The ISA sprouts from the DA 
and migrates in the space between the muscle block (M) and midline structures. 
Subcellular structure can be resolved including mitochondria (arrows) and dense 
granules (G). Scale bars represent 30 µm, (A) 10 µm(B). Adapted from (Armer et al., 
2009). 
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3.2.2 Identification and 3D Reconstruction of ISA Anastomosis through 
Correlative Confocal – FIB/SEM Imaging 
The collection of a large dataset as described in the previous section holds a 
wealth of information but also reiterates how complex tissue and organism architecture 
is. This complexity increases the difficulty of locating the AOI without the use of 
markers. It was therefore decided to undertake a correlative imaging study to relocate 
and images the anastomotic process using FIB/SEM.  A 28hpf fli1:eGFP embryo was 
anaesthetised and embedded in agarose for live imaging. The embryo was imaged until 
ISAs undergoing fusion were identified and measurements to be used for AOI 
relocation were taken (Fig 3.16A-B). The embryo was subsequently fixed, prepared for 
FIB/SEM and mounted as in Fig3.13A.  A dataset of 1778 images was collected in ~ 87 
hours, with a volume of 2.42x106µm3 at a 1:1:1 voxel resolution of 72nm3. 
Markers are placed through the 3D dataset to pinpoint parts of the AOI and 
project a curved slice as a 2D image (Fig 3.17A). The segmented ECs can be 
superimposed onto the curved slice to identify the ECs within the image (Fig 3.17B); it 
must be noted that some distortion may occur in displaying the 3D plane as a 2D image 
and therefore the scale bar is unidirectional. The ECs overlap and touch as suggested by 
the segmentation (Fig 3.17C). Another observation that is complementary with Fig3.3 
and Movie5 is the morphology of ECs in this environment, less than 500 nm in 
thickness in places, adding evidence for the change in morphology that I have alluded to 
earlier in this chapter. In line with our aim to investigate the relationship and interaction 
between the ECS and the environment, a granular cell was observed wrapped around 
the point of contact between the two ECS (Fig 3.16F and Movie3). Previous work from 
our group and others (Gerhardt, 2003, Fantin et al., 2010, Rymo et al., 2011) had 
suggested that macrophages could be playing a role in assisting angiogenesis, and 
anastomosis in particular.  Live imaging of fli1:eGFP embryos also sheds light on the 
role of macrophage-like cells in the process of anastomosis (Movie3). The role of such 
cells will be discussed in Ch.5. 
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Fig 3.16 Anastomosis of the DLAV by correlative fluorescence confocal and 
FIB/SEM. 
A. Still from live confocal imaging of a 28hpf Tg(fli1: EGFP)y1 transgenic zebrafish at 
the point of anastomosis of filopodia from adjacent ISAs, overlaid on a phase image of 
the zebrafish. Measurements of the AOI are made in relation to gross physical markers 
like the yolk sac and yolk tube. B. High magnification image of boxed area in (A) 
showing the point of anastomosis (arrow) and indicating vessels reconstructed in D ,E, 
F and G (orange and yellow box). C.Screenshot of Amira software (Visage Imaging 
Inc.) used to visualize and segment data acquired. It enables the data to be visualized in 
all orthoslices. D, E, F and G. Features within the FIB/SEM dataset were segmented 
using Amira. Endothelial cells from adjacent ISAs (orange and yellow) form a thin 
layer between the neural tube (blue) and the somites. At the point of anastomosis 
filopodia from each cell overlap and contact (arrow). A cell is seen wrapping around the 
point of connection (G, green cell). Scale bars represent 10 µm in D and 3 µm in F. 
Adapted from (Armer et al., 2009). 
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Fig 3.17 CurveSlice to improve visualization of EC connection. 
It is only possible to visualise the ECs in the raw data by creating a curving plane 
through the volume using software (A, CurvedSlice, Amira). B. Overview of the 
CurvedSlice data with the 3D reconstruction overlaid to highlight the filopodia of the 
ECs which narrow to 500 nm in places. When viewed in two dimensions the 
CurvedSlice distorts the data but captures the entire filopodia in one section 
demonstrating continuity. C. High magnification of the AOI (box in B) from the 
CurvedSlice. Scale bars 5 µm in B, unidirectional and 2.5 µm in C, unidirectional. 
Adapted from (Armer et al., 2009). 
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3.2.3 Ultrastructure of the Formed DLAV using SBF/SEM 
By 48hpf the DLAVs have formed through the fusion of the ISVs. These vessels 
mature and become lumenized, allowing the flow of blood.  To asses the use of 
SBF/SEM in understanding the ultrastructure of the formed vessels, a 72hpf fli:eGFP 
embryo was imaged, fixed and prepared for imaging (Fig 3.18A). SBF/SEM has the 
advantage of slicing at a faster rate, collecting 1000 images at 50nm/section in ~15 
hours for a total sample volume of 1.2x105µm3. The detector fitted on this equipment 
was able to give a lateral resolution of 24nm2. The detector gives a different contrast in 
the SEM images as compared to the one in FIB/SEM (Fig 3.18B and Fig 3.15B) but one 
can equally well identify sub-cellular structures such as z-discs (Movie7) and the 
pigmented vacuoles in xanthophores present below the scales (Fig 3.18B and D). One 
must admire the level of detail obtained when considering that half of the whole embryo 
trunk is being imaged, whilst still maintaining the resolution to identify such fine 
structures. These images were not taken at the highest possible magnification but used 
to image a large field of view to include as much information on the ultrastructure of the 
zebrafish trunk and associated vasculature. The formed DLAV has a visible lumen and 
blood cells are present within the vessel (Fig 3.18B and F). As the DLAV is not a 
straight structure, the CurveSlice algorithm was used to create a curved slice as describe 
above (Fig 3.18C-D). Some portions of the DLAV have fully opened lumen while 
others present a more restricted/collapsed lumen (Fig 3.18D). There are electron dense 
structures present at the ECs boundaries, which could be attributed to tight junctions 
(Fig 3.18E and F, black arrows) even though at this magnification such a claim is 
someway overstated. The ISVs running between the neural tube and the muscle blocks 
(NT and M) do not display a clear open lumen. It is likely that the maintenance of an 
open lumen relies on the presence of blood pressure as blood flow has been shown to 
not be required for initial lumen formation but important for its maintenance (Wang et 
al., 2010a). 
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Fig 3.18 Ultrastructure of the formed DLAV. 
A. Confocal projection of 72 hpf Tg(fli1: EGFP)y1 transgenic zebrafish showing the 
fully formed DLAV. B. Transverse section through 3View SBF/SEM dataset showing 
both DLAVs (dashed line in A). Scales (SC), muscle blocks (M), neural tube (NT). (C) 
Profile of the CurvedSlice (Amira) through the volume which selects one of the DLAVs 
(dashed line in (C). D. Overview of the CurvedSlice data showing the lumenized 
DLAV. Lumen (L), erythrocyte (E). E. Higher resolution image of the DLAV from the 
boxed area in D showing electron dense patches between ECs which may represent cell-
cell junctions (arrows). F. Transverse section through the DLAV. Scale bars represent 
50 µm in A, (B) 5 µm in B,  5 µm unidirectional in D, 2.5 µm unidirectional in E, 2.5 
µm in F. Adapted from (Armer et al., 2009). 
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3.2.4 3D EM dataset contain a wealth of information 
The adaptation of such 3D EM techniques for use in a whole embryo to study 
angiogenesis demonstrated that an unprecedented amount of detail for such large 
datasets is achievable. To prove that data acquired for one particular study can still yield 
information in further investigations in unrelated fields we analysed the FIB/SEM 
dataset to identify neuronal projections form the neural tube. 48hpf zebrafish embryos 
were stained for acetylated tubulin to identify neuronal projections that emanate from 
the NT into the intraembryonic space between somites and medial structures (Fig 3.19 
A). The neurons were identified via their morphology and presence of dense 
neurofilaments, and reconstructed in the FIB/SEM dataset, comparable to what is 
observed with antibody staining (Fig 3.19B). This comparative analysis demonstrates 
the usefulness of such 3D EM techniques and investing the time to collect such large 
datasets to benefit multiple disciplines. 
 
 
Fig 3.19 3D Reconstruction of neuronal projections in a FIB/SEM dataset 
originally collect for a vascular study.  
A. 48 hpf Tg(fli1: EGFP)y1 transgenic zebrafish displaying formed ISVs and DLAV 
(green) which grow around and over the NT (blue, DAPI staining). The DLAV lies 
underneath bundles of neurofilaments (acteylated tubulin, red). Neuronal projections 
from the NT can also be observed. B. 3D reconstruction and segmentation of a 
FIB/SEM dataset showing neurons (red) exiting the NT (blue). 3D rendered features are 
shown overlying x, y and z orthoslices from the original dataset. Notochord (N). Scale 
bars represent in A 50 µm, in B 10 µm. Adapted from (Armer et al., 2009). 
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3.3 Discussion 
 
The data described in this chapter gives new insights into the morphogenetic processes 
that occur during sprouting angiogenesis in the formation of zebrafish DLAVs.  
 
3.3.1 All ECs in Sprouting ISA exhibit some level of activation 
Sprouting angiogenesis is characterized by the activation of quiescent ECs, 
breaking out from the pre-existing vessel in which they reside. EC activation leads to 
one cell being selected as the tip cell to lead sprout growth and extend filopodia, whilst 
the trailing cells are referred to as stalk cell (Gerhardt, 2003). Here I have shown that 
filopodia are present along most of the growing ISV, with stalk cells also extending 
filopodia suggesting some level of activation. 
Tip cell selection is initiated by VEGFA stimulation, inducing migratory 
behaviour and filopodia to sense the environment (Gerhardt, 2003). Many reports have 
investigated the mechanism of tip cell selection and the Dll4/Notch pathway has been 
identified as a major player in this process. VEGFA induces Dll4 expression in the tip 
cell, which signals to the neighbouring cells through Notch activation. This 
downregulates VEGFR2 and upregulates VEGFR1 in stalk cells (Suchting et al., 2007), 
making ECs less responsive to VEGFA (Leslie et al., 2007). The bottom line from such 
studies was that VEGFA/VEGFRs and Dll4/Notch pathways interact to restrain the 
sprouting response and allowing a moderate number of tip cells to commence sprouting 
(Leslie et al., 2007, Siekmann and Lawson, 2007, Hellström et al., 2007, Suchting et al., 
2007, Lobov et al., 2007). Indeed if Dll4 is removed, its function blocked or Notch 
activation inhibited there is excessive sprouting in both developmental settings and 
pathological situations (Noguera-Troise et al., 2006). This signalling feedback loop 
results in the selection of one tip cell per sprout as described in the mouse postnatal 
angiogenesis model, with only cells at the vascular front exhibiting filopodia and 
migratory behaviour. The data here presented suggests that stalk cells might be 
exhibiting some activation, as observed by filopodia present along the entirety of the 
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ISA. As activation I am referring to exploratory filopodia behaviour, as opposed to 
general VEGFR2 activation, which of course must occur as stalk cells proliferate. The 
expression of membrane-tagged eGFP confirmed that such filopodia are present not 
only on the tip cell (Fig 3.2). This raises questions about the current model of tip cell 
selection and EC activation.  
One way to reconcile this observation with current work is to take into 
consideration other members of the DSL family of Notch ligands. Jag1 is able to bind 
Notch1 but the signalling output can be the complete opposite when compared to Dll4-
induced Notch activation (Benedito et al., 2009). In the mouse retina model, Jag1 and 
Dll4 are believed to compete for Notch1 binding. The glycosyltransferase lunatic fringe 
can modify Notch1 leading to increased Dll4-signaling and reduced Jag1-dependent 
signalling. This results in Jag1 having a proangiogenic effect, and its overexpression 
increases tip and filopodia numbers as well as EC proliferation (Benedito et al., 2009). 
As Jag1 is not expressed in tip cells, it is believed that it helps increase the robustness of 
the system, preventing stalk cells from activating Notch in tip cells but also decreasing 
stalk cell-to-stalk cell Dll4/Notch signalling at the vascular front, helping maintain high 
levels of VEGFR2 expression. This should allow rapid activation of stalk cells when the 
formation of a new tip cell is required (Benedito et al., 2009). A similar phenomenon 
could be happening in the zebrafish ISAs, where stalk cells may be primed and partially 
activated, ready to switch to the full tip cell phenotype if need be. This also fits with the 
fact that many cells in the DA do not possess filopodia suggesting these are not 
activated. To add to this, recent data from our lab using single cell clonal analysis of 
ECs expressing membrane labelled eGFP in the retina clearly show that cells that are 
not at the vascular front also posses filopodia, albeit much less than bona fide tip cells. 
These filopodia are polarized towards the periphery and thus towards the gradient of 
VEGF, again supporting the notion that stalk cells can be partially active and may not 
simply respond to VEGFA by proliferating as is currently believed (Lapi et al 
unpublished). When looking at the retinal vasculature the term stalk cell might become 
blurred as ECs further back in the plexus, considered stalk cells, can sprout to fill gaps 
in the plexus to give the correct density This partial activation hypothesis is further 
hinted to by work proving that the tip/stalk cell fates are not permanent and ECs 
compete for the tip position as well as shuffling within the sprout (Jakobsson et al., 
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2010). Competitive advantage is dependent on VEGFRs level acting upstream of 
Dll4/Notch. The ability of EC shuffling is evident in EB sprouting assay but also in the 
zebrafish vasculature, with tip cell competition observed in the head vasculature 
(Jakobsson et al., 2010) and more recently also in the sprouting ISAs (Zygmunt et al., 
2011), suggesting that stalk cells in the ISA have the angiogenic potential to overtake 
the tip.  
Filopodia activity is only seen to end once the ISAs are lumenized (Movie4). 
Previous work in understanding how ECs sense oxygen tension has highlighted the role 
of prolyl hydroxylase 2 (PHD2) as regulator of EC quiescence (Mazzone et al., 2009). 
In the presence of oxygen PHDs hydroxylate HIF family members inducing their 
proteolytic degradation. In low oxygen tension as is found during development or in 
tumours, PHD2 is not able to modify HIF-2α for degradation and thus HIF-2α can 
activate hypoxia-responsive genes, causing EC activation and angiogenic sprouting 
(Mazzone et al., 2009). Heterozygosity of PHD2 decreases a cell’s ability to destabilize 
HIFs and its DNA binding activity. This in turn results in the upregulation of sFlt1 and 
VE-cadherin, leading to  amore quiescent vasculature. Upregulation of VE-cadherin 
stabilizes EC adherens and tight junctions (Carmeliet et al., 1999, Taddei et al., 2008) 
and sFlt1 acts to restrain excessive sprouting (Krueger et al., 2011, Zygmunt et al., 
2011). These pathways can thus provide a link between the observations of lack of 
filopodia on ECs in the DA, which is perfused, compared to the sprouting ISAs that are 
not lumenized. The oxygenated aortic ECs will have high oxygen levels and the 
associated increased PHDs activity. PHDs will hydroxylate HIFs, tagging them for 
degradation. In the ISAs where blood flow is yet to commence, PHDs have low activity 
allowing HIFs stability, which can induce expression of pro-angiogenic target genes. 
This model would allow ECs to retain higher angiogenic potential, projecting filopodia 
even when in the stalk position. 
 
3.3.2 Adaptive morphological changes 
Endothelial cells demonstrate a high level of plasticity, able to change from 
quiescent, cobblestone-like morphology to an activated and pro-migratory state. ECs 
Chapter 3 Observations of Zebrafish Angiogenesis  
 123 
must adapt to their environment at the signalling level as well as at the physical level. 
The 3D EM data here presented stresses the spatial constraints which the ISAs must 
face. The space in which the tip cell must migrate and bifurcate to form the DLAV is as 
small as 500nm in the medial to lateral direction (Fig 3.3, Fig 3.16). The EC undergoes 
distinct morphological changes as it reaches the neural tube, increasing the size of the 
lamellopodia at the leading edge. It appears that the cell is adhering and wrapping onto 
the neural tube and this change in behaviour is very apparent and sudden (Fig 3.3). It 
would be fascinating to understand how such a change in cellular morphology is 
brought about. As the sprout migrates from the DA, the space between the notochord 
and the somites is not as restrictive as what is found just further dorsally between the 
neural tube and the somites. One can speculate that for a cell to force itself into such an 
environment, it must experience either some tremendous chemoattraction or repulsion 
by the rest of the tissues. VEGFA is expressed within the medial portion of somites and 
in the hypochord but not in the dorsal part of the somites therefore it is unlikely that this 
could be the attractant (Liang et al., 1998, Lawson, 2002). VEGFC is also expressed in 
the zebrafish and is required for ISA formation (Ober et al., 2004, Covassin et al., 
2006). VEGFC knockdown results in an arrest in the migration at the myoseptum, just 
ventral to the neural tube but VEGFC expression is only observed in the hypochord and 
the DA (Covassin et al., 2006). Factors implicated in neuronal development and growth 
cone guidance are now accepted as playing important functions in vascular 
development too (Adams and Eichmann, 2010).  Thrombospondin type I domain 
containing 7A (thsd7a) is a molecule that has been shown to affect EC migration and 
tubulogenesis (Wang et al., 2011). In zebrafish thsd7a is expressed in the neural tube, 
most strongly along the ventral side and where it is in proximity of the somites (Wang 
et al., 2011). Decreased expression of thsd7a results in stalled ISA migration and 
aberrant ISA patterning later in development. In saying this the ISA migratory defect 
recovers by 50hpf, showing patterning defects close to the DLAV with extra functional 
branches connecting ISAs along the myoseptum and along the neural tube (Wang et al., 
2011). This suggests that a molecule such as thsd7a might be involved in driving the tip 
cells over the neural tube but other mechanisms must also be in place as the migration 
defects in the morphant are able to recover. A chemoattractive molecule such as thsd7a 
found on the surface of the neural tube could also be an appealing explanation why 
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ISAs bifurcate upon reaching the dorsal aspect of the embryo. Bifurcation is necessary 
for DLAV formation to complete primary angiogenic sprouting.  
 
3.3.3 Tip cell Proliferation does not Affect Tip cell Selection and 
Migration 
The expansion of the vasculature is a large-scale feat, starting with 
differentiation, migration and proliferation. One must marvel at the intricate control of 
these different morphogenetic processes occurring while the system is expanding as 
well as functional. The integrity and barrier function are maintained to avoid perturbing 
tissue homeostasis. One of the major issues in a tubular system is cell division whilst 
maintaining integrity, particularly in the ISAs where a lumenized vessel cross-section 
consists of one to two cells. In the zebrafish this problem is circumvented by a collapse 
of the lumen at the site of division and is later reinstated through the opening of EC 
junctions (Fig 3.13). An important question is raised by this observation: how does the 
cell know that the lumen must be collapsed? The ISA in question appears to be 
unicellular (even though with this transgenic line it is difficult to deduce) and the lumen 
collapses prior to the commencement of cell division. Hence it cannot be assumed that 
lumen collapse is coupled to the initiation of cytokinesis and formation of the 
contractile ring. Is it a process regulated by cell division checkpoints? Could it be that 
the maintenance of a lumen is an active process that can be blocked, possibly through 
loss of cell polarization or through a reverse mechanism to lumen formation? MLCII-
driven shape changes maybe reversed by dephosphorylation of the motor protein. Some 
support for this hypothesis rests on the requirement Moesin1 in the maintenance of 
luminal membrane (Wang et al., 2010a).  The quick re-establishment of a luminal 
surface following division is also astonishing and raises its own set of questions. Are 
junctions formed across the lumen prior to cell division upon lumen collapse? Or is the 
cell able to round up, divide almost seamlessly at the same time as creating a new 
junction with the daughter cell to prevent leakage? 
The standard model of Dll4/Notch lateral inhibition regulating tip/stalk cell selection 
dictates that the absence/reduced Notch signalling experienced by tip cells prevents 
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them from proliferating and this appears to be the case in the mouse retina model 
(Gerhardt, 2003). In zebrafish there has been a hint at tip cell proliferation by looking at 
EC nuclei (Blum et al., 2008) but not the morphology of the dividing cell, which is how 
tip cells are currently identified due to lack of reliable markers. Here I show that tip 
cells do indeed divide during zebrafish ISA formation and amazingly cell division does 
not affect tip cell selection or migration as the cell found at the tip prior division 
maintains its position and continues to migrate (Fig 3.5). An agent-based computational 
model involving the VEGFR2-Dll4/Notch feedback loop can simulate tip cell selection, 
without the need for higher regulation (Bentley et al., 2008). The model has been 
refined and expanded using data here described to include the effects of anastomosis on 
tip selection (Bentley et al., 2009). It is fascinating that this biological process can be 
simplified to these two interacting pathways, of which we have some knowledge but are 
still far from having elucidated their entire mechanisms and intricacies. One prediction 
is that cell division will alter the Dll4/Notch battling that occurs between ECs and thus 
destabilize the current pattern, inducing phenotype switching. The differences between 
biology and simulation can of course be easily summed up by the oversimplification of 
the model. But if one is to take a mechanistic view of the discrepancies it could very 
well be related to the partial activation of ECs within the sprout and the fact that most 
cells within the sprout experience a medium level of activation. This, along with work 
relating to Jag1’s role (Benedito et al., 2009), might prevent stalk cells from having 
enough Notch influence on the dividing tip cell. The segregation of Notch receptors and 
DSL ligands has not been investigated in ECs and could very well provide some 
explanation for the lack of new battling upon cell division. Even though ECs round up 
and lose most of their lamellopodia and filopodia during division some level of 
polarization must be conserved as tip cells instantly restart to extend filopodia and 
migrate in the correct direction. The ability of EC tip cells to round up for division both 
while migrating and during anastomosis has to occur in a tight space as discussed above 
but this stresses the importance of such a cell shape change for cell division.  It is 
believed that such rounding is required for a cell to position the cellular machinery 
needed for cell division. These shape changes are driven by a balance of osmotic 
pressure (outward) and actomyosin cortex contractility (inward)  (Stewart et al., 2011), 
and loss of shape change can affect cell division (Fink et al., 2011). 
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Cell division during anastomosis does not induce further sprouting, again 
suggesting that more work is required to look at the dynamics of Notch signalling at the 
single cell level to truly grasp how the level of Notch activation relates to the 
exploratory behaviour and possible tip cell overtaking/shuffling (Fig 3.6). 
3.3.4 Mechanism of Lumen Formation 
There appear to be two mechanisms of lumen formation in zebrafish ISAs. 
Firstly as shown in Fig 3.11 the lumen is established as a result of junctional opening 
between two ECs within the ISA stem. It is notable early on in the sequence that the 
junction becomes delineated, as if the junctional architecture has been changed. The cell 
junction shape reiterates what has been previously described by Blum et al on VE-
cadherin and ZO-1 distribution within the ISA (Blum et al., 2008), and is again 
confirmed in this study with the use of the flk1:mG construct (Fig 3.2).  The time taken 
for junctional release is extremely short, within 2 minutes, and therefore the modulation 
of junctional integrity must be rapid. VE-cadherin phosphorylation can induce rapid 
changes in junctional stability by decreasing the protein’s adhesive properties (Dejana 
et al., 2009). Phosphorylation of the intracellular tail can block the binding of armadillo 
family proteins p120-catenin and β-catenin preventing VE-cadherin stabilization at the 
membrane (Gavard and Gutkind, 2006). The absence of these proteins from adherens 
junctions allows β-arrestin2 to bind and induce VE-cadherin internalization through 
clathirn-mediated endocytosis, further decreasing junctional stability (Gavard and 
Gutkind, 2006). The opening of the lumen in the above observations is a quick process 
occurring in a few minutes, well below the hours required in pinocytic vesicle fusion 
model derived from Kamei et al’s observations (Kamei et al., 2006).  The rapid opening 
is compatible with the hypothesis that initial junction opening is induced by the 
relocation of negatively charged sialomucins to the luminal membrane, which through 
repulsion help to overcome the adherens junction force (Strilic et al., 2009, Strilić et al., 
2010). The collapse following initial junctional opening further discredits the simple 
unicellular vesicular fusion model, whereas it supports the need for EC polarization to 
determine the apical domain. Once this has occurred and the necessary components 
relocate (VE-cadherin, sialomucins, Moesin and MLC II) then the vessel is primed for 
lumen opening. This likely occurs through a combination of force-induced cell shape 
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changes via the action of activated MLC II (Strilic et al., 2009), and through the 
initiation of blood flow as it has been shown to be required for maintenance of lumen 
but not for the initial formation (Isogai, 2001, Wang et al., 2010b). 
The second mechanism of lumen formation described is reminiscent of 
unicellular lumen formation in the Drosophila trachea. The lumen pushes through a cell 
and then connects with pre-existing lumen through the readjustment of a junction (Fig 
4.12). Again in this case the advance of the lumen is rapid and does not hint at a 
presence of vesicles. It is likely that intracellular vesicle are involved in lumen 
formation through their targeting to specify the apical membrane and expansion of the 
luminal domain upon EC-EC repulsion. 
 
3.3.5 Anastomosis in Angiogenesis 
Anastomosis is a key step in the formation of a tubular network that develops by 
sprouting. Here the dynamics of anastomosis were investigated by qualitatively and 
quantitatively describing the process (Fig 3.7-9).  Sprout fusion had not been previously 
investigated and it was assumed that EC tip cells simply come into contact and fuse. It 
is immediately obvious that anastomosis is not a straightforward process simply based 
on two tip cells coming into contact. The ability of two tip cells to find one another is in 
itself quite incredible considering that this is done through thin, long filopodia 
connections. The fact that the sprouts do not grow over the NT but bifurcate suggests 
something is signalling to the ECs to change course. It is known that ECs secrete VEGF 
and this is required in an autocrine signalling loop for survival (Lee et al., 2007) but it 
has not been demonstrated that this can have chemoattractive effects on other ECs. This 
could be a plausible explanation for the attraction between tip cells but no VEGFA 
mRNA has been detected in ISAs to date. Interestingly flt4 is strongly expressed in 
nascent ISAs, especially tip cells (Covassin et al., 2006) but its main ligand VEGFC is 
not expressed ahead of the vasculature (Covassin et al., 2006) and thereforeVEGFR3 
maybe acting in heterodimers with VEGFR2 to bind VEGFA (Dixelius, 2003, Nilsson 
et al., 2010). Another plausible explanation may rest on the ECM found over the NT. 
Recent evidence has highlighted how certain ECM components can directly or 
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indirectly alter EC behaviour. Fibronectin and laminin change migration and even 
Dll4/Notch signalling in ECs (Stenzel et al., 2011, Estrach et al., 2011b). Fibronectin’s 
effects are both at the level of trapping VEGFA and directing the projection of filopodia 
(Stenzel et al., 2011). Another possible ECM –related mechanism may be to do with 
EC-induced mechanical changes to the ECM present on the NT, which can be sensed by 
nearby cells (Reinhart-King et al., 2008) and induce attraction of tip cells towards one 
another. Thsd7a, mentioned above, is required for ISAs to migrate past the myoseptum, 
at the height of the NT; it could induce ECs to grow along the NT without 
discriminating on the directionality. The fact that it is not expressed in the dorsal part of 
the NT (Chu et al., 2011) may explain why ISAs do not crossover prior to anastomosis. 
Whatever the mechanism involved, ISA tip cells are always able to find one 
another but the subsequent filopodia contacts do not always lead to fusion (Fig. 3.9). 
The filopodia themselves are not directly attracted but tend to grow in the direction of 
the neighbouring ISA which again hints at polarized projection. The fact that not all 
contacts are “constructive” (leading to anastomosis) provides a number of possibilities 
in the mechanism of fusion. Adhesion molecules such as VE-cadherin are important for 
the stability of newly formed vasculature (Crosby et al., 2005, Montero-Balaguer et al., 
2009) as E-cadherin is important in Drosophila tracheal fusion (Tanaka-Matakatsu et 
al., 1996). It is therefore conceivable that different filopodia possess substantially 
different amounts of such adhesion molecule on their surface, possibly due to stochastic 
probability or through a more active process requiring myosin-X-dependent transport 
along actin filaments to the tip of filopodia (Almagro et al., 2010). The active transport 
of VE-cadherin is important to initiate EC-EC junction formation in vitro. Previous 
work on VE-cadherin in zebrafish was not able to resolve the presence of the adhesion 
molecule on filopodia and the investigation looked at adhesion molecules distribution at 
later stages, once the EC cell bodies were in contact (Blum et al., 2008); generating a 
fluorescent protein-VE-cadherin fusion protein would be instrumental in understanding 
how VE-cadherin changes in localization during the initial steps of tip cell contact and 
the subsequent decision for filopodia to remain attached and lead to anastomosis; 
unfortunately this feat has not proved successful to date. Non-constructive filopodia 
contacts have limited duration and more than three quarters of the instances recorded 
last less than eight minutes (Fig 3.9A). Therefore the decision as to whether the pair 
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will remain connected is quick, most likely as a result of retraction of the filopodia 
without much resistance from the recently formed contact point. In the Drosophila 
trachea upon the establishment of DE-cadherin contacts, formin3 is recruited to aid the 
formation of actin structures required for the completion of anastomosis and subsequent 
lumen opening (Tanaka, 2004). It would be of interest to assess if such mechanisms are 
conserved in the formation of the vasculature. 
There is no statistically significant difference between the mean (~9µm) or the 
variance of the length of constructive and non-constructive pairs (Fig 3.9B). However 
the maximum length of filopodia measured shows a profound difference with the fusing 
pair maximum being almost 50% of the maximum value for non-fusing pairs. I believe 
there are three possible explanations for this result. Firstly there tend to be very few 
filopodia that exceed the maximum fusing/constructive length of ~20µm. The 75% 
percentile is the same for constructive/non-constructive filopodia. It could therefore just 
be that as there are so few very long (up to 38µm) filopodia the likelihood that they will 
encounter one from the neighbouring ISA are low.  It must also be taken into 
consideration that such long structures tend to occur when the cell bodies have begun to 
squeeze over the NT and maybe transitioning into a different environmental setting. 
This leads to the second possibility that anastomosis, and whether filopodia remain 
connected, is governed by the local environment. If ECs experience a change in 
environmental cues when they reach the top of the NT that lead to preparing the tip cell 
for anastomosis, the filopodia will be shorter as at this stage cell bodies will have 
moved closer, bringing a spatio-temporal element to the process. I believe that 
conclusions made from the study of Sema/Plexin in angiogenesis must be included in 
this discussion. In obd mutants (plxnD1 lesion) and in plxnD1 morphants ISAs are able 
to grow in regions of the embryo that are normally avascular and accordingly fuse with 
their neighbours at the height of the myoseptum (Torresvazquez, 2004).  This evidence 
does not support the environmental cues hypothesis related to the NT, even if the 
situations being discussed are examples of mispatterned vasculature. The ability of an 
EC to fuse might be intrinsic and a function that is not restricted to a subset of ECs. 
Data on the time delays between contact and fusion brought to light interesting 
points. The first contact between tip cells is not important with regards to fusion unless 
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of course anastomosis occurs through this event. It remains unclear whether this is 
something intrinsic of the individual filopodia or whether it rests upon the failure to 
generate an intracellular signal. The fact that the delay between final contact and fusion 
is between one and two and a half hours indicates the possible requirement for outside-
in signalling to allow the stabilization of the newly format contact. Further investigation 
of this phenomenon becomes technically and technologically difficult. The investigation 
of possible candidates involved in the control of anastomosis would require loss and 
gain of function studies of pathways such as Dll4/Notch and junctional proteins such as 
VE-cadherin. These important regulators of angiogenesis are now accepted and 
implemented in the current models (Potente et al., 2011) and meddling with their 
function has drastic effects on vessel growth. Therefore to assess the effects of their 
manipulation on anastomosis would require single cell, rapidly inducible systems for 
activation/inhibition of these components in specified cells. Even so such manipulations 
may result in decreased angiogenic potential and allow trailing ECs to replace the 
original tip cell. 
Some of the observations described here were used to instruct a second 
generation agent-based model of tip/stalk selection in sprouting angiogenesis (explained 
above)(Bentley et al., 2009) based on a previous version (Bentley et al., 2008). The 
model output was compared to the quantitative data obtained from live imaging 
zebrafish embryonic ISAs. The datasets match well, meaning that even with such a 
simplistic view on the signalling regulating sprouting and tip/stalk selection, the 
negative feedback loop is sufficient to predict certain aspects of EC behaviour. This 
highlights the power of using agent-based models where simple local rules can govern 
and translate to large-scale ‘population’ behaviours. 
 
3.3.6 3 Dimensional EM techniques in Angiogenesis 
The 3D EM data acts as proof of concept that such techniques can be used 
successfully in large datasets, at the whole organism level in this case. Importantly the 
relocation of AOI within such a large volume with the aid of correlative confocal 
microscopy supports the notion that such techniques are not limited by one’s ability to 
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find the AOI without markings and guides. It was indeed fascinating to view the 
ultrastructure of the zebrafish trunk to such a high spatial resolution. 3D EM techniques 
have been used for smaller samples, somewhere around two orders of magnitude 
smaller than the datasets here presented (Knott et al., 2008). The reconstructed images 
reveal the presence of granular cells at sites of anastomosis, supporting recent work 
implicating macrophages and angiogenesis (Kubota et al., 2009, Fantin et al., 2010, 
Rymo et al., 2011) (discussed in Ch.5). The fact that the resolution and magnification 
were not pushed to the limit in these experiments, for the sake of increasing the chances 
of relocating the AOI, meaning that there is still a considerable scope to take these 3D 
EM techniques further and really obtain high quality subcellular resolution to shed light 
on the intracellular intricacies of anastomosis. 
The generation of large datasets presents itself with another set of difficulties 
regarding data handling. Problems were encountered when attempting to segment the 
data, even when using top of the range graphic cards and RAM memory. This is a 
problem that is becoming increasingly apparent and critical, with pressing needs to 
address it. The volume of data that can be captured with the techniques described in this 
study, as well as many other imaging techniques, not only increase in size but also in 
the information density and efforts are required to implement workflows that allow the 
segmentation and the extraction of useful, quantifiable parameters. 
 
3.3.7 Future Directions 
The data here presented help us to understand a little better some of the 
morphological processes that occur during angiogenic sprouting. These steps are well 
coordinated in their dynamics to allow the functionality of the system throughout most 
of its development.  
One of the main points that derives from what is probably the simplest piece of 
data in this study, and an observation that no one has really commented on previously, 
is the need to revisit the model of tip cell selection (Potente et al., 2011). The fact ECs 
other than tip cells have filopodia projections and that these cells tend to be only present 
in the migrating ISA opens up the possibility of differing levels of EC activation. 
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Mazzone et al’s work hints in this direction too with the introduction of a third EC 
phenotype, the phalanx cell (Mazzone et al., 2009). I personally envisage a less 
restrictive approach to describing what is happening and would be interested to see 
whether there is a way to gauge EC activation, something that can be inferred from the 
cell shuffling and tip cell overtaking experiments (Jakobsson et al., 2010). It may be 
that ECs have an activation scale and this correlates with their angiogenic potential, 
prevalence and persistence at the tip etc. 
Another important node of understanding the differential cellular responses to 
angiogenic stimuli is what does this difference boil down to. How are the signals from 
the same ligand and the same receptor integrated differently? Are the different 
phosphorylation sites on VEGFR2 phosphorylated at different rates and therefore 
certain will only react if the receptor is fully activated? In theme with the environmental 
cues, I am still intrigued by how ISA tip cell are instructed to bifurcate, and what is the 
mechanism of bifurcation.  Bifurcation increases the density of the plexus and 
understanding the molecular players involved may open up new therapeutic avenues to 
modulate angiogenesis to reduce/increase vessel density. 
It is clear that anastomosis relies on adhesion molecules, whether this is simply 
form a new junction or is involved in a signalling event.  The possibility of following 
the distribution of certain adhesion molecules (VE-cadherin) live and monitor the 
dynamics of their accumulation is of great importance if we are to fully understand the 
multiple steps that transform a nascent sprout to a functional vessel. I have mentioned 
the technical challenges of generating transgenic lines that would allow this as well as 
the lack of a technology for single cell inducible LOF an GOF experiments at the 
specific site of anastomosis. The 3D EM techniques here presented are a neat addition 
to the toolbox available to scientists to increase the volume and resolution of data 
acquired. We are currently pursuing this further to obtain higher magnification, higher 
resolution images of fusing ISAs. Lumen formation is another critical step in 
angiogenesis and elucidating its mechanism may allow novel anti-angiogenic therapies 
to be developed. Anti-angiogenics have focused on stopping angiogenic growth but 
there is now evidence that it is not necessary to thwart the growth of blood vessels but 
simply to render them dysfunctional. This can be achieved by Dll4 inhibition, leading to 
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hypersprouting but resulting in a non-perfused plexus, inhibiting tumour growth 
(Noguera-Troise et al., 2006). Coupling anastomosis and lumen formation, there are 
many unanswered questions. Firstly the specification of the apical (luminal) membrane 
through the relocalization of molecules such Par family members is still unclear. This is 
important for the initiation of lumen formation for the targeting of sialomucins and 
actomyosin to the correct domain of the EC. We have no idea how a cell senses that it is 
the right time to lumenize, with VEGFA possibly involved. ECM is likely to be part of 
this mechanism, especially with regards to determining apical/basal polarity. 
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Chapter 4. The Role of heca in angiogenesis and 
lumen formation 
 
In this chapter I will be addressing the question of whether anastomosis may be 
regulated by a genetic programme. As mentioned in Ch.3 the time delay between the 
final filopodia contact and fusion occurring is within a range that can accommodate for 
gene transcription, translation and protein activity. For this reason it was decided to 
investigate possible regulators of anastomosis.  Here I describe the role of heca, the 
zebrafish homologue of the Drosophila gene headcase that is involved in tracheal 
anastomosis. Heca does not seem to play a direct role in ISA anastomosis but is 
involved in the later process of DLAVs crossover and fusion. Unexpectedly 
overexpression of heca induces early lumenization of the nascent sprouts, an effect 
shown to be endothelial cell autonomous. Combined with the earlier observation in 
Ch.3 where full cessation of filopodia activity only occurs following vessel 
lumenization, these results suggests that if Heca is playing a role in lumenization (as 
observed in GOF experiments), loss of Heca could be involved in instructing cells to 
lumenized and/or dampen filopodia activity a upon lumen formation. 
 
4.1.1 Knockdown of heca in zebrafish embryos leads to early cross over 
of the DLAVs 
Many parallels can be drawn between the development of the Drosophila tracheal 
system and sprouting angiogenesis such as the requirement for a morphogen gradient, 
tip cell selection through Dll/Notch lateral inhibition and the need for anastomosis to 
form a functional network (Affolter and Caussinus, 2008). Some of the growing 
tracheal sprouts must connect with their neighbours and this anastomosis involves the 
expression of a defined set of genes in a restricted number of fusion cells (one per 
sprout) (Samakovlis et al., 1996b) events. Six genes have been identified as fusion cell 
markers during tracheal development, with escargot (esg) controlling the regulation of 
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the other five; headcase (hdc) is one such gene (Samakovlis et al., 1996b). Hdc was 
firstly discovered as a marker for cell-cycle re-entry of imaginal discs (Weaver and 
White, 1995). It was later shown to have a role in tracheal morphogenesis. This is a 
system that develops with almost no cell division and hdc’s role has been pinpointed to 
the terminal branching/fusion process that occurs during the maturation of the tracheal 
network (Steneberg et al., 1998).  
Retinas from osteopetrotic mice (op/op), which lack tissue macrophages, display 
a decreased branching/fusion vascular phenotype in post-natal retinal vessels (Rymo et 
al., 2011). Microarray data comparing op/op retinas with wildtype highlights increased 
expression of heca, the hdc murine homologue (Gerhardt, unpublished). It was therefore 
decided to investigate heca’s potential role in angiogenesis and anastomosis. This study 
was initiated by assessing whether heca really does play a part in angiogenesis and 
anastomosis. I decided to begin with functional studies using the power of zebrafish for 
Morpholino-based screening, prior to investing resources and time into understanding 
the expression and regulation of heca.  
Two Morpholinos were designed, one targeting the ATG translational start site 
(MO1) and the other targeting the exon1-intron1 boundary to prevent correct splicing 
(MO2). The reverse primer used to test heca expression is within exon2 so missplicing 
(which will include intron1) will not result in the amplification of the fragment, as the 
DNA polymerase lack the processivity to synthetize the large insert within the RNA 
(Fig 4.1A). Morpholinos were microinjected into 1-4 cells stage embryos. Co-injection 
of ~3ng of p53 Morpholino was performed to reduce any potential p53-dependent 
toxicity that has been associated with such oligonucleotides (Robu et al., 2007). 
Injection with the splice blocking Morpholino (HecaMO2) leads to the loss of the 
correctly spliced fragment (forward primer at end of exon 1, reverse primer at middle of 
exon 2, ~480bp; Fig 4.1A-B). The Morpholino effectively leads to the inclusion of 
intron1 in the mRNA and thus prevents PCR amplification. Knockdown of Heca does 
not have any major effects on the overall morphology of the embryo at 24, 28 and 32hpf 
and development of the vasculature is normal (Fig4.2). Sprouting ISAs do not display 
migratory delays nor do they have defects in anastomosis.  
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Figure 4.1 Heca gene structure 
A. Diagram of exons and introns of the zebrafish heca gene. Primers to check for heca 
expression are marked (Fw and Rev, red arrows) as well the site of Morpholino binding 
(MO1, mauve, and MO2, green). The positions of in situ probe complementarity are 
indicated by the blue bars (Probe1-5). B. RT-PCR of cDNA using Heca RT primer pair. 
Positive control (+ve) is 48hpf wildtype cDNA, negative control (-ve) is mouse 
pulmonary endothelial cell cDNA, which shouldn’t be complementary for primers. 
Rpl13a and b-actin were used as control primers. 
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The DLAVs form bilaterally along the trunk of the embryo and by 48hpf there are two 
parallel DLAVs along the entire length of the embryo (Isogai, 2001). At this stage there 
are very few cross connections between the DLAVs and these are limited to thin 
filopodia in the most caudal portion of the trunk (Isogai, 2001). Following 48hpf the 
DLAVs begin to connect over the neural tube in a caudal to rostral direction but limited 
to the caudal portion of the trunk, remaining as separate parallel vessels in the cranial 
part of the trunk. By 3dpf the caudal DLAVs have fused into a reticular plexus whereas 
the more rostral portion remains as parallel vessels. It is not until 7dpf that the cranial 
portion of the DLAVs becomes connected (Isogai, 2001). In heca morphants the 
DLAVs crossovers are already evident at 48hpf (Fig 4.3A) and are present along the 
whole trunk, even  in the cranial portion of the DLAVs, a region where this does not 
normally occur until 7dpf (Fig 4.3B). Quantification of such ectopic DLAV connections 
demonstrates a significant increase between heca morphants compared to control 
morphants or uninjected embryos (Fig4.3D).  The ectopic connections are not simple 
filopodia crossing over but lumenized vessels (Fig 4.3C). The phenotype resulting from 
use of the splice-blocking Morpholino is recapitulated with the use of a translation 
blocking oligonucleotide (HecaMO1, Fig 4.3). It must be noted that penetrance of this 
phenotype was low, observed only in around 12% of injected embryos. Live imaging of 
such DLAV connection formation was attempted but the resolution obtained fell short 
of our expectations. This was due to 1) the difficulty of positioning the embryo 
vertically so as to have the two parallel DLAVs in the same imaging plane and 2) the 
optical distortion caused by the tissue architecture along the dorsal aspect of the 
embryo. 
Zebrafish angiogenesis is fascinating as it is based on at least two rounds of 
angiogenic sprouting that occur sequentially to give a patterned arterial and venous 
network. Recent work in understanding the mechanisms that discriminate between the 
different modes of angiogenic sprouting has unearthed some interesting findings. VEGF 
is important for the sprouting of the vessels from DA and not from the PCV whereas 
BMP2 is critical for venous sprouting without affecting arterial angiogenesis (Wiley et 
al., 2011). As hdc in Drosophila is regulated by Dpp which is a TGF/BMP family 
member, and therefore is an indirect downstream Dpp effector, it maybe possible that 
heca is an effector of BMP activity in zebrafish.  
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Knockdown of heca does not induce any defects in sprouting from the PCV that allows 
normal formation of the caudal plexus (Fig 4.3E) Sprouts emanate form the PCV and a 
venous networked is formed by 48hpf. Secondary sprouting from the PCV to either 
connect to the ISVs or to form the parachordal vessel is not impaired by decrease heca 
expression.  Heca knockdown does not affect EC proliferation as the number of ECs per 
ISV was not altered (Fig 4.8B) 
Overall, loss of heca expression leads to normal embryonic and vascular 
development with a specific effect on the connections between the DLAVs over the NT. 
Such an observation can be considered particularly significant as morphant embryos 
tend to be growth retarded when compared to uninjected ones, and thus possibly even 
reducing the temporal phenotype observed. 
 
4.2 Heca overexpression leads to early lumenization of 
migrating sprouts 
 
4.2.1 Migrating sprouts lumenize precociously due to heca expression 
The effect of heca overexpression in zebrafish embryo development was 
investigated by injection of in vitro transcribed mRNA synthetized from cloned heca 
cDNA. The mRNA was titrated to find a dose that would result in minimal toxicity.  
Injection of ~100pg of heca mRNA in zebrafish embryos does not alter the normal 
overall development (Fig4.4), nor result in early vascular defects as the trunk axial 
vessels are able to form through vasculogenesis, evidence that angioblasts specification 
and migration from the lateral plate mesoderm are not affected (Fig 4.5A). The ISAs do 
not exhibit morphological or migratory abnormalities but lumenize extremely early, 
already showing extensive lumen opening by the time they reach the horizontal 
myoseptum. Cross-sections of the ISAs show that the entirety of the nascent vessel is 
lumenized (Fig4.5B). As this method of overexpression is at the whole embryo level, it 
was decided to test whether heca’s effect on ISA lumenization was endothelial cell 
autonomous or was related to its expression in the surrounding environment. To do so 
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heca cDNA was cloned downstream of the flk1 promoter fragment to drive endothelial 
specific expression, and upstream of a 2A viral peptide followed by dTomato to label 
overexpressing clones. Viral peptides such as the 2A system employed here can be used 
to link two open reading frames to give stoichiometric expression of both proteins from 
a bicistronic sequence. 2A peptides are short amino acid sequences (~20aa) found in 
picornaviruses and represent a superior alternative to Internal Ribosome Entry 
Sequences (IRES). The mechanism relies around a Gly-Pro sequence within the 2A 
peptide that leads to ribosome stalling during translation, the skipping to the following 
codon and the cleavage of the Gly-Pro bond in the nascent polypeptide. The ribosome 
can then continue to translate the subsequent portion of the mRNA that contains the 
second coding sequence, leading to a 1:1 ratio of the two encoded proteins (Szymczak 
et al., 2004). From my experience with the use of the flk1 promoter it has become 
evident that the fluorescent protein marker can be extremely difficult to detect at the 
early stages of ISV sprouting but it is evident at later stages (Fig 4.6B). Endothelial 
specific expression of heca by transient expression also leads to the aberrant 
lumenization phenotype (Fig4.6A), illustrating that it is an endothelial cell autonomous 
phenomenon but is still a multicellular process as lumen formation is not a unicellular 
event.  
To determine whether the lumenization of early ISAs was functional and 
connected to the trunk circulation, microangiography with fluorescent quantum dots 
(Qdots) was performed. Qdots are present within the migrating sprouts of heca 
overexpressing embryos while none are observed in control embryos, confirming the 
presence of open functional lumen within the vessel (Fig 4.7A-B). Concomitant with 
the early lumen, some ISAs exhibit local cell clustering, with many nuclei close 
together in the sprout (white asterisks, Fig 4.7B). 
 
4.2.2 Cell cluster phenotype is a result of increased cell numbers 
The cell clustering observed in ISAs could be due to an increase in the number 
of cells in the sprout.  Hdc is required for imaginal discs to re-enter into the mitotic cell 
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cycle (Weaver and White, 1995) while in human head & neck cancer cell lines heca has 
the opposite effect (Dowejko et al., 2009).  
 
 
 
Figure 4.3 Early crossover of DLAVs is observede upon decreased heca expression.  
Knockdown of heca expression leads to early and ectopic crossover connection between 
the DLAVs (A, white arrows). Similar results are observed with splice blocking or 
translation blocking Morpholinos (Heca M2 and MO1 respectively).  B. Close up of 
ectopic connections in cranial portion of DLAVs. C. Crossover connections are 
lumenized (cross section in right panel). D. Quantification of crossovers shows 
significant difference between uninjected and control injected embryos with morphants 
Heca morphants embryos. (* p<0.05, **p<0.005, 4 independent experiments). E. No 
developmental defects can be observed in the BMP2-dependent vascular plexus 
formation. Scale bars represent 40um in A, 10µm in B, 10µm in C. 
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Figure 4.4 No general developmental defects are induced by moderate heca 
overexpression.  
Injection of 100pg of heca mRNA does not affect development. A higher dose 
slows/stops development of embryos (n=185, 3 independent experiments). The lower 
does was used for overexpression experiments. 
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Figure 4.5 Heca overexpression leads to early ISA lumenization.  
A. No vascular phenotype is observed at 28hpf therefore Heca isn’t affecting axial 
vessel formation. Precociously lumenized vessels can be seen in the trunk (red 
arrowheads). B-C. No lumen is observed in the cross section of control ISAs (B-B’) 
whereas the ISA is fully lumenized in Heca mRNA injected embryos (C-C’, white 
arrow). Scale bars represent 50µm in A, 10µm in B-C 
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Either way heca appears to affect cell proliferation in certain systems, though this is not 
the case in the tracheal network. To asses whether there was an increase in cell numbers 
in the ISVs, I used the Tg(flk1:nls-eGFP) line (Blum et al., 2008) with endothelial 
specific nuclear-localized eGFP expression to quantify the number of EC nuclei in 
overexpressing embryos. Overall there was no difference in the number of cells 
observed per ISA at the whole embryo level (Fig 4.8A-D). If however one compares the 
average number of EC nuclei in sprouts displaying cell clustering then there is a clear 
increase in the average (Fig 4.8D). In the most drastic cases three nuclei are seen at the 
leading edge of the migrating sprout, some lacking the elongated EC appearance, 
possibly as a result of such crowding at the tip of the ISA (Fig 4.9B-B”). In Fig 4.9 an 
ISA that has yet to pass the myoseptum contains 5 nuclei, a stage at which usually two 
to three nuclei are observed (Fig 4.9A-A”). As for the knockdown, the overexpression 
phenotype was evident in only 10% of injected embryos. 
 
4.2.3 Cell adhesions in ectopic lumen formation 
The overexpression phenotypes of early lumenization suggest that heca leads to 
an early determination of the apical surface of ECs whilst cell clustering supports the 
notion that ECs numbers are greatly increased in sprouting ISAs.  The most recent 
models of vascular lumen formation initially involve the formation of an apical domain 
of the ECs that allow the segregation of surface molecules such as sialomucins, believed 
to aid the opening of the lumen. A molecule that is important for the establishment of 
EC polarity, especially during lumen formation is VE-cadherin (Strilic et al., 2009, 
Strilić et al., 2010, Wang et al., 2010a). The rearrangement of junctional molecules is 
also important in lumen formation with regards to cellular movement and intercalation 
(Blum et al., 2008). VE-cadherin is an important protein in adhesion junctions and plays 
a major role in vascular stability (Dejana et al., 2009).  The migratory behaviour of ECs 
can also be affected by levels of VE-cadherin and is required for the movement of ECs 
within a tissue (Perryn et al., 2008). Ve-cadherin localization was assessed in heca 
overexpressing embryos by carrying out immunostaining for ZO-1, a tight junction 
protein shown to colocalize with VE-cadherin (Blum et al., 2008). This was to ascertain 
whether the heca GOF-induced phenotypes are related to changes in EC junctions. 
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When observing normal ISAs found in heca overexpressing embryos, the junctional 
architecture is rather similar to what is found in control embryos and with what has 
been previously described  (Fig 4.10A’’’, B’’’)(Blum et al., 2008). This is not the case 
for ISAs exhibiting clustered ECs, where the junctions clearly reflect the chaotic 
arrangement of cells (Fig 4.10B’’’, white arrow). Even so the junctions still maintain 
strong ZO-1 presence at cell boundaries compared to normal ISAs, suggesting that heca 
overexpression is not affecting the formation of EC junctions. 
 
4.3 Heca expression  
 
4.3.1 Zebrafish  
The loss and gain of function experiments revealed that heca has a role in 
zebrafish angiogenesis. Therefore I set out to characterize its expression and regulation 
by using a combination of in vivo and in vitro approaches. Only one orthologue of hdc 
is found in zebrafish.  The expression pattern of heca was firstly analysed by in situ 
hybridization using five riboprobes that were designed de novo (Fig 4.1A), to include 
all exonic sequences in the analysis. At 28hpf heca is ubiquitously expressed at low 
levels throughout the embryo, with slightly stronger staining observed in the head. (Fig 
4.11B-F and 4.12B-F). This pattern is consistent for all 5 riboprobes. The weak, sparse 
expression in the trunk seems to concentrate within the somites as shown in transverse 
sections (Fig4.12G). The presence of heca transcript was confirmed by reverse 
transcriptase PCR at 8, 24, 32 and 48hpf and by qPCR at 30hpf (Fig4.13). The broad 
expression in the trunk neither confirmed nor excluded endothelial contribution to heca 
mRNA expression in zebrafish. 
The use of commercial anti-Heca antibodies for immunofluorescence did not 
yield detectable signal in zebrafish embryos therefore custom anti-peptide antibodies 
were generated using Eurogentec 28-day super speedy polyclonal immunisation 
protocol (Eurogentec, Seraing, Belgium). Rabbits were immunized with one of two 
selected peptides.  
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Figure 4.6 Endothelial cell autonomous 
effect of Heca on ISA lumenization.  
A. EC-specific expression of heca by 
injection 1-2 cell state embryos with flk:mG 
construct results in the precocious 
lumenization of ISAs at 28hpf, as observed 
with heca mRNA injections.  B. The 
presence of dTomato  in the ISAs confirms 
the construct is being expressed. 
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Figure 4.8 Heca overexpression leads to cell clumping due to increase in the 
number of ECs per ISA.  
Injection of Heca mRNA leads to ECs clumping together in certain ISAs (C). 
Knockdown of Heca expression did not lead to such a phenotype (B). Overall number 
of cells per ISA is not altered by gain or loss of function Heca but analysis of ISA 
shows clear increase in heca overexpressing ISAs (* = p < 0.05) (D). n = 62, 2 
independent experiments. 
 
Chapter 4 The Role of heca in Angiogenesis  
 149 
 
 
Figure 4.9 Extreme case of nuclei crowding at leading edge of ISA in Heca 
overexpressing embryo. 
 Overall vascular appearance is normal in Heca overexpressing embryos (compare A-B) 
apart from 1 ISA where 4 nuclei are bunched at the growing front (red asterisks in B’). 
In this extreme case overall nuclei number in ISA are elevated (circled in red in B”) 
with a total of 5 nuclei when compared to control embryos were only 2 nuclei are 
present at this stage (A”). Scale bars represent 10µm. 
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Figure 4.10 Adhesions in heca overexpressing embryos. A-A’’’.  
Control embryos display normal junctional staining as had been previously described by 
Blum et al (Blum et al., 2008). B-B’’’. Heca overexpressing embryos possess ISAs with 
increased number of ECs and the junctions are accordingly affected. Many more 
junctions are observed in the overcrowded ISA (B’’’, white arrow) due to the presence 
of more cells. Scale bars represent 10µm. 
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Figure 4.11 heca in situ hybridization reveals weak expression.  
5 heca riboprobes give a weak signal in the trunk while the expression appears stronger 
in the head (B-F). flk1 in situ was performed as control. 
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Figure 4.12 Heca expression in the trunk seem 
concentrated in the somites.  
Expression of heca in the trunk seems to 
concentrate in the somite (B-F). Transverse 
sections reveal the diffuse staining (G). flk1 in 
situ was performed as control (A). 
Chapter 4 The Role of heca in Angiogenesis  
 153 
 
 
 
 
Figure 4.13heca is expressed throughout zebrafish embryonic development.  
A. RT-PCR detects expression of heca at 8, 24, 32 and 48hpf. B. Expression of heca at 
30hpf is confirmed by qPCR, comparing its cycle counts with flk1 and actb. 
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Figure 4.14Custom Heca antibody staining of zebrafish embryos.  
A-C. Zebrafish embryos at different developmental stages show presence of Heca 
protein (with Ab 500) within the somites, with the strongest signal detected at 24hpf. D-
F. Similar results are obtained when using Ab 501, with a slightly stronger detectable 
signal compare to Ab500. Scale bars represent 40µm. 
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Both peptides matched portions of the C-terminus, which is an extremely well 
conserved region, with 100% homology between species (Fig1.13), hoping to result in 
antibodies with cross-species reactivity. The antibodies were tested for peptide binding 
by ELISA and both rabbits developed antibodies that were strongly immunoreactive 
against one of the two peptides used for immunization. Heca expression pattern is 
similar to the mRNA, ubiquitous and weak, with higher expression in the somites 
within the trunk (Fig4.14). 
 
4.3.2 Heca expression in mouse retinal vasculature and embryoid bodies 
As the in vivo zebrafish experiments fell short of confirming endothelial 
expression of heca, its expression was tested in mouse tissue by immunofluorescence to 
investigate further the localization of its expression. Mouse post-natal retinal 
vasculature and sprouting embryoid bodies were assayed for the presence of Heca 
protein.  
In mouse post-natal retinas Heca is present in astrocytic nuclei (Fig 4.15A’, B’), 
which can be easily recognized due to their triangular shape and presence of Pax2 
(Fig.415C). Astrocytes are glial cells found in the CNS and play an important role in 
supporting endothelial cells and in the specific case of the retina, they pre-pattern the 
retina with VEGF to direct angiogenic sprouting to the hypoxic tissue (Gerhardt, 2003). 
Heca is also present in some ECs and is both nuclear and cytoplasmic, with 
characteristic elongated EC nuclei (Fig 4.15A’). No difference in presence of 
expression or levels is evident between the sprouting front, capillary plexus and tip/stalk 
cells. 
Embryoid bodies (EBs) are aggregates of embryonic stem cells that can be 
induced to differentiate into ECs by plating the spheroids in a collagen matrix and 
supplementing the growth medium with VEGF. Heca is observed in PECAM-1 positive 
cells, confirming its presence in ECs, again with no difference between tip and stalk 
cells, even though some difference in expression is observed between ECs (Fig4.16A’-
B’). Surprisingly though, the Heca antibody staining accumulated in the nucleus, even 
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though previous literature describes it as a cytoplasmic protein (Weaver and White, 
1995)  
 
4.3.3 Possible Regulation of Heca 
In Drosophila hdc is under the transcriptional control of esg, which is a member 
of the Snail family transcriptional repressors/activators (Samakovlis et al., 1996b, 
Whiteley et al., 1992). Esg is induced in tracheal fusion cells once the sprouts have 
reached the location within the target tissue where the tracheal metameres need to 
connect. These areas are marked by expression of Dpp, a member of the TGF/BMP 
superfamily (Vincent et al., 1997). I therefore investigated whether heca in zebrafish 
could be under control of the TGF/BMP-Snail axis. 
Dpp is believed to be homologous with BMPs.  I investigated the extent of BMP 
signalling in zebrafish embryos by looking for the presence of phosphorylated R-Smad 
1/5/8 (P-Smad 1/5/8). At 30hpf P-Smad 1/5/8 was present in the dermis, in the dorsal 
portion of the NT and in the pronephric duct (Fig 4.17C). The use of a BMP reporter 
line (BRE-RFP) (Wu et al., 2011) crossed with fli1:eGFP highlights active BMP 
signalling in the same regions as with immunofluorescence (Fig 4.18).  Neither 
technique indicated that there was any BMP signalling in ECs present in the DA, PCV 
and ISAs. No signal is observed in the caudal plexus whose formation is BMP-
dependent and regulated by phosphorylation of R-Smads (Wiley et al., 2011). Whether 
this is because of a clear lack of P-Smad 1/5/8-dependent signalling in this vascular bed 
or because of inadequate sensitivity of the assay is unclear.  
Snail family proteins are important in gastrulation as they increase cell motility 
by decreasing expression of adhesion molecules such as cadherins (Cano et al., 2000). 
Oddly in Drosophila esg leads to the upregulation of DE-Cadherin that is required to 
form the new junction between the two fusion cells leading to anastomosis (Tanaka-
Matakatsu et al., 1996). In human dermal microvascular ECs ectopic expression of 
Snail family proteins by breast cancer cell-conditioned medium has been shown to 
downregulate VE-cadherin, an effect achieved by direct binding and repression of the 
VE-cadherin promoter region (Lopez et al., 2009). It is thus unclear exactly what effect 
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Snails may have on ECs as VE-cadherin is required for EC movement within a sprout 
(Perryn 2008) but an increase in Snail family members leads to a shift to mesenchymal 
characteristics through downregulation of cadherin (Cano et al., 2000). Snail knockout 
mice are embryonic lethal due to very early gastrulation defects (Carver et al., 2001) but 
epiblast specific deletion of Snai1 leads to embryonic lethality that has been attributed 
to vascular network formation and not endothelial differentiation (Lomelí et al., 2009). 
Snai1a RNA is detectable in the head mesenchyme, brachial arches, in somites and in 
the tail bud of zebrafish embryos (Herbomel et al., 2001).  Snail protein is found in EC 
nuclei in zebrafish ISAs at what seem to be quite high levels (Fig 4.19). It is possible 
that Snail is required to allow ECs to move in the vasculature throughout its 
development. Slug protein could not be detected with the antibodies used. The above 
data provide evidence of BMP signalling in the area of the embryo where the ectopic 
and precocious DLAVs crossovers are observed but P-Smad1/5/8 staining indicates that 
BMPs are not acting on ECs. On the other hand angiogenic events such as the sprouting 
from the caudal plexus that are dependent on BMP signalling are not affected by loss of 
expression of heca (Fig 4.3E). 
In mouse retinas Heca co-localizes with Snail in astrocytic nuclei but this cannot 
be interpreted as direct evidence of Snail induced Heca expression (Fig 4.15D). BMP4 
protein can be observed surrounding the retinal vasculature with the highest level 
present at the sprouting from. BMP4 is also present ahead of the growing plexus but at 
lower levels (Fig 4.20A-B). Evaluation of BMP signalling in the retina for P-Smad 
1/5/8 resulted inconclusive.  
To further investigate the regulation of Heca expression in vitro cellular assays 
were used. The effects of a series of agonists and inhibitors on the expression of Heca 
and Snail family proteins were tested. EBs can be induced to differentiation into EC by 
the addition of VEGF to the growth medium. In line with this differentiation, the 
resulting ECs are able to respond to genetic and pharmacological intervention as in vivo 
ECs would. Known inhibitors were used on sprouting EBs to assess whether they had 
an effect on heca and snails expression. 
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Figure 4.15 Heca is present in ECs and astrocytes within mouse retinal 
vasculature.  
Retinal vasculature at the sprouting front (A) and in the capillary plexus (B). Heca is 
observed in elongated EC nuclei (A’ and B’, outlined in red), with some more diffused 
cytoplasmic staining. Astrocytic nuclei also express Heca (A’-B’, outlined in yellow) 
and can be recognized by their triangular shape (see C, outlined in yellow). D. Snail and 
Heca co-localize in astrocytic nuclei. Scale bars 10 µm 
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Figure 4.16 Heca is present in EC in EB sprouting assay.  
In sprouting embryoid bodies Heca is present in ECs nuclei and at lower levels in the 
cytoplasm in sprouting vessels in EB assays (A”, B”, C”).  
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Figure 4.17 Evidence of BMP signalling zebrafish.  
P-Smad 1/5/8 is observed in the dermis (red arrowheads), the dorsal portion of the 
neural tube (red bracket) and pronephric duct (red dotted outline).  
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Figure 4.18 BRE-RFP reporter line shows similar BMP signalling activity as P-
Smad 1/5/8 immunofluorescence.  
The BRE-RFP line was crossed with fli:eGFP to investigate whether BMP signalling is 
detectable in ECs. RFP expression confirms the results observed with P-Smad 1/5/8 
immunofluorescence, top of neural tube (A, C, red bracket) and dermis (A, C, red 
arrowhead). Strong expression is also observed in the somites (A. C). 
Chapter 4 The Role of heca in Angiogenesis  
 162 
 
 
 
 
Figure 4.19 Snail in zebrafish.  
fli1:eGFP embryos were immunostained for Snail. It is present in the somites as 
previously reported (Herbomel et al., 2001) and in most ECs in both the tail region (A-
A”) and the trunk (B”, some nuclei circled in red). 
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The morphological response to such inhibitors was used to test whether the EBs were 
responding correctly to treatment and thus whether any changes in expression could be 
directly linked to the inhibitor. EBs increased their sprouting following inhibition of 
Notch signalling following the addition of DAPT due to increase in tip cell numbers 
(Fig 4.21B) (Jakobsson et al., 2010). Blocking either endogenous TGF-β or BMP 
signalling with SBI or Noggin (an endogenous BMP inhibitor) (Kang et al., 2009) also 
increased the vessel density but the resulting network is more chaotic and less well 
reorganized (Fig 4.21C-D), which is likely due to defective patterning as vessels were 
composed of CD31 positive cells, meaning EC differentiation was not affected. 
Treatment with TGF-β does not affect initial EC differentiation and sprouting but leads 
to larger calibre and shorter vessels (Fig 4.22F). This treatment also increases the 
number of pericytes, as assayed by NG2 immunostaining, and results in looser 
attachment to the vessels (Fig 4.22B”,D”), confirming TGF-β is important in the 
differentiation of mural cell differentiation shown to rely on Snail (Kokudo et al., 2008). 
Addition of TGF-β four days following plating in collagen, once sprouting has begun, 
leads to similar large calibre vessels. The bEND5 endothelial cell line was used to test 
for changes in gene expression through qPCR analysis. Cells treated with TGF-β 
leading to a massive upregulation of Snai2 (also known as Slug) as would be expected 
(Fig 4.22E). Unfortunately, the use of antibodies in EBs and qPCR in bEND5 to 
determine the effect of such treatments on Heca and Snail family protein was not 
conclusive. 
Short hairpin oligonucleotides for expression using the pSilencer3.1 H1 system 
(Ambion) were designed to knockdown Heca and Snail family proteins to assess their 
effect on sprouting angiogenesis. The use of shRNA is preferred over siRNA in this 
setting due to the long set up time of the EB sprouting assay. EBs require 4 days of 
differentiation in hanging drops and a further 7 days to achieve optimal sprouting. The 
usual lifetime of siRNA is a few days therefore their activity will most likely be lost 
prior to the initiation of sprouting. The shRNA system has been shown to give effective 
gene knockdown, even though efficiency and success rates are low (M. Busse, 
unpublished data). Unfortunately none of the shRNA designed gave the desired 
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knockdown of target genes. This was both at the transient transfection level as well as 
through selection with antibiotic markers. 
 
 
 
 
Figure 4.20 BMP4 is present in close association with ECs in retinal vasculature.  
Immunofluorescence for BMP4 highlights its presence in the vicinity of the retinal 
vasculature, in a pattern that is reminiscent of astrocytes (A’-B’). BMP4 expression is 
highest at the vascular front and is present at low levels ahead of the vasculature (B’). 
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Figure 4.21 EB response to different signalling inhibitors. 
EBs were plated in collagen and medium supplemented with signalling inhibitors was 
added. Sprouting was checked 7 days post plating. B. DAPT treatment resulted in the 
expected increase in tip cells and migration speed. C-D. TGF- and BMP signalling 
blockade with SBI and Noggin respectively leads to a chaotic and poorly structured 
sprouts. The effect is more drastic with SBI as no real sprouts are observed and are 
replaced by CD31+ migrating cells. 
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4.4 Discussion 
In this chapter I have described the role of heca in angiogenesis. Loss and gain of 
function experiments lead to quite distinct effects on angiogenesis, by affecting 
sprouting and lumenization respectively.  Contextualizing these observations can help 
formulate a hypothesis for heca’s activity linking it to how lumen formation could be 
regulating sprouting. 
Following sprouting nascent vessels must connect through anastomosis to be able 
to lumenize and carry blood flow. The only other tubular system where anastomosis 
during development has been studied is the Drosophila trachea. In this system headcase 
is a fusion cell marker, a cellular phenotype required to undergo anastomosis. Because 
this gene had come to our attention through a microarray comparing retinas from 
osteopetrotic mice that exhibit decreased branching/fusion, heca’s role was investigated 
in angiogenesis. 
I tested the effects of heca knockdown on zebrafish ISA sprouting and formation 
of DLAVs through anastomosis. Decrease in heca expression does not lead to defects in 
EC specification, vasculogenesis, sprouting or anastomosis.  The phenotype observed is 
limited to the crossing over of the DLAVs to join together and form a plexus. The 
process normally begins at 48hpf at the tail end of the embryo and progresses towards 
the head, ending at around 7dpf (Fig 4.3) (Isogai, 2001). On its own this result is hard to 
interpret as attempts made at determining the possible regulation of heca, through BMP 
and Snail as in Drosophila, did not yield conclusive results. Evidence for active BMP 
signalling is present in the dorsal portion of the NT but this is not endothelial. More 
importantly Snail is found expressed in ECs. ECs have been shown to move within the 
plexus during vessel morphogenesis (Blum et al., 2008, Jakobsson et al., 2010, 
Zygmunt et al., 2011). Snail family proteins are involved in increased cellular motility 
and epiblast-specific deletion of Snail allows EC differentiation but the embryo dies as 
a result of defective EC migration to form the axial vessel (Lomelí et al., 2009). It is 
also true that Snail can directly repress VE-cadherin expression, which would be 
expected to increase cell motility (Lopez et al., 2009). 
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Expression analysis in zebrafish does not give a clear answer to whether heca is 
expressed in the endothelium but work in the mouse retina model as well a in vitro EB 
sprouting assays confirm that heca is present in ECs (Fig 4.15-16). What I find 
particularly interesting is the phenotype observed in the gain of function experiments. 
Overexpression of heca at the whole organism or EC-autonomous level leads to 
precocious lumen formation in the nascent sprouts (Fig 4.5-6). The only other published 
study where migrating ISAs lumenize to this extent is a recent report on the role of flt1 
as a negative regulator of tip cell formation in zebrafish (Krueger et al., 2011). This 
reinforces what has been proposed by Jakobsson et al, with flt1 acting in a Notch-
dependent manner to decrease angiogenic potential (Jakobsson et al., 2010). 
Surprisingly though the authors of the zebrafish study did not pick up or comment on 
the ISA lumenization. What I personally find even more reassuring about the published 
data is that it confirms the predictions that arise from the original tip/stalk selection 
mechanism that was proposed following the flourish of Dll4/Notch-focused papers in 
2007. The reasoning goes as follows: stalk cells are characterized by lower expression 
of VEGFR2 and higher VEGFR1. This is the basis for the differential response of tip 
and stalk cells upon VEGF stimulation, with tip cells migrating and stalk cells 
proliferating (Gerhardt, 2003). Both in vitro and in vivo work have confirmed that levels 
of these two receptors affect the angiogenic potential of individual ECs in a chimeric 
competition setting (Jakobsson et al., 2010). Krueger et al’s data shows that ectopically 
expressing soluble flt1 places the whole ISA in an environment similar, or even more 
extreme, than normal stalk cells experience. Accordingly the ECs exhibit robust stalk 
cell behaviour and engage in lumen formation (Krueger et al., 2011). The data indicates 
that lumen formation is directly or indirectly dependent on VEGFA signalling. Another 
study stresses the importance of sflt1 at limiting vessel branching, again confirming that 
membrane bound flt1 has little effect on angiogenesis (Zygmunt et al., 2011).  
The situation in heca overexpression is similar with regards to lumen formation 
but the loss of function defects do not match. Flt1 morphants exhibit ectopic branching 
in the dorsal part of the ISAs where as for heca this does not occur, instead the extra 
branching is over the neural tube. One may also expect some defects in lumenization in 
flt1 morphants but none are observed and even the ectopic branches are functional 
(Krueger et al., 2011). Notch is a pathway that does not directly affect lumenization but 
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can affect vessel calibre. Notch controls vessel diameter by preventing ECs from over-
responding to angiogenic stimuli, limiting the number of ECs that migrate away from 
the vessel (Benedito et al., 2008). Oddly enough removing Notch signalling through 
loss of Dll4 upregulates VEGFR2 as expected but also Robo4, a molecule that has been 
proven to increase vessel stability in vivo (Jones et al., 2008). Even though there clearly 
are no ECs migrating away from the ISA, if heca is an effector of Notch signalling it 
could be inducing similar effects as sflt1, increasing the stalk behaviour of ECs, 
promoting lumen formation. However, so far the in vitro work carried out did not reveal 
any link between Notch and heca expression, nor with regards to VEGFA stimulation. 
It is not yet clear whether the cell clumping phenotype precedes or follows 
lumenization. It is likely to occur prior to lumen formation as sprouts with many nuclei 
have yet to lumenize (Fig 4.9). There is a significant increase in the number of nuclei 
found within the sprout and in some cases they are all clustered at the leading edge (Fig 
4.9). It might be expected that such a defect is due to increased proliferation or defective 
migration.  An example of increased cell proliferation is found in rbpsuh morphant 
zebrafish embryos that have decreased Notch target genes expression (Siekmann and 
Lawson, 2007). The ISAs contain increased number of EC nuclei when compared to 
control morphants, corroborating work done in dll4 deficient mouse embryos 
(Hellström et al., 2007, Suchting et al., 2007, Lobov et al., 2007). What is striking 
though is that ECs do not cluster but are more than able to migrate normally (Siekmann 
and Lawson, 2007). These morphant cells have increased angiogenic potential as a 
result of sustained flt4 expression, which is reflected in the ectopic sprouting seen from 
the ISAs (Siekmann and Lawson, 2007) but this is not the case in heca overexpressing 
cells. 
Very little is currently known with regard to heca’s function and activity, and its 
lack of functional domains, conserved folds and homologues makes it difficult to 
speculate on its potential role. The protein contains a cysteine rich region that is 
attributed to protein-protein or protein-RNA interactions. Its localization within the 
nucleus is puzzling as no Nuclear Localizing Sequence (NLS) is found. A plausible 
explanation could be that Heca interacts with another protein able to translocate to the 
nucleus. In the Drosophila trachea it is involved in preventing terminal differentiation 
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(Steneberg et al., 1998) and this could be through interaction with one of the many 
bHLH transcription factors regulating tracheal development. The fact that it acts non-
cell autonomously opens up the possibility that its effect is related to lateral signalling 
such as through Dll/Notch, maybe potentiating the ligand’s signal sending potential.  In 
cancer cells, heca controls cell proliferation (Dowejko et al., 2009). As in Drosophila 
heca is believed to interact with cdks (Stanyon et al., 2004), the mitotic effect could be 
through such a mechanism; this also supports heca interacting with other proteins. 
To attempt to reconcile the heca loss and gain of function results it is important to 
first conceptualize the phenotypes trying to find a common link. Sprouting and lumen 
formation can be almost regarded as opposites, with sprouting requiring migration, 
filopodia extension and the subsequent formation of a new junction, whilst lumen 
opening stabilizes the vasculature, leads to rearrangements and loss of some junctions. 
If the heca knockdown data is interpreted as ectopic sprouting and the overexpression 
work is related to precocious lumenization then we can assume the phenotypes are 
opposites. This can be coupled to the observation in Ch.3 about filopodia activity and 
lumen formation. It has been assumed that because of the Dll4/Notch lateral inhibition 
only tip cells will have filopodia activity.  This point is supported by the absence of 
filopodia on the DLAVs in control embryos, as opposed to the large number of 
filopodia emanating in Dll4 morphants or DAPT treated embryos (Leslie et al., 2007), 
providing support for the notion that engagement of Dll4/Notch during anastomosis and 
not blood flow induces a quiescent vasculature. In light of the observations presented in 
this study, I think it is possible that blood flow is playing a more important role in 
blocking exploratory filopodia. Current work is highlighting the importance of 
haemodynamic forces on the vasculature and how this can cause changes at the cellular 
and molecular level (Nicoli et al., 2010, Bussmann et al., 2011). In Movie4 we observe 
that even though a patent connections is made, filopodia do not cease until the lumen 
opens throughout the DLAV. By this stage the Dll4/Notch pathway should have 
inhibited exploratory behaviour in the ECs that have just anastomosed. On the other 
hand cas knockdown in embryos, which prevents blood flow, does not lead to ectopic 
sprouting by 60hpf. 
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4.5 Future Directions 
Loss and gain of function of heca has lead to some unexpected effects on the 
zebrafish developing vasculature. Because of singularity in sequence and lack of 
conserved stretches, it would be important to carry out some biochemical analyses to 
determine whether heca is phosphorylated, can any binding partners be identified 
through mass spectroscopy? Is heca found associated directly or indirectly with 
chromatin? This will also require the development of new tools as this study was partly 
limited by the availability of tools and the difficulty in generating our own. Of the two 
phenotypes I find the gain of function the most intriguing also due to the two 
phenomenon of EC clustering and precocious lumenization in the ISAs. I believe that 
the two are linked and as mentioned in Ch.3 it would be invaluable to obtain an 
adhesion molecule fusion with a fluorescence protein to track changes in EC junctional 
arrangement. The differences in junctions between control and heca morphants can only 
be attributed to the chaotic arrangement of cells if one bases the conclusion on the static 
images. The low penetrance of the phenotype raises further questions to what heca’s 
role might really be. Does this suggest that there are proteins that can takeover heca’s 
function? Or is heca the molecule that is present as a spare or safety in case the more 
prominent protein fails? If either is true then why do we not observe any fold or 
sequence similarity between heca and other gene products? One approach that may 
yield more fruitful results would be to try and gain more information on the function of 
heca in Drosophila where more about the regulation and role is understood. 
Heca may be involved in either sensing that lumen has formed and therefore alter 
cell behaviour or be required for the induction of lumenization. The latter hypothesis is 
the least likely, as lumenization is not affected in morphants. The former hypothesis 
would fit with the both phenotypes: loss of heca means that ECs do no sense 
lumenization and therefore maintain filopodia activity causing the early DLAV 
crossovers. This would only have effect in that particular vascular bed. Localized 
effects on the vasculature have been previously reported, where certain vessel portion 
can show exquisite sensitivity to partial pathway inhibition (Nicoli et al., 2010). 
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Chapter 5. Macrophages in Angiogenesis 
 
Live imaging experiments have highlighted the presence of macrophages close to 
the growing vasculature, with the 3D EM data in Ch.3 showing a granular cell in close 
contact with two anastomosing tip cells. I therefore decided to investigate such 
interactions through live imaging and the effect of loss of macrophages on angiogenesis 
via different approaches. It is clear that macrophages actively interact with ECs during 
anastomosis and that their loss is not catastrophic for vascular development but leads to 
a subtle phenotype were the growing sprouts are retarded and display decreased 
migratory behaviour. Recently three papers were published describing similar 
observations in mouse (Kubota et al., 2009, Fantin et al., 2010, Rymo et al., 2011).  
 
5.1 Macrophages in retinal vasculature 
Endothelial cells are not the only cell type involved in angiogenesis. ECs form the 
vessel proper but they require accessory cells for the expression of VEGF (such as 
astrocytes in the retina) to induce their sprouting, migration and proliferation, pericytes 
for induction of quiescence and stabilising the newly formed vessel and smooth muscle 
cells for the vessel’s contractility.  A cell type that has gained attention due to its 
involvement in angiogenesis especially in cancer and inflammation is the macrophage. 
Macrophages can influence the various stages of angiogenesis through the secretion of 
bFGF, VEGF, GM-CSF, angiotropin, TNF-α, TGF-α/β, IFNα/γ and Wnt ligands to 
name a few (Sunderkötter et al., 1994). Macrophages can control the environment by 
release of metalloproteases that can alter the extracellular matrix to aid angiogenesis or 
process immobilized growth factors to alter the morphogen gradient (Squadrito and 
Palma, 2011). 
The mouse retinal vasculature develops post-natally and radiates from the optic 
nerve (Fig 1.3). In the post-natal retina a special type of macrophage is present, the 
microglia.  
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Figure 5.1 Microglia interact with tip cells in 
mouse retinal vasculature.  
Macrophage-like microglial cells already pre-pattern 
the retina prior to the outgrowth of the vasculature 
(A). Microglia are stained with isolectinB4 and 
express Iba-1 (A’-A”). These cells interact with tip 
cells in the vasculature (B). C. Close up of 
microglial cell interacting with endothelial tip cells.  
Scale bars represent 20µm. 
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Figure 5.2 Macrophages interact with endothelial cell filopodia in zebrafish 
developing ISAs.  
 A-A”. A macrophage attracts EC filopodia extension and makes contact (white arrow). 
B-B”. Two macrophages closely interact with ECs while they are in the process of 
fusing with their neighbouring ISAs. C-C”. Macrophages can be identified with anti-L-
plastin immunostaining. Some of such macrophages also show eGFP(and this fli1) 
expression (white arrowheads). Other macrophages do not (red arrowhead) meaning 
that there will be many macrophages not visualized using the fli:eGFP line. Scale bars 
represent 10µm in A and B, 20µm in C. 
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The retina is pre-patterned with microglial cells that are evenly spaced ahead of the 
growing vasculature. These cells are identified by their affinity for IsolectinB4 and 
expression of ionized calcium binding adaptor molecule 1 that is a known 
macrophage/microglial marker (Iba-1, Fig 5.1A-B) (Imai et al., 1996, Gerhardt, 2003, 
Rymo et al., 2011), with tip cells closely interacting with microglia. In Fig 3.16 the 
correlative fluorescence/3D EM data indicates that a granular cell is found at the point 
of anastomosis between tip cells of ISAs in developing zebrafish embryos and is in 
physical contact with the fusion point, in some way replicating what is seen in the 
mouse retina (Fig 5.1A-B). The absence of retinal microglial cells leads to decreased 
branching/fusion of the vasculature, with tip cells growing radially with a straight 
trajectory, a decreased exploratory angle of their filopodia and decreased attraction 
towards other tip cells. (Rymo et al., 2011). One possible explanation for this could be 
that retinal microglia facilitate tip cells in finding one another`, by attracting the ECs 
and directing anastomosis and thus the correct patterning of the retina. A recent report 
investigating the role of microglia in the development of the deeper retinal plexus by 
Stefater and colleagues discovered that in this context microglia possibly attract the 
growing sprouts from the superficial layer into the deeper layer of the retina`, but then 
regulate plexus density by inducing turning of the tip cells. This effect is induced by 
Wnt-induced expression of soluble Flt1, believed to dampen VEGF signalling by 
sequestering VEGF-A, translating to a decrease in branching (Stefater et al., 2011). 
Such evidence as well as the characterisation of pro- and anti-angiogenic macrophages 
in tumour microenvironment (Squadrito and Palma, 2011) highlights the importance of 
context in which the role of macrophages is studied. It was briefly mentioned in Ch.3 
that macrophages are observed in the vicinity of growing ISAs. Therefore zebrafish 
embryos were used as a model to investigate the dynamics of possible EC-macrophage 
interactions and the effect of macrophage ablation through Morpholino knockdown on 
angiogenesis. 
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Figure 5.3 Macrophages aid the correct fusion and maturation of failing 
anastomoses.  
28hpf fli:eGFP were imaged by confocal microscopy (spinning disc), focusing on the 
formation of the DLAV. It can occur that two tip cells come into contact, attempt to 
fuse but the connection weakens and begins to thin out (A, white arrowhead). A 
macrophage arrives at the site of contact and wraps around it (B, white arrow), 
remaining till the  connection is salvaged (C-E) and lumen begins to form through the 
connection (F). The red * marks a stationary macrophage that has arborized. Scale bars 
represent 10µm. 
 
Chapter 5 Macrophages in Angiogenesis 
 177 
 
Figure 5.4 Macrophage guides contact of filopodia between two anastomosing tip 
cells.  
28hpf fms:Gal4 embryos were imaged by confocal microscopy.  Two tip cells that are 
coming into contact (A) extend filopodia towards a macrophage that appears at the site 
of contact (B, white arrowhead) and the filopodia can then be guided to connect with 
one another (C, white arrowhead). Scale bars represent 10µm. 
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5.2 Macrophages interact with ECs during DLAV formation 
The fli1:eGFP line not only exhibits eGFP expression in ECs, some can also be 
found in some macrophages (Fig 5.2). The identity of such ameoboid cells is confirmed 
by the presence of L-plastin, a known macrophage marker in zebrafish (Fig 5.2) (de 
Arruda et al., 1990). L-plastin is an actin-binding protein that is conserved throughout 
eukaryote evolution and expressed in the haematopoietic lineage becoming restricted to 
macrophages following myeloid development (de Arruda et al., 1990). Fli1 positive 
macrophages roam throughout the embryonic tissue and migrate along the neural tube 
where the DLAV will later form (Fig 5.2, Movie1). When the migrating ISAs begin to 
bifurcate and come into contact with the neighbouring ISAs macrophages can be 
observed in the vicinity of such events. Macrophages migrate towards the ECs, which in 
turn extend filopodia and make contact with the macrophages (Fig 5.2). These filopodia 
behave as though they are actively attracted to the macrophages, even changing 
direction quite drastically as if in an effort to respond to the macrophage attraction (Fig 
5.5).  
It can occur that the connection between two tip cells on their way to anastomose 
begins to fail (Fig. 5.3, Movie3). A macrophage wraps around the junction of interest 
and remains in contact with ECs until the connection is stabilized and the lumen has 
begun to push through the anastomosis point (Fig 5.3, Movie3), similar to what has 
been recently described by Fantin et al. With regards to contextualizing the role of 
macrophages in angiogenesis, such pro-angiogenic macrophages involved in 
developmental angiogenesis display similar characteristics to pro-angiogenic TEM like 
the expression of tie2 and nrp1 (Fantin et al., 2010). 
 
5.3 Loss of macrophages leads to delay in anastomosis 
PU.1 is an ETS-domain transcription factor required for B-lymphoid cell and 
myeloid differentiation, especially monocytes and macrophages (Klemsz et al., 1990). 
Loss of pu.1 in mice results in loss of tissue macrophages, leading to aberrant 
angiogenesis in the retina and hindbrain (Fantin et al., 2010, Rymo et al., 2011). 
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Figure 5.5 Filopodia actively grow towards macrophages by abrupt changes in 
filopodia direction.  
28hpf fms:Gal4 embryos were imaged by confocal microscopy. A filopodia is observed 
protruding from the point of anastomosis towards the  macrophage (B, red cell). The 
filopodia kinks, growing more directly towards the macrophage (C, red arrowhead). 
Scale bars represent 10µm. 
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Knockdown of pu.1 expression using a Morpholino effectively disrupts macrophage 
specification (Rhodes et al., 2005). This Morpholino was used to ablate macrophages in 
fli1:eGFP embryos to assess their effect on angiogenesis with a particular focus on ISA 
migration and DLAV formation. Loss of macrophages was confirmed by L-plastin 
immunofluorescence (Fig.5.6). The absence of macrophages leads to a highly 
significant increase in the contact times between non-fusing filopodia of ISAs prior to 
forming the DLAV (Fig 5.6E). This increase was not related to any changes in the total 
number of contacts between tip cells prior to anastomosis (Fig 5.6F). The loss of 
macrophages results in a 30% increase in the average final contact to fusion delay but 
this is not statistically significant (Fig 5.6G). The overall vasculature does not exhibit 
developmental defects and the number of filopodia present per ISA is not altered but the 
ISAs are retarded and do not bifurcate as freely as in control morphants (Movie8).  The 
fms:Gal4 line was used to confirm these observations. In this line the presence of an 
mCherry-nitroreductase (nfsB) fusion protein allows the conversion of the prodrug 
metronidazole into the toxic active compound. Addition of 5mM of metronidazole at 
8hpf leads to the effective ablation of most mCherry-nfsB cells in zebrafish embryos 
(Fig 5.7) (Gray et al., 2011). ISAs of metronidazole treated fms:Gal4 embryos display 
similar filopodia abnormalities, with shorter filopodia observed at the growing front 
(Fig 5.7) 
Two L-plastin Morpholinos were designed to knockdown its expression (one 
translation blocking and one splice blocking). Both oligonucleotides resulted in a 
considerable decrease in expression of l-plastin as assayed by qPCR as well as the 
decrease in macrophage-like cells in the fms:Gal4 line (Fig 5.7C) but the splice 
blocking Morpholino exhibited non-specific toxicity. L-plastin morphants display 
similar migratory phenotype defects as the other two macrophage-ablating techniques, 
with decreased length of filopodia (Fig 5.7B).  
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Figure 5.6 Macrophage depletion through loss of pu.1 leads to ISA morphology 
defects and delay in anastomosis.  
PU.1 Morpholino injected embryos exhibit loss of macrophages as assayed by L-plastin 
immunofluorescence (A-B). Macrophage ablation leads to altered ISA morphology (C-
D). This translates into increased contact time between tip cells during anastomosis but 
does not affect the number of contacts (E-F). There is an increase observed in the time 
delay between the final contact and fusion but this is not statistically significant (8 
independent experiments). Scale bars represent 20µm. 
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Figure 5.7 Loss of macrophages through two other strategies leads to similar ISV 
defects. A.  
fms:Gal4; UAS:mCherry-NMT embryos were treated with 5mM metronidazole leads to 
depletion of mCherry expressing cells (A”). This results in  aberrant morphology of the 
ISAs as they migrate. A similar situation is encountered when using l-plastin 
Morpholino to ablate macrophages (B). 
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5.4 Discussion 
 
Macrophages have been implicated in promoting angiogenesis within the tumour 
microenvironment but their role in developmental angiogenesis is still not clear. Here I 
present evidence showing macrophages actively interacting with ECs and involved in 
anastomosis. Experiments on loss of macrophages reveal that they are not essential for 
angiogenesis but may act as facilitators. 
 
5.4.1 Macrophages actively interact with ECs during anastomosis 
Endothelial cells rely on other cell types to induce the correct development of 
the vasculature. Many cell types express VEGFA, pericytes help stabilize the 
vasculature, smooth muscle cells allow contraction and in certain vascular beds 
astrocytes provide support for EC survival. Here I show that macrophages actively 
interact with ECs during angiogenesis. A number of studies have been published while 
this work was being carried out (Kubota et al., 2009, Fantin et al., 2010, Rymo et al., 
2011). In all these studies, microglia (specialized macrophage type cells in the CNS) or 
macrophages are seen in contact with ECs in the developing vasculature but all of the 
data is on fixed tissue. There is one piece of data in zebrafish indicating there are 
interaction between ECs and macrophages (Fantin et al., 2010) but the resolution is far 
from optimal. The images I present here clearly show that filopodia from ECs grow 
towards macrophages and act as if they are actively attracted to these myeloid cells.  
Ablation of macrophages affects angiogenesis in the retina and the hindbrain but these 
defects are not drastic and are not a cause of lethality. The data here suggests similar 
effects of loss of macrophages on the vasculature, with a mild phenotype that recovers 
later in development.  
The attraction of ECs towards macrophages raises the first question as to what 
exactly is attracting filopodia extension. Fantin et al demonstrated in the mouse that 
VEGFA is not required in macrophages to allow normal vascular development (Fantin 
et al., 2010) therefore the obvious candidate can be excluded. A report that was 
published just prior to the printing of this study gives a hint as to what might be 
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occurring. Tammela et al show macrophages express VEGFC, a member of the VEGF 
family.  VEGFC is able to activate VEGFR3 and VEGFR2, likely through heterodimers 
of the receptors.  Not all macrophages express VEGFC, only the ones that are at the 
vascular front, especially the ones present at anastomosing tip cells and branch points 
(Tammela et al., 2011). The authors then go on to show data supporting the fact that 
VEGFC is able to induce Notch target genes through its action on VEGFR3. 
Heterozygosity for vegfc results in a less dense plexus with more tip cells present at the 
sprouting front (Tammela et al., 2011). This data though does not really indicate that 
macrophage derived VEGFC is responsible for tip cell-macrophage attraction. Tip cells 
are still able to find one another but what seems to be altered is the stability of the new 
connections. Loss of macrophage VEGFC results in many empty collagenIV sleeves at 
the front, which are the remnants of ECs that had come into contact but did not 
anastomose properly and thus released, the reason why more tip cells are seen at the 
angiogenic front. Movie3 leads to a similar conclusion regarding macrophages helping 
stabilize connections, where the cell wraps around the failing anastomosis until it is 
salvaged (Fig 5.3). It seems that VEGFC acts through VEGFR3 to induce Notch target 
genes and stabilize Notch signalling to allow anastomosis and junction formation to 
occur. This phenotype is proposed to be similar to what is observed in osteopetrotic 
mice (Rymo et al., 2011) even though there appear to be more tip cells making more 
connection in VEGFC heterozygous retinas. Intriguingly another recent report suggests 
that Dll4 found on tip cells activates macrophages through Notch1 and this is required 
for the correct interaction between the two cell types (Outtz et al., 2011). Another 
interesting point is that VEGFC expressing macrophages are also Tie2-postive. This is a 
molecular signature of pro-angiogenic macrophages and is the receptor required for 
macrophages to respond to tumour-secreted Ang2. The Ang2-Tie2 interaction is 
required for macrophage EC interaction in tumours and subsequent induction of 
angiogenesis (Mazzieri et al., 2011).  Ang2 blockade is currently being tested as an 
antiangiogenic therapy with a number of investigational agents and this could be an 
unexpected but positive addition to the mechanism of action of such agents. It also 
offers a cleaner toxicology profile by eliminating a lot of the serious side effects 
VEGFA/VEGFR2 inhibition can cause. The mild effects on developmental 
angiogenesis are also encouraging in the sense that macrophage ablation (especially 
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pro-angiogenic TAMs) could be a potential therapeutic strategy against tumours. One 
would of course increase the risk of infections. 
 
5.4.2 Future Directions 
I think that understanding what exactly is the factor that attracts ECs to 
macrophages is an important questions that remains to be answered. Also no vegfc has 
been detected in zebrafish macrophages, possibly through a lack of adequate sensitivity. 
A point that has not yet been addressed is what attracts macrophages to sprouting ECs. 
A two way communication system has been hinted at by others (Rymo et al., 2011). In 
the case of the retina this might not be as critical as the microglia pre-pattern the retina 
prior to vascularization but in the zebrafish they clearly purposefully migrate to the sites 
of anastomosis. The factor involved might be the same (if there is one) that draws tip 
cells towards one another. Or it could be solely attracting macrophages that in turn 
attract tip cells. One must also remember that in the lines used in this study we are not 
able to visualize all macrophages therefore understanding more about macrophage cell 
biology may aid in the generation of better macrophage specific reporter lines. 
The fms:Gla4;UAS:mCherry-NMT line used in this study is a great tool to 
address some of these question. It is now possible to design miRNAs that target specific 
sequences to obtain the desired gene knockdown. Such miRNAs can be cloned and used 
to generate transgenic lines expressing them. Combine this with a cell specific driver 
(such as the fms:Gal4) and one can investigate the knockdown of specific genes in 
system organisms like the zebrafish where tissue specific knockouts are still no an easy 
feat.  
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Chapter 6. Conclusion 
Angiogenesis is a complex developmental process that involves many coordinated 
morphological events. The work I have described in this study furthers our 
understanding of angiogenesis, and in particular a qualitative and quantitative 
description of the events leading to angiogenesis. The data also provides evidence for 
the involvement on heca in lumenization and the downregulation of filopodia activity, 
hinting at a flow specific control of sprouting. Macrophages have been shown to play 
part in angiogenesis and here I show dynamic interactions between macrophages and 
ECs as well as a mild angiogenic defect upon macrophage ablation. 
 A lot of work has gone into understanding how sprouting angiogenesis is 
initiated, what factors induce it, how vessels are guided and patterned but little attention 
has been given to how new sprouts go on to form a functional loop through anastomosis 
and subsequent lumen formation.  In Ch.3 I present various observations with regards to 
filopodia activity, anastomosis, cell division and lumen formation. The fact that all ECs 
in the growing sprout exhibit some degree of filopodia activity questions the current 
model of tip cell selection where only the tip cell posses filopodia/migratory phenotype 
(Phng and Gerhardt, 2009). Recent evidence begins to support a notion where ECs can 
possess a spectrum of activation levels and this can result in tip cell change and EC 
shuffling within the sprout (Jakobsson et al., 2010). This links up with the report on the 
presence of more than two EC phenotypes in the growing vasculature, with the addition 
of the quiescent phalanx cell along tip and stalk cells (Mazzone et al., 2009). All these 
data taken together leads to a model where ECs in the sprout might be able to rapidly 
respond in case the present tip cell shows decreased VEGFR2 signalling and thus 
suboptimal migration as suggested by Benedito et al with regards to the role of Jag1 in 
the retinal plexus  (Benedito et al., 2009).  
 The data clearly shows that anastomosis is not a rapid process and tip cells in 
adjacent ISAs usually get into contact multiple times prior to remaining connected and 
fusing. Filopodia play an important role in tip cells find one another and bringing the 
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cell bodies closer for anastomosis. The quantitative analysis indicates that the time 
frame between contact and fusion may involve genetic regulation. 
Lumen formation is shown to occur through a mechanism compatible with 
junctional opening, which indicates a prior determination of apical luminal surface. 
Such a mechanism has been described in the mouse aorta but not in the zebrafish 
(Strilic et al., 2009).  A second mechanism that involves the lumen pushing through 
what appears to be a single cell is described. This may also be related to an EC junction 
opening very much like a zipper. Both these mechanisms and their time scale do not 
agree with previous work on intracellular pinocytic vesicle fusion, leading to a solely 
unicellular and intracellular lumen (Kamei et al., 2006). 
In Ch.4 I investigated the role of heca in zebrafish angiogenesis and in 
anastomosis. Heca is shown to have quite unique effects in gain and loss of function 
experiments, with the former resulting in precocious sprout lumenization whereas 
knockdown leads to ectopic fusion between the DLAVs over the NT. The phenotypes 
may seem unrelated but if this is contexualised with the observations that lumen 
formation appears to be the driver for termination of filopodia activity, then some link 
can be made. It is quite possible that lumen formation can control EC activity, if one 
considers that increasing the supply of oxygen is what drives angiogenesis. Heca does 
not affect filopodia protrusion and lumen but also at the level of the number of ECs 
present in the sprout, suggesting that EC organisation and possibly junctional 
arrangement are affected (even though I do not report any). 
Finally, while this study was on-going a few reports have emerged linking 
macrophages to developmental angiogenesis. Here I demonstrate dynamic and direct 
interaction between macrophages and ECs. The phenotype observed upon macrophage 
ablation is not drastic, meaning that macrophage paly a non-essential role in 
angiogenesis but can be seen as fine tuning the system and facilitating the process.  
Overall this work indicates how the various morphological processes in 
angiogenesis are important for the correct development of the vasculatures. It also 
highlights how all these events may be interlinked, with the initial step of filopodia 
activity being controlled by the final step of lumen formation. 
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